impact of pandemic essay

• Newsletters

Site search

• Israel-Hamas war
• Home Planet
• 2024 election
• Supreme Court
• All explainers
• Future Perfect

Filed under:

Read these 12 moving essays about life during coronavirus

Artists, novelists, critics, and essayists are writing the first draft of history.

Share this story

• Share this on Facebook
• Share this on Twitter
• Share this on Reddit
• Share All sharing options

Share All sharing options for: Read these 12 moving essays about life during coronavirus

The world is grappling with an invisible, deadly enemy, trying to understand how to live with the threat posed by a virus . For some writers, the only way forward is to put pen to paper, trying to conceptualize and document what it feels like to continue living as countries are under lockdown and regular life seems to have ground to a halt.

So as the coronavirus pandemic has stretched around the world, it’s sparked a crop of diary entries and essays that describe how life has changed. Novelists, critics, artists, and journalists have put words to the feelings many are experiencing. The result is a first draft of how we’ll someday remember this time, filled with uncertainty and pain and fear as well as small moments of hope and humanity.

At the New York Review of Books, Ali Bhutto writes that in Karachi, Pakistan, the government-imposed curfew due to the virus is “eerily reminiscent of past military clampdowns”:

Beneath the quiet calm lies a sense that society has been unhinged and that the usual rules no longer apply. Small groups of pedestrians look on from the shadows, like an audience watching a spectacle slowly unfolding. People pause on street corners and in the shade of trees, under the watchful gaze of the paramilitary forces and the police.

His essay concludes with the sobering note that “in the minds of many, Covid-19 is just another life-threatening hazard in a city that stumbles from one crisis to another.”

Writing from Chattanooga, novelist Jamie Quatro documents the mixed ways her neighbors have been responding to the threat, and the frustration of conflicting direction, or no direction at all, from local, state, and federal leaders:

Whiplash, trying to keep up with who’s ordering what. We’re already experiencing enough chaos without this back-and-forth. Why didn’t the federal government issue a nationwide shelter-in-place at the get-go, the way other countries did? What happens when one state’s shelter-in-place ends, while others continue? Do states still under quarantine close their borders? We are still one nation, not fifty individual countries. Right?

Award-winning photojournalist Alessio Mamo, quarantined with his partner Marta in Sicily after she tested positive for the virus, accompanies his photographs in the Guardian of their confinement with a reflection on being confined :

The doctors asked me to take a second test, but again I tested negative. Perhaps I’m immune? The days dragged on in my apartment, in black and white, like my photos. Sometimes we tried to smile, imagining that I was asymptomatic, because I was the virus. Our smiles seemed to bring good news. My mother left hospital, but I won’t be able to see her for weeks. Marta started breathing well again, and so did I. I would have liked to photograph my country in the midst of this emergency, the battles that the doctors wage on the frontline, the hospitals pushed to their limits, Italy on its knees fighting an invisible enemy. That enemy, a day in March, knocked on my door instead.

In the New York Times Magazine, deputy editor Jessica Lustig writes with devastating clarity about her family’s life in Brooklyn while her husband battled the virus, weeks before most people began taking the threat seriously:

At the door of the clinic, we stand looking out at two older women chatting outside the doorway, oblivious. Do I wave them away? Call out that they should get far away, go home, wash their hands, stay inside? Instead we just stand there, awkwardly, until they move on. Only then do we step outside to begin the long three-block walk home. I point out the early magnolia, the forsythia. T says he is cold. The untrimmed hairs on his neck, under his beard, are white. The few people walking past us on the sidewalk don’t know that we are visitors from the future. A vision, a premonition, a walking visitation. This will be them: Either T, in the mask, or — if they’re lucky — me, tending to him.

Essayist Leslie Jamison writes in the New York Review of Books about being shut away alone in her New York City apartment with her 2-year-old daughter since she became sick:

The virus. Its sinewy, intimate name. What does it feel like in my body today? Shivering under blankets. A hot itch behind the eyes. Three sweatshirts in the middle of the day. My daughter trying to pull another blanket over my body with her tiny arms. An ache in the muscles that somehow makes it hard to lie still. This loss of taste has become a kind of sensory quarantine. It’s as if the quarantine keeps inching closer and closer to my insides. First I lost the touch of other bodies; then I lost the air; now I’ve lost the taste of bananas. Nothing about any of these losses is particularly unique. I’ve made a schedule so I won’t go insane with the toddler. Five days ago, I wrote Walk/Adventure! on it, next to a cut-out illustration of a tiger—as if we’d see tigers on our walks. It was good to keep possibility alive.

At Literary Hub, novelist Heidi Pitlor writes about the elastic nature of time during her family’s quarantine in Massachusetts:

During a shutdown, the things that mark our days—commuting to work, sending our kids to school, having a drink with friends—vanish and time takes on a flat, seamless quality. Without some self-imposed structure, it’s easy to feel a little untethered. A friend recently posted on Facebook: “For those who have lost track, today is Blursday the fortyteenth of Maprilay.” ... Giving shape to time is especially important now, when the future is so shapeless. We do not know whether the virus will continue to rage for weeks or months or, lord help us, on and off for years. We do not know when we will feel safe again. And so many of us, minus those who are gifted at compartmentalization or denial, remain largely captive to fear. We may stay this way if we do not create at least the illusion of movement in our lives, our long days spent with ourselves or partners or families.

Novelist Lauren Groff writes at the New York Review of Books about trying to escape the prison of her fears while sequestered at home in Gainesville, Florida:

Some people have imaginations sparked only by what they can see; I blame this blinkered empiricism for the parks overwhelmed with people, the bars, until a few nights ago, thickly thronged. My imagination is the opposite. I fear everything invisible to me. From the enclosure of my house, I am afraid of the suffering that isn’t present before me, the people running out of money and food or drowning in the fluid in their lungs, the deaths of health-care workers now growing ill while performing their duties. I fear the federal government, which the right wing has so—intentionally—weakened that not only is it insufficient to help its people, it is actively standing in help’s way. I fear we won’t sufficiently punish the right. I fear leaving the house and spreading the disease. I fear what this time of fear is doing to my children, their imaginations, and their souls.

At ArtForum , Berlin-based critic and writer Kristian Vistrup Madsen reflects on martinis, melancholia, and Finnish artist Jaakko Pallasvuo’s 2018 graphic novel Retreat , in which three young people exile themselves in the woods:

In melancholia, the shape of what is ending, and its temporality, is sprawling and incomprehensible. The ambivalence makes it hard to bear. The world of Retreat is rendered in lush pink and purple watercolors, which dissolve into wild and messy abstractions. In apocalypse, the divisions established in genesis bleed back out. My own Corona-retreat is similarly soft, color-field like, each day a blurred succession of quarantinis, YouTube–yoga, and televized press conferences. As restrictions mount, so does abstraction. For now, I’m still rooting for love to save the world.

At the Paris Review , Matt Levin writes about reading Virginia Woolf’s novel The Waves during quarantine:

A retreat, a quarantine, a sickness—they simultaneously distort and clarify, curtail and expand. It is an ideal state in which to read literature with a reputation for difficulty and inaccessibility, those hermetic books shorn of the handholds of conventional plot or characterization or description. A novel like Virginia Woolf’s The Waves is perfect for the state of interiority induced by quarantine—a story of three men and three women, meeting after the death of a mutual friend, told entirely in the overlapping internal monologues of the six, interspersed only with sections of pure, achingly beautiful descriptions of the natural world, a day’s procession and recession of light and waves. The novel is, in my mind’s eye, a perfectly spherical object. It is translucent and shimmering and infinitely fragile, prone to shatter at the slightest disturbance. It is not a book that can be read in snatches on the subway—it demands total absorption. Though it revels in a stark emotional nakedness, the book remains aloof, remote in its own deep self-absorption.

In an essay for the Financial Times, novelist Arundhati Roy writes with anger about Indian Prime Minister Narendra Modi’s anemic response to the threat, but also offers a glimmer of hope for the future:

Historically, pandemics have forced humans to break with the past and imagine their world anew. This one is no different. It is a portal, a gateway between one world and the next. We can choose to walk through it, dragging the carcasses of our prejudice and hatred, our avarice, our data banks and dead ideas, our dead rivers and smoky skies behind us. Or we can walk through lightly, with little luggage, ready to imagine another world. And ready to fight for it.

From Boston, Nora Caplan-Bricker writes in The Point about the strange contraction of space under quarantine, in which a friend in Beirut is as close as the one around the corner in the same city:

It’s a nice illusion—nice to feel like we’re in it together, even if my real world has shrunk to one person, my husband, who sits with his laptop in the other room. It’s nice in the same way as reading those essays that reframe social distancing as solidarity. “We must begin to see the negative space as clearly as the positive, to know what we don’t do is also brilliant and full of love,” the poet Anne Boyer wrote on March 10th, the day that Massachusetts declared a state of emergency. If you squint, you could almost make sense of this quarantine as an effort to flatten, along with the curve, the distinctions we make between our bonds with others. Right now, I care for my neighbor in the same way I demonstrate love for my mother: in all instances, I stay away. And in moments this month, I have loved strangers with an intensity that is new to me. On March 14th, the Saturday night after the end of life as we knew it, I went out with my dog and found the street silent: no lines for restaurants, no children on bicycles, no couples strolling with little cups of ice cream. It had taken the combined will of thousands of people to deliver such a sudden and complete emptiness. I felt so grateful, and so bereft.

And on his own website, musician and artist David Byrne writes about rediscovering the value of working for collective good , saying that “what is happening now is an opportunity to learn how to change our behavior”:

In emergencies, citizens can suddenly cooperate and collaborate. Change can happen. We’re going to need to work together as the effects of climate change ramp up. In order for capitalism to survive in any form, we will have to be a little more socialist. Here is an opportunity for us to see things differently — to see that we really are all connected — and adjust our behavior accordingly. Are we willing to do this? Is this moment an opportunity to see how truly interdependent we all are? To live in a world that is different and better than the one we live in now? We might be too far down the road to test every asymptomatic person, but a change in our mindsets, in how we view our neighbors, could lay the groundwork for the collective action we’ll need to deal with other global crises. The time to see how connected we all are is now.

The portrait these writers paint of a world under quarantine is multifaceted. Our worlds have contracted to the confines of our homes, and yet in some ways we’re more connected than ever to one another. We feel fear and boredom, anger and gratitude, frustration and strange peace. Uncertainty drives us to find metaphors and images that will let us wrap our minds around what is happening.

Yet there’s no single “what” that is happening. Everyone is contending with the pandemic and its effects from different places and in different ways. Reading others’ experiences — even the most frightening ones — can help alleviate the loneliness and dread, a little, and remind us that what we’re going through is both unique and shared by all.

Will you support Vox today?

We believe that everyone deserves to understand the world that they live in. That kind of knowledge helps create better citizens, neighbors, friends, parents, and stewards of this planet. Producing deeply researched, explanatory journalism takes resources. You can support this mission by making a financial gift to Vox today. Will you join us?

We accept credit card, Apple Pay, and Google Pay. You can also contribute via

Next Up In Culture

Sign up for the newsletter today, explained.

Understand the world with a daily explainer plus the most compelling stories of the day.

Thanks for signing up!

Check your inbox for a welcome email.

Oops. Something went wrong. Please enter a valid email and try again.

Biden promised to defeat authoritarianism. Reality got in the way.

Why are whole-body deodorants suddenly everywhere?

The known unknowns about Ozempic, explained

Is it ever okay to film strangers in public?

“I lost trust”: Why the OpenAI team in charge of safeguarding humanity imploded

ChatGPT can talk, but OpenAI employees sure can’t

How to Write About Coronavirus in a College Essay

Students can share how they navigated life during the coronavirus pandemic in a full-length essay or an optional supplement.

Writing About COVID-19 in College Essays

Getty Images

Experts say students should be honest and not limit themselves to merely their experiences with the pandemic.

The global impact of COVID-19, the disease caused by the novel coronavirus, means colleges and prospective students alike are in for an admissions cycle like no other. Both face unprecedented challenges and questions as they grapple with their respective futures amid the ongoing fallout of the pandemic.

Colleges must examine applicants without the aid of standardized test scores for many – a factor that prompted many schools to go test-optional for now . Even grades, a significant component of a college application, may be hard to interpret with some high schools adopting pass-fail classes last spring due to the pandemic. Major college admissions factors are suddenly skewed.

"I can't help but think other (admissions) factors are going to matter more," says Ethan Sawyer, founder of the College Essay Guy, a website that offers free and paid essay-writing resources.

College essays and letters of recommendation , Sawyer says, are likely to carry more weight than ever in this admissions cycle. And many essays will likely focus on how the pandemic shaped students' lives throughout an often tumultuous 2020.

But before writing a college essay focused on the coronavirus, students should explore whether it's the best topic for them.

Writing About COVID-19 for a College Application

Much of daily life has been colored by the coronavirus. Virtual learning is the norm at many colleges and high schools, many extracurriculars have vanished and social lives have stalled for students complying with measures to stop the spread of COVID-19.

"For some young people, the pandemic took away what they envisioned as their senior year," says Robert Alexander, dean of admissions, financial aid and enrollment management at the University of Rochester in New York. "Maybe that's a spot on a varsity athletic team or the lead role in the fall play. And it's OK for them to mourn what should have been and what they feel like they lost, but more important is how are they making the most of the opportunities they do have?"

That question, Alexander says, is what colleges want answered if students choose to address COVID-19 in their college essay.

But the question of whether a student should write about the coronavirus is tricky. The answer depends largely on the student.

"In general, I don't think students should write about COVID-19 in their main personal statement for their application," Robin Miller, master college admissions counselor at IvyWise, a college counseling company, wrote in an email.

"Certainly, there may be exceptions to this based on a student's individual experience, but since the personal essay is the main place in the application where the student can really allow their voice to be heard and share insight into who they are as an individual, there are likely many other topics they can choose to write about that are more distinctive and unique than COVID-19," Miller says.

Opinions among admissions experts vary on whether to write about the likely popular topic of the pandemic.

"If your essay communicates something positive, unique, and compelling about you in an interesting and eloquent way, go for it," Carolyn Pippen, principal college admissions counselor at IvyWise, wrote in an email. She adds that students shouldn't be dissuaded from writing about a topic merely because it's common, noting that "topics are bound to repeat, no matter how hard we try to avoid it."

Above all, she urges honesty.

"If your experience within the context of the pandemic has been truly unique, then write about that experience, and the standing out will take care of itself," Pippen says. "If your experience has been generally the same as most other students in your context, then trying to find a unique angle can easily cross the line into exploiting a tragedy, or at least appearing as though you have."

But focusing entirely on the pandemic can limit a student to a single story and narrow who they are in an application, Sawyer says. "There are so many wonderful possibilities for what you can say about yourself outside of your experience within the pandemic."

He notes that passions, strengths, career interests and personal identity are among the multitude of essay topic options available to applicants and encourages them to probe their values to help determine the topic that matters most to them – and write about it.

That doesn't mean the pandemic experience has to be ignored if applicants feel the need to write about it.

Writing About Coronavirus in Main and Supplemental Essays

Students can choose to write a full-length college essay on the coronavirus or summarize their experience in a shorter form.

To help students explain how the pandemic affected them, The Common App has added an optional section to address this topic. Applicants have 250 words to describe their pandemic experience and the personal and academic impact of COVID-19.

"That's not a trick question, and there's no right or wrong answer," Alexander says. Colleges want to know, he adds, how students navigated the pandemic, how they prioritized their time, what responsibilities they took on and what they learned along the way.

If students can distill all of the above information into 250 words, there's likely no need to write about it in a full-length college essay, experts say. And applicants whose lives were not heavily altered by the pandemic may even choose to skip the optional COVID-19 question.

"This space is best used to discuss hardship and/or significant challenges that the student and/or the student's family experienced as a result of COVID-19 and how they have responded to those difficulties," Miller notes. Using the section to acknowledge a lack of impact, she adds, "could be perceived as trite and lacking insight, despite the good intentions of the applicant."

To guard against this lack of awareness, Sawyer encourages students to tap someone they trust to review their writing , whether it's the 250-word Common App response or the full-length essay.

Experts tend to agree that the short-form approach to this as an essay topic works better, but there are exceptions. And if a student does have a coronavirus story that he or she feels must be told, Alexander encourages the writer to be authentic in the essay.

"My advice for an essay about COVID-19 is the same as my advice about an essay for any topic – and that is, don't write what you think we want to read or hear," Alexander says. "Write what really changed you and that story that now is yours and yours alone to tell."

Sawyer urges students to ask themselves, "What's the sentence that only I can write?" He also encourages students to remember that the pandemic is only a chapter of their lives and not the whole book.

Miller, who cautions against writing a full-length essay on the coronavirus, says that if students choose to do so they should have a conversation with their high school counselor about whether that's the right move. And if students choose to proceed with COVID-19 as a topic, she says they need to be clear, detailed and insightful about what they learned and how they adapted along the way.

"Approaching the essay in this manner will provide important balance while demonstrating personal growth and vulnerability," Miller says.

Pippen encourages students to remember that they are in an unprecedented time for college admissions.

"It is important to keep in mind with all of these (admission) factors that no colleges have ever had to consider them this way in the selection process, if at all," Pippen says. "They have had very little time to calibrate their evaluations of different application components within their offices, let alone across institutions. This means that colleges will all be handling the admissions process a little bit differently, and their approaches may even evolve over the course of the admissions cycle."

Searching for a college? Get our complete rankings of Best Colleges.

10 Ways to Discover College Essay Ideas

Tags: students , colleges , college admissions , college applications , college search , Coronavirus

2024 Best Colleges

Search for your perfect fit with the U.S. News rankings of colleges and universities.

College Admissions: Get a Step Ahead!

Sign up to receive the latest updates from U.S. News & World Report and our trusted partners and sponsors. By clicking submit, you are agreeing to our Terms and Conditions & Privacy Policy .

Ask an Alum: Making the Most Out of College

You May Also Like

10 destination west coast college towns.

Cole Claybourn May 16, 2024

Scholarships for Lesser-Known Sports

Sarah Wood May 15, 2024

Should Students Submit Test Scores?

Sarah Wood May 13, 2024

Poll: Antisemitism a Problem on Campus

Lauren Camera May 13, 2024

Federal vs. Private Parent Student Loans

Erika Giovanetti May 9, 2024

14 Colleges With Great Food Options

Sarah Wood May 8, 2024

Colleges With Religious Affiliations

Anayat Durrani May 8, 2024

Protests Threaten Campus Graduations

Aneeta Mathur-Ashton May 6, 2024

Protesting on Campus: What to Know

Sarah Wood May 6, 2024

Lawmakers Ramp Up Response to Unrest

Aneeta Mathur-Ashton May 3, 2024

Writing about COVID-19 in a college admission essay

by: Venkates Swaminathan | Updated: September 14, 2020

Print article

For students applying to college using the CommonApp, there are several different places where students and counselors can address the pandemic’s impact. The different sections have differing goals. You must understand how to use each section for its appropriate use.

The CommonApp COVID-19 question

First, the CommonApp this year has an additional question specifically about COVID-19 :

Community disruptions such as COVID-19 and natural disasters can have deep and long-lasting impacts. If you need it, this space is yours to describe those impacts. Colleges care about the effects on your health and well-being, safety, family circumstances, future plans, and education, including access to reliable technology and quiet study spaces. Please use this space to describe how these events have impacted you.

This question seeks to understand the adversity that students may have had to face due to the pandemic, the move to online education, or the shelter-in-place rules. You don’t have to answer this question if the impact on you wasn’t particularly severe. Some examples of things students should discuss include:

• The student or a family member had COVID-19 or suffered other illnesses due to confinement during the pandemic.
• The candidate had to deal with personal or family issues, such as abusive living situations or other safety concerns
• The student suffered from a lack of internet access and other online learning challenges.
• Students who dealt with problems registering for or taking standardized tests and AP exams.

Jeff Schiffman of the Tulane University admissions office has a blog about this section. He recommends students ask themselves several questions as they go about answering this section:

• Are my experiences different from others’?
• Are there noticeable changes on my transcript?
• Am I aware of my privilege?
• Am I specific? Am I explaining rather than complaining?
• Is this information being included elsewhere on my application?

If you do answer this section, be brief and to-the-point.

Counselor recommendations and school profiles

Second, counselors will, in their counselor forms and school profiles on the CommonApp, address how the school handled the pandemic and how it might have affected students, specifically as it relates to:

• Grading scales and policies
• Graduation requirements
• Instructional methods
• Schedules and course offerings
• Testing requirements
• Your academic calendar
• Other extenuating circumstances

Students don’t have to mention these matters in their application unless something unusual happened.

Writing about COVID-19 in your main essay

Write about your experiences during the pandemic in your main college essay if your experience is personal, relevant, and the most important thing to discuss in your college admission essay. That you had to stay home and study online isn’t sufficient, as millions of other students faced the same situation. But sometimes, it can be appropriate and helpful to write about something related to the pandemic in your essay. For example:

• One student developed a website for a local comic book store. The store might not have survived without the ability for people to order comic books online. The student had a long-standing relationship with the store, and it was an institution that created a community for students who otherwise felt left out.
• One student started a YouTube channel to help other students with academic subjects he was very familiar with and began tutoring others.
• Some students used their extra time that was the result of the stay-at-home orders to take online courses pursuing topics they are genuinely interested in or developing new interests, like a foreign language or music.

Experiences like this can be good topics for the CommonApp essay as long as they reflect something genuinely important about the student. For many students whose lives have been shaped by this pandemic, it can be a critical part of their college application.

Want more? Read 6 ways to improve a college essay , What the &%$! should I write about in my college essay , and Just how important is a college admissions essay? .

Homes Nearby

Homes for rent and sale near schools

How our schools are (and aren't) addressing race

The truth about homework in America

What should I write my college essay about?

What the #%@!& should I write about in my college essay?

Yes! Sign me up for updates relevant to my child's grade.

Please enter a valid email address

Thank you for signing up!

Server Issue: Please try again later. Sorry for the inconvenience

The pandemic has had devastating impacts on learning. What will it take to help students catch up?

Subscribe to the brown center on education policy newsletter, megan kuhfeld , megan kuhfeld senior research scientist - nwea @megankuhfeld jim soland , jim soland assistant professor, school of education and human development - university of virginia, affiliated research fellow - nwea @jsoland karyn lewis , and karyn lewis director, center for school and student progress - nwea @karynlew emily morton emily morton research scientist - nwea @emily_r_morton.

March 3, 2022

As we reach the two-year mark of the initial wave of pandemic-induced school shutdowns, academic normalcy remains out of reach for many students, educators, and parents. In addition to surging COVID-19 cases at the end of 2021, schools have faced severe staff shortages , high rates of absenteeism and quarantines , and rolling school closures . Furthermore, students and educators continue to struggle with mental health challenges , higher rates of violence and misbehavior , and concerns about lost instructional time .

As we outline in our new research study released in January, the cumulative impact of the COVID-19 pandemic on students’ academic achievement has been large. We tracked changes in math and reading test scores across the first two years of the pandemic using data from 5.4 million U.S. students in grades 3-8. We focused on test scores from immediately before the pandemic (fall 2019), following the initial onset (fall 2020), and more than one year into pandemic disruptions (fall 2021).

Average fall 2021 math test scores in grades 3-8 were 0.20-0.27 standard deviations (SDs) lower relative to same-grade peers in fall 2019, while reading test scores were 0.09-0.18 SDs lower. This is a sizable drop. For context, the math drops are significantly larger than estimated impacts from other large-scale school disruptions, such as after Hurricane Katrina—math scores dropped 0.17 SDs in one year for New Orleans evacuees .

Even more concerning, test-score gaps between students in low-poverty and high-poverty elementary schools grew by approximately 20% in math (corresponding to 0.20 SDs) and 15% in reading (0.13 SDs), primarily during the 2020-21 school year. Further, achievement tended to drop more between fall 2020 and 2021 than between fall 2019 and 2020 (both overall and differentially by school poverty), indicating that disruptions to learning have continued to negatively impact students well past the initial hits following the spring 2020 school closures.

These numbers are alarming and potentially demoralizing, especially given the heroic efforts of students to learn and educators to teach in incredibly trying times. From our perspective, these test-score drops in no way indicate that these students represent a “ lost generation ” or that we should give up hope. Most of us have never lived through a pandemic, and there is so much we don’t know about students’ capacity for resiliency in these circumstances and what a timeline for recovery will look like. Nor are we suggesting that teachers are somehow at fault given the achievement drops that occurred between 2020 and 2021; rather, educators had difficult jobs before the pandemic, and now are contending with huge new challenges, many outside their control.

Clearly, however, there’s work to do. School districts and states are currently making important decisions about which interventions and strategies to implement to mitigate the learning declines during the last two years. Elementary and Secondary School Emergency Relief (ESSER) investments from the American Rescue Plan provided nearly $200 billion to public schools to spend on COVID-19-related needs. Of that sum, $22 billion is dedicated specifically to addressing learning loss using “evidence-based interventions” focused on the “ disproportionate impact of COVID-19 on underrepresented student subgroups. ” Reviews of district and state spending plans (see Future Ed , EduRecoveryHub , and RAND’s American School District Panel for more details) indicate that districts are spending their ESSER dollars designated for academic recovery on a wide variety of strategies, with summer learning, tutoring, after-school programs, and extended school-day and school-year initiatives rising to the top.

Comparing the negative impacts from learning disruptions to the positive impacts from interventions

To help contextualize the magnitude of the impacts of COVID-19, we situate test-score drops during the pandemic relative to the test-score gains associated with common interventions being employed by districts as part of pandemic recovery efforts. If we assume that such interventions will continue to be as successful in a COVID-19 school environment, can we expect that these strategies will be effective enough to help students catch up? To answer this question, we draw from recent reviews of research on high-dosage tutoring , summer learning programs , reductions in class size , and extending the school day (specifically for literacy instruction) . We report effect sizes for each intervention specific to a grade span and subject wherever possible (e.g., tutoring has been found to have larger effects in elementary math than in reading).

Figure 1 shows the standardized drops in math test scores between students testing in fall 2019 and fall 2021 (separately by elementary and middle school grades) relative to the average effect size of various educational interventions. The average effect size for math tutoring matches or exceeds the average COVID-19 score drop in math. Research on tutoring indicates that it often works best in younger grades, and when provided by a teacher rather than, say, a parent. Further, some of the tutoring programs that produce the biggest effects can be quite intensive (and likely expensive), including having full-time tutors supporting all students (not just those needing remediation) in one-on-one settings during the school day. Meanwhile, the average effect of reducing class size is negative but not significant, with high variability in the impact across different studies. Summer programs in math have been found to be effective (average effect size of .10 SDs), though these programs in isolation likely would not eliminate the COVID-19 test-score drops.

Figure 1: Math COVID-19 test-score drops compared to the effect sizes of various educational interventions

Source: COVID-19 score drops are pulled from Kuhfeld et al. (2022) Table 5; reduction-in-class-size results are from pg. 10 of Figles et al. (2018) Table 2; summer program results are pulled from Lynch et al (2021) Table 2; and tutoring estimates are pulled from Nictow et al (2020) Table 3B. Ninety-five percent confidence intervals are shown with vertical lines on each bar.

Notes: Kuhfeld et al. and Nictow et al. reported effect sizes separately by grade span; Figles et al. and Lynch et al. report an overall effect size across elementary and middle grades. We were unable to find a rigorous study that reported effect sizes for extending the school day/year on math performance. Nictow et al. and Kraft & Falken (2021) also note large variations in tutoring effects depending on the type of tutor, with larger effects for teacher and paraprofessional tutoring programs than for nonprofessional and parent tutoring. Class-size reductions included in the Figles meta-analysis ranged from a minimum of one to minimum of eight students per class.

Figure 2 displays a similar comparison using effect sizes from reading interventions. The average effect of tutoring programs on reading achievement is larger than the effects found for the other interventions, though summer reading programs and class size reduction both produced average effect sizes in the ballpark of the COVID-19 reading score drops.

Figure 2: Reading COVID-19 test-score drops compared to the effect sizes of various educational interventions

Source: COVID-19 score drops are pulled from Kuhfeld et al. (2022) Table 5; extended-school-day results are from Figlio et al. (2018) Table 2; reduction-in-class-size results are from pg. 10 of Figles et al. (2018) ; summer program results are pulled from Kim & Quinn (2013) Table 3; and tutoring estimates are pulled from Nictow et al (2020) Table 3B. Ninety-five percent confidence intervals are shown with vertical lines on each bar.

Notes: While Kuhfeld et al. and Nictow et al. reported effect sizes separately by grade span, Figlio et al. and Kim & Quinn report an overall effect size across elementary and middle grades. Class-size reductions included in the Figles meta-analysis ranged from a minimum of one to minimum of eight students per class.

There are some limitations of drawing on research conducted prior to the pandemic to understand our ability to address the COVID-19 test-score drops. First, these studies were conducted under conditions that are very different from what schools currently face, and it is an open question whether the effectiveness of these interventions during the pandemic will be as consistent as they were before the pandemic. Second, we have little evidence and guidance about the efficacy of these interventions at the unprecedented scale that they are now being considered. For example, many school districts are expanding summer learning programs, but school districts have struggled to find staff interested in teaching summer school to meet the increased demand. Finally, given the widening test-score gaps between low- and high-poverty schools, it’s uncertain whether these interventions can actually combat the range of new challenges educators are facing in order to narrow these gaps. That is, students could catch up overall, yet the pandemic might still have lasting, negative effects on educational equality in this country.

Given that the current initiatives are unlikely to be implemented consistently across (and sometimes within) districts, timely feedback on the effects of initiatives and any needed adjustments will be crucial to districts’ success. The Road to COVID Recovery project and the National Student Support Accelerator are two such large-scale evaluation studies that aim to produce this type of evidence while providing resources for districts to track and evaluate their own programming. Additionally, a growing number of resources have been produced with recommendations on how to best implement recovery programs, including scaling up tutoring , summer learning programs , and expanded learning time .

Ultimately, there is much work to be done, and the challenges for students, educators, and parents are considerable. But this may be a moment when decades of educational reform, intervention, and research pay off. Relying on what we have learned could show the way forward.

Related Content

Megan Kuhfeld, Jim Soland, Beth Tarasawa, Angela Johnson, Erik Ruzek, Karyn Lewis

December 3, 2020

Lindsay Dworkin, Karyn Lewis

October 13, 2021

Education Policy K-12 Education

Governance Studies

Brown Center on Education Policy

Annelies Goger, Katherine Caves, Hollis Salway

May 16, 2024

Sofoklis Goulas, Isabelle Pula

Melissa Kay Diliberti, Elizabeth D. Steiner, Ashley Woo

The Impact of COVID-19 Pandemic

The year 2019 will forever be engraved in many people’s hearts and minds as the time when a deadly virus known as the coronavirus disease 2019 (COVID-19) invaded almost all the sectors, thereby disrupting daily activities. It is described as a communicable respiratory illness which is triggered by a new strain of coronavirus which leads to various ailments in human beings. There is currently no known cure or vaccine for the virus as scientists worldwide are still trying to learn about the illness to respond appropriately through research (Goodell, 2020). This paper aims at exploring the effects that the pandemic has had on society regarding the economy, social life, education, religion, and family.

The emergence of the pandemic, which began in China-2019, quickly spread to other nations across the world with devastating effects on their economies As a way of containing the disease, many countries instituted strict measures, such as curfews, the mandatory wearing of masks, and social distancing of 1 meter apart (Goodell, 2020). Covid-19 has significantly changed the way these preventive methods relate with each concerning trade matters. The majority of the states affected opted to close their borders as fear among the citizens increased. The implementation of the strict rules interfered with the business operations of many nations. It became difficult for international trade to continue as a result of the closed borders. Most businesses have also had to close due to financial constraints.

When it comes to socialization, people have been forced to use other means to meet their friends and families across the world. Social media platforms have seen an increased usage during this difficult time as people try to find new ways of socializing. It has happened especially in such countries as Australia, where the restrictions were extreme as it enforced a lockdown for close to a hundred days (Goodell, 2020). The use of masks is also quickly becoming the new norm across numerous states. Unlike in developed countries where the governments have offered their citizens some aid mostly in terms of cash transfers, developing countries have struggled to balance between the people’s livelihood and the containment of the Covid-19. As such, most people have turned to social media platforms as a medium of communication and socialization due to lockdowns.

Learning institutions have also not been spared by the Covid-19 pandemic. Most countries affected by the spread of the virus were forced to suspend their educational curriculum calendar to allow children and university students to stay home until the time when the disease is finally neutralized (Goodell, 2020). However, students and parents have been pushing the governments to resume schools with clear protocols which ensure that both the students and the teachers follow the rules, including the mandatory wearing of masks. Religion has also been significantly affected as it has become difficult for people to seek for spiritual nourishment (Goodell, 2020). Many religious leaders have had to devise other ways of reaching out to the congregates. For example, many churches now have to move their services online by using such platforms as YouTube, Facebook, Zoom, among others to convey essential teachings.

Covid-19 has also directly affected many families across the world, as the majority have succumbed to the disease. The United States of America and Italy are some of the pandemic’s worst casualties, where many people were killed by the lethal virus (Goodell, 2020). Some people have in the end lost more than one member of the family because of the disease, and in some worse case scenarios, the illness has claimed a whole family.

In conclusion, this paper has highlighted the impacts of the Covid-19 pandemic on the economy, social life, education, religion, and family units. Many countries and businesses had underestimated the disease’s impact before they later suffered from the consequences. Therefore, international bodies, such as the World Health Organization, need to help developing countries establish critical management healthcare systems, which can help to deal with the future pandemics.

Goodell, J. W. (2020). COVID-19 and finance: Agendas for future research. Finance Research Letters , 35 , 101512. Web.

Cite this paper

• Chicago (N-B)
• Chicago (A-D)

StudyCorgi. (2022, March 19). The Impact of COVID-19 Pandemic. https://studycorgi.com/the-impact-of-covid-19-pandemic/

"The Impact of COVID-19 Pandemic." StudyCorgi , 19 Mar. 2022, studycorgi.com/the-impact-of-covid-19-pandemic/.

StudyCorgi . (2022) 'The Impact of COVID-19 Pandemic'. 19 March.

1. StudyCorgi . "The Impact of COVID-19 Pandemic." March 19, 2022. https://studycorgi.com/the-impact-of-covid-19-pandemic/.

Bibliography

StudyCorgi . "The Impact of COVID-19 Pandemic." March 19, 2022. https://studycorgi.com/the-impact-of-covid-19-pandemic/.

StudyCorgi . 2022. "The Impact of COVID-19 Pandemic." March 19, 2022. https://studycorgi.com/the-impact-of-covid-19-pandemic/.

This paper, “The Impact of COVID-19 Pandemic”, was written and voluntary submitted to our free essay database by a straight-A student. Please ensure you properly reference the paper if you're using it to write your assignment.

Before publication, the StudyCorgi editorial team proofread and checked the paper to make sure it meets the highest standards in terms of grammar, punctuation, style, fact accuracy, copyright issues, and inclusive language. Last updated: March 19, 2022 .

If you are the author of this paper and no longer wish to have it published on StudyCorgi, request the removal . Please use the “ Donate your paper ” form to submit an essay.

• COVID-19 and your mental health

Worries and anxiety about COVID-19 can be overwhelming. Learn ways to cope as COVID-19 spreads.

At the start of the COVID-19 pandemic, life for many people changed very quickly. Worry and concern were natural partners of all that change — getting used to new routines, loneliness and financial pressure, among other issues. Information overload, rumor and misinformation didn't help.

Worldwide surveys done in 2020 and 2021 found higher than typical levels of stress, insomnia, anxiety and depression. By 2022, levels had lowered but were still higher than before 2020.

Though feelings of distress about COVID-19 may come and go, they are still an issue for many people. You aren't alone if you feel distress due to COVID-19. And you're not alone if you've coped with the stress in less than healthy ways, such as substance use.

But healthier self-care choices can help you cope with COVID-19 or any other challenge you may face.

And knowing when to get help can be the most essential self-care action of all.

Recognize what's typical and what's not

Stress and worry are common during a crisis. But something like the COVID-19 pandemic can push people beyond their ability to cope.

In surveys, the most common symptoms reported were trouble sleeping and feeling anxiety or nervous. The number of people noting those symptoms went up and down in surveys given over time. Depression and loneliness were less common than nervousness or sleep problems, but more consistent across surveys given over time. Among adults, use of drugs, alcohol and other intoxicating substances has increased over time as well.

The first step is to notice how often you feel helpless, sad, angry, irritable, hopeless, anxious or afraid. Some people may feel numb.

Keep track of how often you have trouble focusing on daily tasks or doing routine chores. Are there things that you used to enjoy doing that you stopped doing because of how you feel? Note any big changes in appetite, any substance use, body aches and pains, and problems with sleep.

These feelings may come and go over time. But if these feelings don't go away or make it hard to do your daily tasks, it's time to ask for help.

Get help when you need it

If you're feeling suicidal or thinking of hurting yourself, seek help.

• Contact your healthcare professional or a mental health professional.
• Contact a suicide hotline. In the U.S., call or text 988 to reach the 988 Suicide & Crisis Lifeline , available 24 hours a day, seven days a week. Or use the Lifeline Chat . Services are free and confidential.

If you are worried about yourself or someone else, contact your healthcare professional or mental health professional. Some may be able to see you in person or talk over the phone or online.

You also can reach out to a friend or loved one. Someone in your faith community also could help.

And you may be able to get counseling or a mental health appointment through an employer's employee assistance program.

Another option is information and treatment options from groups such as:

• National Alliance on Mental Illness (NAMI).
• Substance Abuse and Mental Health Services Administration (SAMHSA).
• Anxiety and Depression Association of America.

Self-care tips

Some people may use unhealthy ways to cope with anxiety around COVID-19. These unhealthy choices may include things such as misuse of medicines or legal drugs and use of illegal drugs. Unhealthy coping choices also can be things such as sleeping too much or too little, or overeating. It also can include avoiding other people and focusing on only one soothing thing, such as work, television or gaming.

Unhealthy coping methods can worsen mental and physical health. And that is particularly true if you're trying to manage or recover from COVID-19.

Self-care actions can help you restore a healthy balance in your life. They can lessen everyday stress or significant anxiety linked to events such as the COVID-19 pandemic. Self-care actions give your body and mind a chance to heal from the problems long-term stress can cause.

Take care of your body

Healthy self-care tips start with the basics. Give your body what it needs and avoid what it doesn't need. Some tips are:

• Get the right amount of sleep for you. A regular sleep schedule, when you go to bed and get up at similar times each day, can help avoid sleep problems.
• Move your body. Regular physical activity and exercise can help reduce anxiety and improve mood. Any activity you can do regularly is a good choice. That may be a scheduled workout, a walk or even dancing to your favorite music.
• Choose healthy food and drinks. Foods that are high in nutrients, such as protein, vitamins and minerals are healthy choices. Avoid food or drink with added sugar, fat or salt.
• Avoid tobacco, alcohol and drugs. If you smoke tobacco or if you vape, you're already at higher risk of lung disease. Because COVID-19 affects the lungs, your risk increases even more. Using alcohol to manage how you feel can make matters worse and reduce your coping skills. Avoid taking illegal drugs or misusing prescriptions to manage your feelings.

Take care of your mind

Healthy coping actions for your brain start with deciding how much news and social media is right for you. Staying informed, especially during a pandemic, helps you make the best choices but do it carefully.

Set aside a specific amount of time to find information in the news or on social media, stay limited to that time, and choose reliable sources. For example, give yourself up to 20 or 30 minutes a day of news and social media. That amount keeps people informed but not overwhelmed.

For COVID-19, consider reliable health sources. Examples are the U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO).

Other healthy self-care tips are:

• Relax and recharge. Many people benefit from relaxation exercises such as mindfulness, deep breathing, meditation and yoga. Find an activity that helps you relax and try to do it every day at least for a short time. Fitting time in for hobbies or activities you enjoy can help manage feelings of stress too.
• Stick to your health routine. If you see a healthcare professional for mental health services, keep up with your appointments. And stay up to date with all your wellness tests and screenings.
• Stay in touch and connect with others. Family, friends and your community are part of a healthy mental outlook. Together, you form a healthy support network for concerns or challenges. Social interactions, over time, are linked to a healthier and longer life.

Avoid stigma and discrimination

Stigma can make people feel isolated and even abandoned. They may feel sad, hurt and angry when people in their community avoid them for fear of getting COVID-19. People who have experienced stigma related to COVID-19 include people of Asian descent, health care workers and people with COVID-19.

Treating people differently because of their medical condition, called medical discrimination, isn't new to the COVID-19 pandemic. Stigma has long been a problem for people with various conditions such as Hansen's disease (leprosy), HIV, diabetes and many mental illnesses.

People who experience stigma may be left out or shunned, treated differently, or denied job and school options. They also may be targets of verbal, emotional and physical abuse.

Communication can help end stigma or discrimination. You can address stigma when you:

• Get to know people as more than just an illness. Using respectful language can go a long way toward making people comfortable talking about a health issue.
• Get the facts about COVID-19 or other medical issues from reputable sources such as the CDC and WHO.
• Speak up if you hear or see myths about an illness or people with an illness.

COVID-19 and health

The virus that causes COVID-19 is still a concern for many people. By recognizing when to get help and taking time for your health, life challenges such as COVID-19 can be managed.

• Mental health during the COVID-19 pandemic. National Institutes of Health. https://covid19.nih.gov/covid-19-topics/mental-health. Accessed March 12, 2024.
• Mental Health and COVID-19: Early evidence of the pandemic's impact: Scientific brief, 2 March 2022. World Health Organization. https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Mental_health-2022.1. Accessed March 12, 2024.
• Mental health and the pandemic: What U.S. surveys have found. Pew Research Center. https://www.pewresearch.org/short-reads/2023/03/02/mental-health-and-the-pandemic-what-u-s-surveys-have-found/. Accessed March 12, 2024.
• Taking care of your emotional health. Centers for Disease Control and Prevention. https://emergency.cdc.gov/coping/selfcare.asp. Accessed March 12, 2024.
• #HealthyAtHome—Mental health. World Health Organization. www.who.int/campaigns/connecting-the-world-to-combat-coronavirus/healthyathome/healthyathome---mental-health. Accessed March 12, 2024.
• Coping with stress. Centers for Disease Control and Prevention. www.cdc.gov/mentalhealth/stress-coping/cope-with-stress/. Accessed March 12, 2024.
• Manage stress. U.S. Department of Health and Human Services. https://health.gov/myhealthfinder/topics/health-conditions/heart-health/manage-stress. Accessed March 20, 2020.
• COVID-19 and substance abuse. National Institute on Drug Abuse. https://nida.nih.gov/research-topics/covid-19-substance-use#health-outcomes. Accessed March 12, 2024.
• COVID-19 resource and information guide. National Alliance on Mental Illness. https://www.nami.org/Support-Education/NAMI-HelpLine/COVID-19-Information-and-Resources/COVID-19-Resource-and-Information-Guide. Accessed March 15, 2024.
• Negative coping and PTSD. U.S. Department of Veterans Affairs. https://www.ptsd.va.gov/gethelp/negative_coping.asp. Accessed March 15, 2024.
• Health effects of cigarette smoking. Centers for Disease Control and Prevention. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/index.htm#respiratory. Accessed March 15, 2024.
• People with certain medical conditions. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html. Accessed March 15, 2024.
• Your healthiest self: Emotional wellness toolkit. National Institutes of Health. https://www.nih.gov/health-information/emotional-wellness-toolkit. Accessed March 15, 2024.
• World leprosy day: Bust the myths, learn the facts. Centers for Disease Control and Prevention. https://www.cdc.gov/leprosy/world-leprosy-day/. Accessed March 15, 2024.
• HIV stigma and discrimination. Centers for Disease Control and Prevention. https://www.cdc.gov/hiv/basics/hiv-stigma/. Accessed March 15, 2024.
• Diabetes stigma: Learn about it, recognize it, reduce it. Centers for Disease Control and Prevention. https://www.cdc.gov/diabetes/library/features/diabetes_stigma.html. Accessed March 15, 2024.
• Phelan SM, et al. Patient and health care professional perspectives on stigma in integrated behavioral health: Barriers and recommendations. Annals of Family Medicine. 2023; doi:10.1370/afm.2924.
• Stigma reduction. Centers for Disease Control and Prevention. https://www.cdc.gov/drugoverdose/od2a/case-studies/stigma-reduction.html. Accessed March 15, 2024.
• Nyblade L, et al. Stigma in health facilities: Why it matters and how we can change it. BMC Medicine. 2019; doi:10.1186/s12916-019-1256-2.
• Combating bias and stigma related to COVID-19. American Psychological Association. https://www.apa.org/topics/covid-19-bias. Accessed March 15, 2024.
• Yashadhana A, et al. Pandemic-related racial discrimination and its health impact among non-Indigenous racially minoritized peoples in high-income contexts: A systematic review. Health Promotion International. 2021; doi:10.1093/heapro/daab144.
• Sawchuk CN (expert opinion). Mayo Clinic. March 25, 2024.

Products and Services

• A Book: Endemic - A Post-Pandemic Playbook
• Begin Exploring Women's Health Solutions at Mayo Clinic Store
• A Book: Future Care
• Antibiotics: Are you misusing them?
• COVID-19 and vitamin D
• Convalescent plasma therapy
• Coronavirus disease 2019 (COVID-19)
• COVID-19: How can I protect myself?
• Herd immunity and coronavirus
• COVID-19 and pets
• COVID-19 antibody testing
• COVID-19, cold, allergies and the flu
• Long-term effects of COVID-19
• COVID-19 tests
• COVID-19 drugs: Are there any that work?
• COVID-19 in babies and children
• Coronavirus infection by race
• COVID-19 travel advice
• COVID-19 vaccine: Should I reschedule my mammogram?
• COVID-19 vaccines for kids: What you need to know
• COVID-19 vaccines
• COVID-19 variant
• COVID-19 vs. flu: Similarities and differences
• COVID-19: Who's at higher risk of serious symptoms?
• Debunking coronavirus myths
• Different COVID-19 vaccines
• Extracorporeal membrane oxygenation (ECMO)
• Fever: First aid
• Fever treatment: Quick guide to treating a fever
• Fight coronavirus (COVID-19) transmission at home
• Honey: An effective cough remedy?
• How do COVID-19 antibody tests differ from diagnostic tests?
• How to measure your respiratory rate
• How to take your pulse
• How to take your temperature
• How well do face masks protect against COVID-19?
• Is hydroxychloroquine a treatment for COVID-19?
• Loss of smell
• Mayo Clinic Minute: You're washing your hands all wrong
• Mayo Clinic Minute: How dirty are common surfaces?
• Multisystem inflammatory syndrome in children (MIS-C)
• Nausea and vomiting
• Pregnancy and COVID-19
• Safe outdoor activities during the COVID-19 pandemic
• Safety tips for attending school during COVID-19
• Sex and COVID-19
• Shortness of breath
• Thermometers: Understand the options
• Treating COVID-19 at home
• Unusual symptoms of coronavirus
• Vaccine guidance from Mayo Clinic
• Watery eyes

Related information

• Mental health: What's normal, what's not - Related information Mental health: What's normal, what's not
• Mental illness - Related information Mental illness

Your gift holds great power – donate today!

Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.

• CBSE Class 10th
• CBSE Class 12th
• UP Board 10th
• UP Board 12th
• Bihar Board 10th
• Bihar Board 12th
• Top Schools in India
• Top Schools in Delhi
• Top Schools in Mumbai
• Top Schools in Chennai
• Top Schools in Hyderabad
• Top Schools in Kolkata
• Top Schools in Pune
• Top Schools in Bangalore

Products & Resources

• JEE Main Knockout April
• Free Sample Papers
• Free Ebooks
• NCERT Notes
• NCERT Syllabus
• NCERT Books
• RD Sharma Solutions
• Navodaya Vidyalaya Admission 2024-25
• NCERT Solutions
• NCERT Solutions for Class 12
• NCERT Solutions for Class 11
• NCERT solutions for Class 10
• NCERT solutions for Class 9
• NCERT solutions for Class 8
• NCERT Solutions for Class 7
• JEE Main 2024
• MHT CET 2024
• JEE Advanced 2024
• BITSAT 2024
• View All Engineering Exams
• Colleges Accepting B.Tech Applications
• Top Engineering Colleges in India
• Engineering Colleges in India
• Engineering Colleges in Tamil Nadu
• Engineering Colleges Accepting JEE Main
• Top IITs in India
• Top NITs in India
• Top IIITs in India
• JEE Main College Predictor
• JEE Main Rank Predictor
• MHT CET College Predictor
• AP EAMCET College Predictor
• GATE College Predictor
• KCET College Predictor
• JEE Advanced College Predictor
• View All College Predictors
• JEE Main Question Paper
• JEE Main Cutoff
• JEE Main Advanced Admit Card
• JEE Advanced Admit Card 2024
• Download E-Books and Sample Papers
• Compare Colleges
• B.Tech College Applications
• KCET Result
• MAH MBA CET Exam
• View All Management Exams

Colleges & Courses

• MBA College Admissions
• MBA Colleges in India
• Top IIMs Colleges in India
• Top Online MBA Colleges in India
• MBA Colleges Accepting XAT Score
• BBA Colleges in India
• XAT College Predictor 2024
• SNAP College Predictor
• NMAT College Predictor
• MAT College Predictor 2024
• CMAT College Predictor 2024
• CAT Percentile Predictor 2023
• CAT 2023 College Predictor
• CMAT 2024 Admit Card
• TS ICET 2024 Hall Ticket
• CMAT Result 2024
• MAH MBA CET Cutoff 2024
• Download Helpful Ebooks
• List of Popular Branches
• QnA - Get answers to your doubts
• IIM Fees Structure
• AIIMS Nursing
• Top Medical Colleges in India
• Top Medical Colleges in India accepting NEET Score
• Medical Colleges accepting NEET
• List of Medical Colleges in India
• List of AIIMS Colleges In India
• Medical Colleges in Maharashtra
• Medical Colleges in India Accepting NEET PG
• NEET College Predictor
• NEET PG College Predictor
• NEET MDS College Predictor
• NEET Rank Predictor
• DNB PDCET College Predictor
• NEET Admit Card 2024
• NEET PG Application Form 2024
• NEET Cut off
• NEET Online Preparation
• Download Helpful E-books
• Colleges Accepting Admissions
• Top Law Colleges in India
• Law College Accepting CLAT Score
• List of Law Colleges in India
• Top Law Colleges in Delhi
• Top NLUs Colleges in India
• Top Law Colleges in Chandigarh
• Top Law Collages in Lucknow

Predictors & E-Books

• CLAT College Predictor
• MHCET Law ( 5 Year L.L.B) College Predictor
• AILET College Predictor
• Sample Papers
• Compare Law Collages
• Careers360 Youtube Channel
• CLAT Syllabus 2025
• CLAT Previous Year Question Paper
• NID DAT Exam
• Pearl Academy Exam

Predictors & Articles

• NIFT College Predictor
• UCEED College Predictor
• NID DAT College Predictor
• NID DAT Syllabus 2025
• NID DAT 2025
• Design Colleges in India
• Top NIFT Colleges in India
• Fashion Design Colleges in India
• Top Interior Design Colleges in India
• Top Graphic Designing Colleges in India
• Fashion Design Colleges in Delhi
• Fashion Design Colleges in Mumbai
• Top Interior Design Colleges in Bangalore
• NIFT Result 2024
• NIFT Fees Structure
• NIFT Syllabus 2025
• Free Design E-books
• List of Branches
• Careers360 Youtube channel
• IPU CET BJMC
• JMI Mass Communication Entrance Exam
• IIMC Entrance Exam
• Media & Journalism colleges in Delhi
• Media & Journalism colleges in Bangalore
• Media & Journalism colleges in Mumbai
• List of Media & Journalism Colleges in India
• CA Intermediate
• CA Foundation
• CS Executive
• CS Professional
• Difference between CA and CS
• Difference between CA and CMA
• CA Full form
• CMA Full form
• CS Full form
• CA Salary In India

Top Courses & Careers

• Bachelor of Commerce (B.Com)
• Master of Commerce (M.Com)
• Company Secretary
• Cost Accountant
• Charted Accountant
• Credit Manager
• Financial Advisor
• Top Commerce Colleges in India
• Top Government Commerce Colleges in India
• Top Private Commerce Colleges in India
• Top M.Com Colleges in Mumbai
• Top B.Com Colleges in India
• IT Colleges in Tamil Nadu
• IT Colleges in Uttar Pradesh
• MCA Colleges in India
• BCA Colleges in India

Quick Links

• Information Technology Courses
• Programming Courses
• Web Development Courses
• Data Analytics Courses
• Big Data Analytics Courses
• RUHS Pharmacy Admission Test
• Top Pharmacy Colleges in India
• Pharmacy Colleges in Pune
• Pharmacy Colleges in Mumbai
• Colleges Accepting GPAT Score
• Pharmacy Colleges in Lucknow
• List of Pharmacy Colleges in Nagpur
• GPAT Result
• GPAT 2024 Admit Card
• GPAT Question Papers
• NCHMCT JEE 2024
• Mah BHMCT CET
• Top Hotel Management Colleges in Delhi
• Top Hotel Management Colleges in Hyderabad
• Top Hotel Management Colleges in Mumbai
• Top Hotel Management Colleges in Tamil Nadu
• Top Hotel Management Colleges in Maharashtra
• B.Sc Hotel Management
• Hotel Management
• Diploma in Hotel Management and Catering Technology

Diploma Colleges

• Top Diploma Colleges in Maharashtra
• UPSC IAS 2024
• SSC CGL 2024
• IBPS RRB 2024
• Previous Year Sample Papers
• Free Competition E-books
• Sarkari Result
• QnA- Get your doubts answered
• UPSC Previous Year Sample Papers
• CTET Previous Year Sample Papers
• SBI Clerk Previous Year Sample Papers
• NDA Previous Year Sample Papers

Upcoming Events

• NDA Application Form 2024
• UPSC IAS Application Form 2024
• CDS Application Form 2024
• CTET Admit card 2024
• HP TET Result 2023
• SSC GD Constable Admit Card 2024
• UPTET Notification 2024
• SBI Clerk Result 2024

Other Exams

• SSC CHSL 2024
• UP PCS 2024
• UGC NET 2024
• RRB NTPC 2024
• IBPS PO 2024
• IBPS Clerk 2024
• IBPS SO 2024
• Top University in USA
• Top University in Canada
• Top University in Ireland
• Top Universities in UK
• Top Universities in Australia
• Best MBA Colleges in Abroad
• Business Management Studies Colleges

Top Countries

• Study in USA
• Study in UK
• Study in Canada
• Study in Australia
• Study in Ireland
• Study in Germany
• Study in China
• Study in Europe

Student Visas

• Student Visa Canada
• Student Visa UK
• Student Visa USA
• Student Visa Australia
• Student Visa Germany
• Student Visa New Zealand
• Student Visa Ireland
• CUET PG 2024
• IGNOU B.Ed Admission 2024
• DU Admission 2024
• UP B.Ed JEE 2024
• LPU NEST 2024
• IIT JAM 2024
• IGNOU Online Admission 2024
• Universities in India
• Top Universities in India 2024
• Top Colleges in India
• Top Universities in Uttar Pradesh 2024
• Top Universities in Bihar
• Top Universities in Madhya Pradesh 2024
• Top Universities in Tamil Nadu 2024
• Central Universities in India
• CUET Exam City Intimation Slip 2024
• IGNOU Date Sheet
• CUET Mock Test 2024
• CUET Admit card 2024
• CUET PG Syllabus 2024
• CUET Participating Universities 2024
• CUET Previous Year Question Paper
• CUET Syllabus 2024 for Science Students
• E-Books and Sample Papers
• CUET Exam Pattern 2024
• CUET Exam Date 2024
• CUET Cut Off 2024
• CUET Exam Analysis 2024
• IGNOU Exam Form 2024
• CUET 2024 Exam Live
• CUET Answer Key 2024

Engineering Preparation

• Knockout JEE Main 2024
• Test Series JEE Main 2024
• JEE Main 2024 Rank Booster

Medical Preparation

• Knockout NEET 2024
• Test Series NEET 2024
• Rank Booster NEET 2024

Online Courses

• JEE Main One Month Course
• NEET One Month Course
• IBSAT Free Mock Tests
• IIT JEE Foundation Course
• Knockout BITSAT 2024
• Career Guidance Tool

Top Streams

• IT & Software Certification Courses
• Engineering and Architecture Certification Courses
• Programming And Development Certification Courses
• Business and Management Certification Courses
• Marketing Certification Courses
• Health and Fitness Certification Courses
• Design Certification Courses

Specializations

• Digital Marketing Certification Courses
• Cyber Security Certification Courses
• Artificial Intelligence Certification Courses
• Business Analytics Certification Courses
• Data Science Certification Courses
• Cloud Computing Certification Courses
• Machine Learning Certification Courses
• View All Certification Courses
• UG Degree Courses
• PG Degree Courses
• Short Term Courses
• Free Courses
• Online Degrees and Diplomas
• Compare Courses

Top Providers

• Coursera Courses
• Udemy Courses
• Edx Courses
• Swayam Courses
• upGrad Courses
• Simplilearn Courses
• Great Learning Courses

Covid 19 Essay in English

Essay on Covid -19: In a very short amount of time, coronavirus has spread globally. It has had an enormous impact on people's lives, economy, and societies all around the world, affecting every country. Governments have had to take severe measures to try and contain the pandemic. The virus has altered our way of life in many ways, including its effects on our health and our economy. Here are a few sample essays on ‘CoronaVirus’.

100 Words Essay on Covid 19

200 words essay on covid 19, 500 words essay on covid 19.

COVID-19 or Corona Virus is a novel coronavirus that was first identified in 2019. It is similar to other coronaviruses, such as SARS-CoV and MERS-CoV, but it is more contagious and has caused more severe respiratory illness in people who have been infected. The novel coronavirus became a global pandemic in a very short period of time. It has affected lives, economies and societies across the world, leaving no country untouched. The virus has caused governments to take drastic measures to try and contain it. From health implications to economic and social ramifications, COVID-19 impacted every part of our lives. It has been more than 2 years since the pandemic hit and the world is still recovering from its effects.

Since the outbreak of COVID-19, the world has been impacted in a number of ways. For one, the global economy has taken a hit as businesses have been forced to close their doors. This has led to widespread job losses and an increase in poverty levels around the world. Additionally, countries have had to impose strict travel restrictions in an attempt to contain the virus, which has resulted in a decrease in tourism and international trade. Furthermore, the pandemic has put immense pressure on healthcare systems globally, as hospitals have been overwhelmed with patients suffering from the virus. Lastly, the outbreak has led to a general feeling of anxiety and uncertainty, as people are fearful of contracting the disease.

My Experience of COVID-19

I still remember how abruptly colleges and schools shut down in March 2020. I was a college student at that time and I was under the impression that everything would go back to normal in a few weeks. I could not have been more wrong. The situation only got worse every week and the government had to impose a lockdown. There were so many restrictions in place. For example, we had to wear face masks whenever we left the house, and we could only go out for essential errands. Restaurants and shops were only allowed to operate at take-out capacity, and many businesses were shut down.

In the current scenario, coronavirus is dominating all aspects of our lives. The coronavirus pandemic has wreaked havoc upon people’s lives, altering the way we live and work in a very short amount of time. It has revolutionised how we think about health care, education, and even social interaction. This virus has had long-term implications on our society, including its impact on mental health, economic stability, and global politics. But we as individuals can help to mitigate these effects by taking personal responsibility to protect themselves and those around them from infection.

Effects of CoronaVirus on Education

The outbreak of coronavirus has had a significant impact on education systems around the world. In China, where the virus originated, all schools and universities were closed for several weeks in an effort to contain the spread of the disease. Many other countries have followed suit, either closing schools altogether or suspending classes for a period of time.

This has resulted in a major disruption to the education of millions of students. Some have been able to continue their studies online, but many have not had access to the internet or have not been able to afford the costs associated with it. This has led to a widening of the digital divide between those who can afford to continue their education online and those who cannot.

The closure of schools has also had a negative impact on the mental health of many students. With no face-to-face contact with friends and teachers, some students have felt isolated and anxious. This has been compounded by the worry and uncertainty surrounding the virus itself.

The situation with coronavirus has improved and schools have been reopened but students are still catching up with the gap of 2 years that the pandemic created. In the meantime, governments and educational institutions are working together to find ways to support students and ensure that they are able to continue their education despite these difficult circumstances.

Effects of CoronaVirus on Economy

The outbreak of the coronavirus has had a significant impact on the global economy. The virus, which originated in China, has spread to over two hundred countries, resulting in widespread panic and a decrease in global trade. As a result of the outbreak, many businesses have been forced to close their doors, leading to a rise in unemployment. In addition, the stock market has taken a severe hit.

Effects of CoronaVirus on Health

The effects that coronavirus has on one's health are still being studied and researched as the virus continues to spread throughout the world. However, some of the potential effects on health that have been observed thus far include respiratory problems, fever, and coughing. In severe cases, pneumonia, kidney failure, and death can occur. It is important for people who think they may have been exposed to the virus to seek medical attention immediately so that they can be treated properly and avoid any serious complications. There is no specific cure or treatment for coronavirus at this time, but there are ways to help ease symptoms and prevent the virus from spreading.

Applications for Admissions are open.

Aakash iACST Scholarship Test 2024

Get up to 90% scholarship on NEET, JEE & Foundation courses

ALLEN Digital Scholarship Admission Test (ADSAT)

Register FREE for ALLEN Digital Scholarship Admission Test (ADSAT)

JEE Main Important Physics formulas

As per latest 2024 syllabus. Physics formulas, equations, & laws of class 11 & 12th chapters

PW JEE Coaching

Enrol in PW Vidyapeeth center for JEE coaching

PW NEET Coaching

Enrol in PW Vidyapeeth center for NEET coaching

JEE Main Important Chemistry formulas

As per latest 2024 syllabus. Chemistry formulas, equations, & laws of class 11 & 12th chapters

Download Careers360 App's

Regular exam updates, QnA, Predictors, College Applications & E-books now on your Mobile

Certifications

We Appeared in

• Share full article

Advertisement

Supported by

Guest Essay

As Bird Flu Looms, the Lessons of Past Pandemics Take On New Urgency

By John M. Barry

Mr. Barry, a scholar at the Tulane University School of Public Health and Tropical Medicine, is the author of “The Great Influenza: The Story of the Deadliest Pandemic in History.”

In 1918, an influenza virus jumped from birds to humans and killed an estimated 50 million to 100 million people in a world with less than a quarter of today’s population. Dozens of mammals also became infected.

Now we are seeing another onslaught of avian influenza. For years it has been devastating bird populations worldwide and more recently has begun infecting mammals , including cattle, a transmission never seen before. In another first, the virus almost certainly jumped recently from a cow to at least one human — fortunately, a mild case.

While much would still have to happen for this virus to ignite another human pandemic, these events provide another reason — as if one were needed — for governments and public health authorities to prepare for the next pandemic. As they do, they must be cautious about the lessons they might think Covid-19 left behind. We need to be prepared to fight the next war, not the last one.

Two assumptions based on our Covid experience would be especially dangerous and could cause tremendous damage, even if policymakers realized their mistake and adjusted quickly.

The first involves who is most likely to die from a pandemic virus. Covid primarily killed people 65 years and older , but Covid was an anomaly. The five previous pandemics we have reliable data about all killed much younger populations.

The 1889 pandemic most resembles Covid (and some scientists believe a coronavirus caused it). Young children escaped almost untouched and it killed mostly older people, but people ages 15 to 24 suffered the most excess mortality , or deaths above normal. Influenza caused the other pandemics, but unlike deaths from seasonal influenza, which usually kills older adults, in the 1957, 1968 and 2009 outbreaks, half or more deaths occurred in people younger than 65. The catastrophic 1918 pandemic was the complete reverse of Covid: Well over 90 percent of the excess mortality occurred in people younger than 65. Children under 10 were the most vulnerable, and those ages 25 to 29 followed.

Any presumption that older people would be the chief victims of the next pandemic — as they were in Covid — is wrong, and any policy so premised could leave healthy young adults and children exposed to a lethal virus.

The second dangerous assumption is that public health measures like school and business closings and masking had little impact. That is incorrect.

Australia, Germany and Switzerland are among the countries that demonstrated those interventions can succeed. Even the experience of the United States provides overwhelming, if indirect, evidence of the success of those public health measures.

The evidence comes from influenza, which transmits like Covid, with nearly one-third of cases transmitted by asymptomatic people. The winter before Covid, influenza killed an estimated 25,000 here ; in that first pandemic winter, influenza deaths were under 800. The public health steps taken to slow Covid contributed significantly to this decline, and those same measures no doubt affected Covid as well.

So the question isn’t whether those measures work. They do. It’s whether their benefits outweigh their social and economic costs. This will be a continuing calculation.

Such measures can moderate transmission, but they cannot be sustained indefinitely. And even the most extreme interventions cannot eliminate a pathogen that escapes initial containment if, like influenza or the virus that causes Covid-19, it is both airborne and transmitted by people showing no symptoms. Yet such interventions can achieve two important goals.

The first is preventing hospitals from being overrun. Achieving this outcome could require a cycle of imposing, lifting and reimposing public health measures to slow the spread of the virus. But the public should accept that because the goal is understandable, narrow and well defined.

The second objective is to slow transmission to buy time for identifying, manufacturing and distributing therapeutics and vaccines and for clinicians to learn how to manage care with the resources at hand. Artificial intelligence will perhaps be able to extrapolate from mountains of data which restrictions deliver the most benefits — whether, for example, just closing bars would be enough to significantly dampen spread — and which impose the greatest cost. A.I. should also speed drug development. And wastewater monitoring can track the pathogen’s movements and may make it possible to limit the locations where interventions are needed.

Still, what’s achievable will depend on the pathogen’s severity and transmissibility, and, as we sadly learned in the United States, how well — or poorly — leaders communicate the goals and the reasons behind them.

Specifically, officials will confront whether to impose the two most contentious interventions, school closings and mask mandates. What should they do?

Children are generally superspreaders of respiratory disease and can have disproportionate impact. Indeed, vaccinating children against pneumococcal pneumonia can cut the disease by 87 percent in people 50 and older. And schools were central to spreading the pandemics of 1957, 1968 and 2009. So there was good reason to think closing schools during Covid would save many lives.

In fact, closing schools did reduce Covid’s spread, yet the consensus view is that any gain was not worth the societal disruption and damage to children’s social and educational development. But that tells us nothing about the future. What if the next pandemic is deadlier than 1957’s but as in 1957, 48 percent of excess deaths are among those younger than 15 and schools are central to spread? Would it make sense to close schools then?

Masks present a much simpler question. They work. We’ve known they work since 1917, when they helped protect soldiers from a measles epidemic. A century later, all the data on Covid have actually demonstrated significant benefits from masks.

But whether to mandate masks is a difficult call. Too many people wear poorly fitted masks or wear them incorrectly. So even without adding in the complexities of politics, compliance is a problem. Whether government mask mandates will be worth the resistance they foment will depend on the severity of the virus.

That does not mean that institutions and businesses can’t or shouldn’t require masks. Nor does it mean we can’t increase the use of masks with better messaging. People accept smoking bans because they understand long-term exposure to secondhand smoke can cause cancer. A few minutes of exposure to Covid can kill. Messaging that combines self-protection with communitarian values could dent resistance significantly.

Individuals should want to protect themselves, given the long-term threat to their health. An estimated 7 percent of Americans have been affected by long Covid of varying severity, and a re-infection can still set it off in those who have so far avoided it. The 1918 pandemic also caused neurological and cardiovascular problems lasting decades, and children exposed in utero suffered worse health and higher mortality than their siblings. We can expect the same from the next pandemic.

What should we learn from the past? Every pandemic we have good information about was unique. That makes information itself the most valuable commodity. We must gather it, analyze it, act upon it and communicate it.

Epidemiological information can answer the biggest question: whether to deploy society-wide public health interventions at all. But the epidemiology of the virus is hardly the only information that matters. Before Covid vaccines were available, the single drug that saved the most lives was dexamethasone. Health officials in Britain discovered its effectiveness because the country has a shared data system that enabled them to analyze the efficacy of treatments being tried around the country. We have no comparable system in the United States. We need one.

Perhaps most important, government officials and health care experts must communicate to the public effectively. The United States failed dismally at this. There was no organized effort to counter social media disinformation, and experts damaged their own credibility by reversing their advice several times. They could have avoided these self-inflicted wounds by setting public expectations properly. The public should have been told that scientists had never seen this virus before, that they were giving their best advice based on their knowledge at the time and that their advice could — and probably would — change as more information came in. Had they done this, they probably would have retained more of the public’s confidence.

Trust matters. A pre-Covid analysis of the pandemic readiness of countries around the world rated the United States first because of its resources. Yet America had the second-worst rate of infections of any high-income country.

A pandemic analysis of 177 countries published in 2022 found that resources did not correlate with infections. Trust in government and fellow citizens did. That’s the lesson we really need to remember for the next time.

John M. Barry, a scholar at the Tulane University School of Public Health and Tropical Medicine, is the author of “The Great Influenza: The Story of the Deadliest Pandemic in History.”

The Times is committed to publishing a diversity of letters to the editor. We’d like to hear what you think about this or any of our articles. Here are some tips . And here’s our email: [email protected] .

Follow the New York Times Opinion section on Facebook , Instagram , TikTok , WhatsApp , X and Threads .

Login | Register

• Current Issues
• Previous Issues
• Editorial Team
• Managerial Board
• Become a Reviewer
• Submission Guidelines
• Harvard Citation Style
• Vancouver Citation Style
• APA Citation Style
• Download RIS
• Download BibTeX

Multistakeholder Participation, Collaboration, and Networking in Disaster Risk Reduction and Pandemic Management: Insights and Future Policy Framework

• Sigamani Panneer (Jawaharlal Nehru University)
• Subhabrata Dutta (Assam University)
• Lekha D Bhat (Central University of Tamil Nadu)
• Prakash Chand Kandpal (Jawa­harlal Nehru University)
• Robert Ramesh Babu P (Department of Social Work)
• Rubavel M (Consultant UNDP)
• Vigneshwaran Subbiah Akkayasamy (Depart­ment of Sociology and Social Work)

The natural and manmade disasters impact a society with loss of assets and human lives. Disasters leavepeople in vulnerable conditions and an overall economic slowdown is observed. The impact of disasters is highly complex and multidimensional in nature. It becomes imperative to handle the complexity of issues with comprehensive approach. Managing disasters effectively is one of the important challenges any government faces when it tries to be prepared with appropriate mitigation, rescue, and relief strategies. The unexpected nature and urgency related to Disaster Risk Reduction makes it important and relevant to involvemultistakeholders. This will help to bring down the severity and impact of the disaster on human lives and losses. Disaster Risk Reductionrequires meticulous planning and sharing of the responsibility among multistakeholders through networking so as to bring down the severity and minimize the negative impact of a disaster. Many research studies have suggested the multistakeholder approach in addressing the disasters. There are several gaps such as inefficiency of vertical management to deal the issues, involvement of multiple stakeholders, and lack of local public supportfor disaster. This paper, considering the case of COVID-19 as a pandemic and disaster, discusses the importance of multistakeholder participation. The paper presents an extensive review of the papers on the relevance ofparticipation of multistakeholdersin Disaster Risk Reduction and explores the scope and challenges involved and suggests policies to address the disasters, which utilizes Multistakeholder Participation.

Keywords: global health diplomacy, governance, collaboration andnetworking, disaster risk reduction, multistakeholder participation, transdisciplinary approach

Panneer, S., Dutta, S., Bhat, L. D., Kandpal, P. C., Babu P, R. R., M, R. & Akkayasamy, V. S., (2024) “Multistakeholder Participation, Collaboration, and Networking in Disaster Risk Reduction and Pandemic Management: Insights and Future Policy Framework”, Social Development Issues 46(2): 11. doi: https://doi.org/10.3998/sdi.5989

Downloads: Download XML Download PDF

12 Downloads

Published on 18 may 2024, peer reviewed, creative commons attribution 4.0, introduction.

Disasters cause not only economic crisis but also humanitarian loss, mental and psychological trauma, and slow downof a society’s development process. Disasters are to be handled with priority and to be addressed comprehensively with innovative and pragmaticmultistakeholder participation approach. In multistakeholder participation, to address disasters most effectively, sharing of information, coordination, and quick decision are most important ( Hayne & Smith, 2005 ). The terms “Multistakeholder platform” and “multistakeholder’s participation”are used to represent the process where different actors witha common pool of resources and common interests come together, discuss the possibilities, and develop proactive and pragmatic solutions for the good of the public ( Warner, Waalewijn, & Hilhorst, 2002 ). The past experiences in disaster risk reduction show that even after efforts, the affected society takes a long timeto cope with the aftermath of disasters because multistakeholder participation is not channelized properly in mitigation and rehabilitation efforts ( Fletcher et al., 2013 ). The COVID-19 pandemic serves as a prime example of global health crisis and the importance of networking, collaboration, and multistakeholder participation in handling disasters. The complexity of handling pandemics and disasters has increased recently, necessitating a more coordinated, inclusive strategy that makes use of a variety of resources and areas of expertise.

After a disaster occurs, a number of key stakeholders are involved in providing relief and rehabilitation support. One of the major challenges in the field of Disaster Risk Reductionis to understand how to develop a response with appropriate coordination between various stakeholders and ensure flexibility and lucidity in the system at the same time ( Nowell, Steelman, Velez, & Yang, 2018 ). During the last two decades, disasters are all transboundary in nature and uncertain, and collective stress is very high which demands rapid responses from multiple agencies or stakeholders ( Ansell, Boin, & Keller, 2010 ). Disasters bring constraints such as hierarchical organizations tend to break down, personnels are hindered by lack of information, lack of flexibility in the administrative procedures, constraints for innovation, and inability to shift resources and actions to meet the new demands quickly, which lead to cumulative stress in the Disaster Risk Reduction ( McDonald & Sinha, 2008 ). Multistakeholders are required to respond, network, and share the information to have strategic, tactical, and operational plans to handle the disasters. Optimal use of available time is one of the crucial aspects in the disaster risk reduction; timely information is required, and it depicts the need for collaboration with involvement of multistakeholders at wider level. A better multistakeholder management can improve the effectiveness and efficiency of Disaster Risk Reduction in humanitarian operations.

The stakeholders involved in disaster management include military and paramilitary forces, contributors, and government and nongovernment organizations, who have to cooperate and collaborate with people from different cultures and ethnic groups ( Cozzolino, 2012 ). Availability of scientific knowledge and appropriate information is mandatory for decision-making, clear assessment, and formulation of appropriate measures ( Zhou et al., 2020 ). Making policy decisions by providing inputs and delegating responsibilities among themselves to develop proactive prevention strategies with the involvement of community are imperative ( Biekart & Fowler, 2018 ). During a disaster, no individual, agency, or government machinery have the legitimacy, authority, or professional competency to handle the situation exclusively; it demands collective action, interaction, and networking ( Nolte & Boenigk, 2013 ). Effective response to a disaster is about networking and enterprising ( Moynihan, 2008 ). Multistakeholder participation has always helped to improve societal ownership and response of the Disaster Risk Reductionor rehabilitation measures. Multistakeholder initiatives are helpful in bringing in collective actions for public benefits; and as theyrely on one common factor, they are more productive, efficient, and effective ( Beisheim & Simon, 2016 ).

Stakeholders are classified into three groups: primary, secondary, and key stakeholders. Key stakeholders are mainly responsible for policy decision and are involved directly. Primary and secondary stakeholders have interest in the program but are not directly involved ( Freeman, Harrison, Wicks, Parmar, & De Colle, 2010 ). The process aims to bring all the stakeholders together, based on recognition to the concept of equity and accountability. The participation process involving multistakeholdersis democratic in nature, following the principles of transparency and participation. This ideally develops partnership and strengthen the networks among them, and thus disaster relief and management becomeefficient and effective ( Hemmati, 2012 ). Multistakeholder participation improves capacity-building, ensures innovation, and promotes faster decision-making process, which ultimately benefits the community ( Achyar, Schmidt-Vogt, & Shivakoti, 2015 ).

There are studies that show the success and relevance of multistakeholder participation in Disaster Risk Reduction. In the case of Hudhud cyclone in Vishakapattanam, multistakeholder participation under the leadership of the State Government has shown a positive impact in terms of rehabilitation and bringing back the normalcy ( Meduri, 2016 ). The study from Indonesia showed that multistakeholder participation and collaboration, as a crucial and important factor, has helped reduce the disaster risk and helped implement balanced Disaster Risk Reduction policies ( Trimurti, Endang, Hardi, & Hartuti, 2020 ). Hui (Hu, Lei, Hu, Zhang, Kavan, 2018) analyzed the situation in China and pointed out that the failure of government networks and its inefficiency of disaster relief measures are due to the lack of multistakeholder collaboration and internal dynamics of the system.

Global health Governance during COVID-19 pandemic was crucial; however, what the world witnessed was that the nations adopted uncoordinated, ad hoc responses partially adhering to the WHO guidelines ( Jones & Hameiri, 2022 ). International organizationssuch as the WHO was tasked with developing and disseminating “best practice” policies, whereas different nations adopted it with a lot of flexibility and their own suitability and adaptability. An overall coordination between nations was largely not observed ( Taylor & Habibi 2020 ). In this paper, we have reviewedthe available literature and identified the role of multistakeholder participation, coordination, and networking in handling disasters (with special focus on COVID-19 pandemic) in an effective manner. As the world is expecting more zoonotic diseases, developing effective strategies for Disaster Risk Reduction of infectious pandemics is very crucial.

COVID-19 Pandemic and the Role of Multi-stakeholders

The pandemic has left a deep impact on the global economy wherein the Gross Domestic Production (GDP) of the countries sharply decreased, and this slowing down of the economies has led to various livelihood issues. The COVID-19 pandemic not only has disturbed the social lives and financial status but also has affected the health and wellbeing ( Jha & Pankaj, 2021 ). International community and various stakeholders have taken steps to provide immediate relief, rehabilitation, and reconstruction. The traditional models orapproaches of coordination are inadequate for volatile and dynamic situations like that of pandemics, floods, and disasters ( Faraj & Xiao, 2006 ). COVID-19 has showed the contingent, fragile nature of global governance institutions, as well as the limitations of power and authority in the face of large-scale crises ( Levy, 2021 ). Multistakeholder collaboration is an important key to handle issues developed by disasters as it reduces the pressure on the government machinery and enhances the effectiveness of relief and rehabilitation.

Multistakeholder partnership in health emergency response situations tends to be futile when concerns about the ownership of outcomes and differences in organizational working practices amalgamate ( Ryu & Johansen, 2017 ). If the collaborative efforts or partners have transparency about the roles and responsibilities, then the public health emergency can be handled more effectively within a short duration ( de Vries et al., 2019 ). When multistakeholder participation is attempted in addressing earlier pandemics in the Asian region, issues such as resource limitation, unethical priority setting, and less confidence in the adopted surveillance technology inhibited effective pandemic preparedness ( Bennett & Carney, 2011 ). Major issues identified in multistakeholder collaboration in health preparedness include the partners’ lack of commitment, non-supportive collaborative work environment, absence of clarity about mutual expectations, informal interactive style of communication, and limited resource commitment over a longer period of time ( Akenroye et al., 2022 ).

It is important to involve multistakeholders before the occurrence of disaster as a preparatory work. Better preparatory works reduce the impactof severity of the pandemics. The preparatory work requires multilevel coordination, collection of information, and appropriate coordination mechanism among stakeholders in the pandemic situation. Hence, there is a need to develop flexible multistakeholder coordination mechanisms that can be easily customized for a specific situation and provide better support for improvised responses ( Janssen, Lee, Bharosa, & Cresswell, 2010 ). Domestic support alone is not sufficient;a collective action isrequired to handle the situation which mainly involves international support, international law, and geopolitics. It reiterates the need to have global partnerships with multilateral and bilateral agencies, media, research institutions, civil society organization (CSOs), religious and cultural groups, and nongovernmental organizations (NGOs). It is important to work on for international cohesion, coordination in disaster response, leveraging the technologies for mitigation, and management of multihazard risks and vulnerability. The multistakeholder platform is helpful mainly to create a space for the empowerment and active participation of common stakeholders intending to search for solutions to a common problem.

It is important to facilitate multistakeholder participation, preparatory activities, clinical intervention, and public health ( Faysse, 2006 ). Multistakeholders should be involved in the policy formulation and implementation to address the complex Disaster Risk Reduction issues. The participatory approaches must be adopted in planning, preparing action plans, training personnels, identifying problems and correcting mistakes, and implementation.

Objectives and Methods

The recent case of COVID-19 provides an example at world level to explore the relevance of multistakeholder participation in the preparedness and response for addressing the pandemic. The paper focuses on the following objectives: (1) to highlight the relevance of multistakeholders in Disaster Risk Reduction, including COVID-19 preparedness and response; (2) to document the issues and challenges in collaboration, networking for timely intervention in health Disaster Risk Reduction including COVID-19; and (3) to provide suggestions to enhance multistakeholder participation in most infectious and reemerging diseases outbreak management. In order to better understand the dynamics of multistakeholder participation in disaster risk reduction, this paper specifically looks at the lessons that may be drawn from the COVID-19 pandemic.

Review Methods

This paper conducts an extensive review, employing a broad and inclusive approach to literature analysis. Key terms such as “Disaster Risk Reduction,” “multistakeholders,” “pandemic,” “transdisciplinary research,” “networking,” and “COVID-19” were used to guide the search across databases including Google Scholar, JSTOR, BMC, Springer, JAMA, Scopus, JPHP, Elsevier, Lancet, PLOS ONE, MDPI Journals, Nature, APA, WHO Documents, Government Policy Documents, and PubMed. The search, from January 2020 to October 2022, aimed to capture a diverse array of sources reflecting the multifaceted nature of multistakeholder participation in disaster risk reduction, with a particular focus on the COVID-19 pandemic. Selected materials included peer-reviewed publications, journal articles, reviews, meta-analyses, disaster mitigation reports, feedback reports, reference books, strategic preparedness, and response plans. Prioritizing English language literature, this review emphasizes empirical studies, reviews, meta-analyses, and policy documents, ensuring a comprehensive understanding of the subject matter.

Multi stakeholder Participation in Disaster Risk Reduction and its Challenges

The international communityshares the responsibilities to provide immediate relief, rehabilitation, and reconstruction, providing health services, including water, sanitation, food, shelter, appropriate medical care, and helping in the livelihood sustainability of the affected population. However, issues of the victims especially related tolivelihood and health continues to be a big challenge. The victims also require psycho-social help, economic reconstruction, and opportunities for livelihood rebuilding. In a post-disaster scenario, the preparatory work requires multilevel coordination, collection of information, and the appropriate coordination mechanism among the stakeholders ( Jillson et al., 2019 ). Therefore, there is a need to develop flexible and multistakeholder networking mechanisms that can easily be customized for the specific situation and provide better support for improvised responses. It highlights the need to have global partnerships with multilateral and bilateral agencies, media, research institutions, CSOs, religious groups, and NGOs. It is important to work for international cohesion, coordination for the disaster response, leveraging the technically viable and economically feasible technologies for mitigation and management of multihazard risk and vulnerability ( Satapathy & Walia, 2007 ). The multistakeholder platform is mainly helpful in creating a space for the empowerment and active participation of common stakeholders intending to search for solutions to a common problem ( Obeng, Marfo, Owusu-Ansah, & Nantwi, 2014 ). It is important to facilitate the multistakeholder participation in preparatory activities, clinical intervention, and public health. Multistakeholders should be involved in policy formulation and implementation to address the complex disaster risk reduction issues. In this review, we have identified some of the important barriers and challenges which are presented in Table 1 .

Challenges and barriers to successful collaboration among multistakeholders

Source : The above data is collected by the authors from different sources.

A Case of COVID-19 Pandemic Management

As per data from the World Health Organization (WHO) as on December 14, 2023, COVID-19 infected cases were 773 million and total reported deaths were 6.98 million. The pandemic which affected the whole world has left deep impact on societies andhas led to heavy economic standstill and losses. One of the strategies to combat the pandemic is to minimize social and economic hardship through multisectoral partnerships (WHO Coronavirus [COVID-19] Dashboard, 2023). The Novel Corona Virus Strategic Preparedness and Responsive Plan released on February 03, 2020 emphasized on the aspectwherein the WHO highlighted the need to encourage networking and multistakeholder participation at all levels, sharing the resources, expertise, and skills.

Based on the intensity of the pandemic, the number of players involved in the preparedness and operation vary. Thispredominantly involvehealthcare providers and administrators, experts, logistics organizations, government and NGOs, communities in the villages, and ethnic groups ( Cozzolino, 2012 ). Many countries carried outexercises to identify the gaps and problems involved in adopting an efficient swift response strategy to address the pandemic aftermath. For example, India, in its preparedness to combat COVID-19, conducted the civil servants feedback survey wherein ten majorgaps wereidentified, which were as follows: (1) hospital preparedness and infrastructure; (2) quarantine and isolation facility; (3) testing facilities; (4) personal protection equipment; (5) lack of public awareness; (6) law and order administration (State/District); (7) foreign travel history and contact tracing; (8) temporary and wage-worker exodus; (9) sanitizing public places; and (10) essential goods and services. (The National preparedness Survey on COVID-19 conducted by the Department of Administrative Reforms and Public Grievances, Government of India [GOI, 2020]). The survey also acknowledged that all the above-mentioned requirements cannot be arranged and coordinated solely by the government system and it called for multistakeholder collaboration, various actors’ role in the restoration, rehabilitation, and reconstruction of the pandemic-affected areas.

Pandemic: Response, Recovery, and Mitigation Experiences

A few countries including South Korea and New Zealand have taken timely efforts to address the pandemic management. In other countries such as Italy, Sweden, France, the UK, and the USA, a strict quarantine mechanism was not enforced during the initial period of COVID-19, whichresulted inthe quick spread of the virus. In India, the Government started intensifying preparedness for the unprecedented threat posed by COVID-19, where it constituted an interministerial committee represented by the ministers of the health and family welfare, civil aviation, external affairs, and home, as well as the National Disaster Management Authority ( Dikid et al., 2020 ). However, no private institutions ororganizationswere involved in preparedness of the pandemic at this early stage. The only decision in the direction where multistakeholderswere engagedwas the attempt made to include the village-level communities. The Panchayat-level governments through the GramSabhastried toconductawareness drives on the clinical presentation of the novel COVID-19 disease, its preventive measures, and the need for reporting the cases especially in the village areas. Much of the technical support was made available by the epidemic intelligence service by the NCDC in collaboration with the US Centers for Disease Control and Prevention (CDC). This was one the important aspects of leveraging technical resource for addressing the COVID-19, and it activelysupported the COVID-19 response. This helped India mobilize external support to update the disease surveillance systems; investigate outbreaks; respond to disasters, emergencies, and mass gatherings; and conduct epidemiological evaluations. This intervention hada great potential in strengthening the epidemiological capacity of health professionals in the country to respond efficiently to public health emergencies such as strengthening core capacity in the areas of disease surveillance, early detection, and rapid response, generating evidence that could be used for policymaking and implementation.

It is suggested to have strong national surveillance to detect COVID-19 cases and other similar future epidemics, respond to active case findings, prompt treatment and isolation of cases, contact tracing, and preventing an outbreak from happening or limiting its spread to the public by taking containment measures. The Corporate Social Responsibility components of profitable companies can play major role as they have already developed rapport and confidence in village communities ( Patuelli, Caldarelli, Lattanzi, & Saracco, 2021 ). The involvement of multistakeholders such as private organizations, technocrats, international agencies, and community members to address the COVID-19 pandemic will ensure more efficiency and effectiveness ( Jiang, 2020 ).

Cooperation and understanding between the Federal (Central) and State governments are also important ( Ghosh, Nundy, & Mallick, 2020 ). It is important that the National Pandemic Preparedness Plan (NPPP) and State Pandemic Preparedness Plan (SPPP) should be coordinated, collaborated, and integrated at an appropriate level to ensure efficiency A rich technical expertise available with a large number of research and academic institutions must be identified and utilized ( Babbar & Gupta, 2022 ). The pharmaceutical industry should beengaged for the promotion of Research and Development in the production of local technology-driven solutions including door-step diagnostics, drugs and vaccines, and as well as the innovative use of information and communication technologies for data collection and analyses (Ayati, Malik, Raees, & Anwar, 2020). COVID-19 has brought untold misery to a large section of low-income strata and to ensure the sustainability of the livelihood and restore normalcy in post-COVID-19 era, collaboration between local self-governments, civil societies, and NGOs is crucial to ensure maximum community participation ( Raychaudhuri, 2020 ).

The involvement of private research organizations, efficient utilization of medical infrastructure, and availability of technical support from both national and global experts are important to adopt and upgrade combat strategy over a period of time. Enhancing the capacities of health workers and mental health institutions to deal with the mental health of patients and quarantine population is also a priority area ( Wosik et al., 2020 ). The pandemic response requires integrated proactive measures and capacities that involve all sectors and professionals from various fields. It is important to secure, coordinate, and involve interested institutions and stakeholders to enhance the effectiveness of COVID-19 combat strategy ( Ballard et al., 2020 ).

The greatest challenge in managing a disaster like thisis arranging and deploying all the necessary resources, reaching the disaster site in minimum possible time, and helping the areas begin the recovery process ( Day, Melnyk, Larson, Davis, & Whybark, 2012 ). Early intervention, decision-making, and on-time deliveryof services are key for addressing pandemics like COVID-19. All these together demand for proactive leadership, proper planning, and involving multistakeholders to control and eliminate COVID-19-like pandemicsin the future ( Holmes et al., 2020 ). A plan of action developed with the involvement of all the stakeholders and executed meticulously would definitely help the communities to face the pandemic complexities. Engaging with the existing health and community-based networks, media, local NGOs, self-help groups, schools, colleges, universities, local governments and other sectors, such as healthcare service providers, education sector, business, travel and food or agriculture sectors, using a consistent mechanism of communication is very important to develop a long-term financially viable, effective strategy and a set of positive interventions (WHO, 2020). The possibilities of IT-based technology, telecommunications, mobile technology, and social media platforms also need to be explored and integrated to the strategy ( He, Zhang, & Li, 2021 ).

Best Practices for Managing the COVID-19 Pandemic

To effectively manage the pandemic and lessen its effects, multiple best practices have been identified. The significance of transparency, efficiency, and equity in pandemic response efforts has been demonstrated by the adoption of these best practices in both high-, low-, and middle-income countries. This underscores the importance of these principles in effectively managing the pandemic and minimizing its impact on healthcare systems and populations. Understanding the execution and implementation of these best practices is crucial to address such pandemics successfully in the future.

Pandemic management demands a multifaceted approach to effectively respond to the global threat. Clear communication is one of the best practices that must be employed for an effective pandemic response. This involves providing accurate, timely, and easily understandable information to the public to reduce fear and confusion, encourage adherence to public health guidelines, and foster trust in healthcare officials. This involves providing timely and transparent updates about the pandemic and involving stakeholders in decision-making processes ( El-Jardali, Bou-Karroum, & Fadlallah, 2020 ). For instance, in the United States, the Centers for Disease Control and Prevention (CDC) offered daily updates on the pandemic and held regular briefings to ensure that all stakeholders were well-informed and engaged in response efforts (CDC, 2020).

Another effective approach is to collaborate with various sectors and stakeholders, such as governments, healthcare providers, and businesses, to leverage their resources and expertise. By doing so, it can guarantee the equitable distribution of essential resources such as personal protective equipment (PPE) and medical equipment, and promote well-coordinated response efforts. Rwanda’s national COVID-19 Task Force devised a thorough plan that encompassed managing the pandemic, procuring and distributing PPE and medical equipment, and engaging and educating the community ( Dzinamarira, Mapingure, Rwibasira, Mukwenha, & Musuka, 2022 ).

In managing a pandemic, it is crucial to prioritize equity and inclusivity by acknowledging the distinct requirements and viewpoints of marginalized groups like low-income individuals, racial and ethnic minorities, and people with disabilities. This involves addressing the fundamental social factors that influence health outcomes. Brazil’s COVID-19 national Task Force has taken this approach by incorporating members from indigenous communities, who are at higher risk of contracting the virus due to inadequate healthcare and sanitation facilities. To safeguard and assist these communities, the Task Force has created a strategy that involves specialized measures ( Flores-Ramírez et al., 2021 ).

In managing a pandemic, adopting data-driven techniques is vital. This entails leveraging data and technology to track the transmission of the virus, detect high-risk areas, and implement appropriate interventions. South Korea employed a thorough data-driven strategy for contact tracing and testing, which was instrumental in containing the spread of virus during the early stages of the pandemic ( Ferretti et al., 2020 ).

Strengthening healthcare systems is a critical aspect of managing the COVID-19 pandemic. Healthcare systems must have the capacity to respond to the pandemic and maintain essential health services. In Kenya, a COVID-19 response plan was developed that included measures to ensure that healthcare workers had access to PPE and training and that health facilities had the necessary resources to manage COVID-19 cases while maintaining other essential health services. This approach allowed Kenya to effectively manage the pandemic and limit its impact on its healthcare system and population ( Wangari et al., 2021 ). Table 2 presents a summary of the best practices in managing the COVID-19 pandemic. Efficient management of COVID-19-like pandemic demands a well-coordinated approach among multiple sectors and stakeholders. The best practices described, which consist of clear communication, coordinated resource allocation, prioritizing equity and inclusivity, data-driven techniques, and reinforcing healthcare systems, have been derived from both high-, low-, and middle-income nations. These practices underscore the significance of openness, effectiveness, and fairness in responding to pandemics.

Best practices for COVID-19 pandemic management

Issues and Challenges in Management of COVID-19

Most profound and consequential impact of COVID-19 was on physical and mental health, well-being, and livelihood of common people ( Wang et al., 2021 ). COVID-19 has posed a new set of unforeseen challenges because all the sectors have been affected with severe job and profit loss, fall in production, and restricted or no migration or international movements ( Paul et al., 2021 ). During the course of the pandemic, it was observed that the cases increased exponentially, the healthcare system reached the optimal operating capacity, and the patientsdid not get adequate medical care. This pattern of pandemic spread was observed even in most of the developed countries ( Kringos et al., 2020 ).

Following COVID-19, it is necessary to adopt focused and sector-wide approaches to restore lives to normalcy and get the country’s economy back on a growth trajectory. ( Le et al., 2020 ). It is important to assess the severity or magnitude of effects with appropriate long-term research and interventions in which people’s participation is ensured. The challenge is to integrate the approaches of vertical management into horizontal management to involve multistakeholders to work on the needs such as new technologies, flexibility, and innovation in addressing the COVID-19 by deploying all the necessary resources ( Panneer et al., 2021 ). The maintenance of effective coordination between different stakeholders to fulfill the demand is very important ( Janssen et al., 2010 ). There is need to increase humanitarian logistics service, neutrality, and impartiality to COVID-19 healthcare and livelihood-related issues ( Tomasini & Van Wassenhove, 2009 ). The political leadership plays a major role in identification of issues, and proactive politicalleadership is required to ensure participatory, goal-oriented decision-making ( Grint, 2020 ). The major challenges faced by multistakeholder approach include implementing an efficient, dynamic, proactive leadership that shapes such processes or decisions, organize stakeholder groups; and the lack of financial or technical capacities to implement multistakeholder platforms ( Djalante, 2012 ). Table 3 presents a summary of the Post-COVID-19 crisis management and strategies.

Post-COVID-19 crisis management and strategies

Suggestions and policy framework

Having successfully combated and controlled COVID-19, the next task is to restore livelihood options because most of the people have been badly affected by the pandemic. This is essential tobring the country’s economy back to the growth trajectory. For this, long- and short-term planning and interventions are required. The multistakeholder involvement, cooperation, and collaboration are key to address these areas effectively and efficiently within the shortest possible period of time ( Memish et al., 2020 ). We propose the following broad guidelines for different stakeholders to effectively develop and deploy multistakeholder participation and networking in controlling the pandemic.

Government (Federal and State governments)

The Government must arrange for the necessary first-line health infrastructure and sufficient medical care facilities along with deployment of healthcare professionals, mental health professionals, development planners, and humanitarian relief workers ( Edwards & Ott, 2021 ). The understanding and mutual respect between different sectors or departments and sufficient dialog between different actors is required ( Sharma, Borah, & Moses, 2021 ). The Government must bring together and coordinate between clinical and social scientists, government and NGOs, affected persons, and experts from other relevant fields ( Twigg, 2001 ). The Government has to promote participation, coordination, and cooperation among the multistakeholders, so that alldimensions related to the pandemic are addressed appropriately. Evidence-based interventions and policies must be given priority; the advisories and guidelines charted out by expert groups such as the WHO must be given adequate importance in the strategy planning or implementation ( Ullah, Pinglu, Ullah, Abbas, & Khan, 2021 ). There must be adequate fund allocation for developing networks and partnerships. The government must facilitate the involvement of the community members to manage the risks and thus promote adoption of locally appropriate solutions ( Carrasco, Ochiai, & Okazaki, 2016 ). Promoting evidence-based approaches would bring effective outcome, and multistakeholder platform will help achieve clear linkages between institutions, agreements, clear targets, accountability, and mechanisms of evaluation ( Bäckstrand, 2006 ). Promoting the usage of e-governance and e-reporting system is also crucial to increase coverage and efficiency of the pandemic combat system ( Hua & Shaw, 2020 ). The promotion of public–private partnership for developing innovative solutions either to control COVID-19 or to promote livelihood in COVID-19 is also an important task for the Government ( Kudtarkar, 2020 ). Developing and maintaining repositories is also the responsibility of government for which partnership with IT sector companies can be of much use ( Budd et al., 2020 ).

Civil Society Organizations (CSO)

This comprises different organizations, including international aid agencies who work in the humanitarian service area. International aid agencies will be able to bring in the required technical expertise and international funds, whereas the local civil society organizations can take part in the ground-level preparedness, combat interventions related to COVID-19 ( Fry, Cai, Zhang, & Wagner, 2020 ). There is need to develop the knowledge and do capacity-building for taking up activities of emergency relief operations, and COVID-19 combat work, so that the sector can contribute to tackle COVID-19 situations ( Mohseni, Azami-Aghdash, Mousavi Isfahani, Moosavi, & Fardid, 2021 ). Apart from COVID-19 containment, these NGOs will also be having expertise and experience in dealing with mental health issues and provide appropriate care to the affected ( Anand, Verma, Aggarwal, Nanjundappa, & Rai, 2021 ).

Local community

Local communities play an important role in reducing risks related to pandemics such as COVID-19. Along with vulnerable communities, involvement and trust-building to combat against COVID-19 can be intensified ( Panigrahi, Majumdar, Galhotra, Kadle, & John, 2021 ). Local community knowledge and practices can be utilized; dissemination and local awareness methods like folk art can be used for propagating social distancing and personal hygiene etiquettes ( Marston, Renedo, & Miles, 2020 ). Community representatives may provide helpful insight on the local settings and act as main actors for dissemination information and as a primary communication or liaison link between the project officials, targeted communities, and their established networks ( Li, Tan, Wu, & Gao, 2020 ). Legitimacy of the community representatives can be verified by talking informally to a random group of community members and heeding their views on who can be representing their interests in the most effective way. When the legitimate leaders who have high acceptance in the community are involved, the community’s overall involvement and cooperation improves, which ultimately helps tackle the pandemic-related issues ( Canals Lambarri, 2020 ).

Other stakeholders

Governments, Civil Society Organizations, communities, self-help groups, and other stakeholders, including other professionals and personnel, can perform through the suggested model as mentioned in Figure 1 , where at the center there will be Local NGOs and Local Self Governments (Municipalities or Panchayats), to effectively contain COVID-19. Scientists, volunteers, philanthropists, social workers, doctors, psychologists, development and emergency planners, and humanitarian relief workers must be involved in good faith and trust ( Moradian et al., 2020 ). Their professional training, resources, skills, and expertise can be utilized to provide effective and efficient services related to COVID-19 control. Public health workforce development will be supported to ensure that a complete spectrum of expertise is covered including epidemiologists, data managers, laboratory technicians, emergency management and risk communications specialists, and public health managers ( Lavazza & Farina, 2020 ). The services and expertise of other partners such as Red Cross humanitarian workers, National Service Scheme volunteers, National Cadet Corps, and police officials, charitable organizations, private and public sector companies, traditional media (television, radio, and print media), participants of social media, politicians or elected representatives, other national and international health organizations and NGOs, local businesses with international links, and the public at large other ministries (Environment, Finance, External Affairs, Home, etc.) can also contribute effectively ( Anwar, Malik, Raees, & Anwar, 2020 ).

The review emphasizes how crucial the role of multistakeholder cooperation is in lessening the effects of pandemics and disasters. It illustrates how varied collaborations can result in more adaptable and successful solutions. In order to ensure that lessons from recent experiences like COVID-19 are incorporated into future disaster risk reduction efforts, the study looks ahead and calls for a persistent focus on novel and inclusive techniques for stakeholder participation. Disaster Risk Reduction including pandemics needs transformative approaches, systems, strategy, and new technologies, which are to be adopted with flexibility and innovation. The approaches have to be changed from single-direction approach to a comprehensive approach. There need to be a change from the traditional system of administration to a modern citizen-centric management system with networking and collaboration by engaging multistakeholders and contributors. It is important to facilitate the collaboration of multiple stakeholders to create synergy to manage risks for effective disaster risk reduction. This in turn also brings resources into a system such as new innovative ideas, experience, skills and competency, technology, and professionalism. It is important to partner with global-level multistakeholders of multilateral or bilateral agencies and look for opportunities to promote public–private partnership to develop appropriate Disaster Risk Reduction strategies and resilience plans. The disaster intervention should focus on evidence-based interventions and approaches to bring better outcome of mitigation, rescue, relief, and rehabilitation. The COVID-19pandemic has taught a lesson that networking and collaboration are significant for the effective governance of COVID-like pandemics in the near future, where the role of the multistakeholders, local, public, and community civil society groups, and public–private partnership is inevitable.

Conflicts of Interest

The authors declare that there are no conflicts of interest to disclose. All authors have read and agreed to this version of the manuscript.

Authors’ Contributions

SP contributed to the conceptualization of the article. SP, LB, and RRP contributed to the methodology. The data analysis synthesis wasdone by SP, SD, LB, and RRP. The writing and preparation of original draft was done by SP, SD, RM, LB, RRP, and VSA. SP, SD, LB, PCK, RRP, and VSA contributed to the review and editing of the manuscript. The visualization and supervision was performed by SP, SD, and LB.

This research received no external funding.

Achyar, E., Schmidt-Vogt, D., & Shivakoti, G. P. (2015). Dynamics of the multi-stakeholder forum and its effectiveness in promoting sustainable forest fire management practices in South Sumatra, Indonesia. Environmental Development , 13, 4–17. https://doi.org/10.1016/j.envdev.2014.11.002 https://doi.org/10.1016/j.envdev.2014.11.002

Akenroye, T. O., Abubakre, A., Elbaz, J., Vishnu, C. R., Beka Be Nguema, J.-N., Rana, G., … Falode, O. (2022). Modeling the barriers to multistakeholder collaboration for COVID-19 pandemic response: Evidence from Sub-Saharan Africa. International Public Management Journal , 25(2), 192–216. https://doi.org/10.1080/10967494.2021.1970061 https://doi.org/10.1080/10967494.2021.1970061

Anand, V., Verma, L., Aggarwal, A., Nanjundappa, P., & Rai, H. (2021). COVID-19 and psychological distress: Lessons for India. PLoS One , 16(8), e0255683. https://doi.org/10.1371/journal.pone.0255683 https://doi.org/10.1371/journal.pone.0255683

Ansell, C., Boin, A., & Keller, A. (2010). Managing transboundary crises: Identifying the building blocks of an effective response system. Journal of Contingencies and Crisis Management , 18(4), 195–207. https://doi.org/10.1111/j.1468-5973.2010.00620.x https://doi.org/10.1111/j.1468-5973.2010.00620.x

Anwar, A., Malik, M., Raees, V., & Anwar, A. (2020). Role of mass media and public health communications in the COVID-19 pandemic. Cureus , 12(9), e10453. https://doi.org/10.7759/cureus.10453 https://doi.org/10.7759/cureus.10453

Ayati, N., Saiyarsarai, P., & Nikfar, S. (2020). Short and long-term impacts of COVID-19 on the pharmaceutical sector. DARU Journal of Pharmaceutical Sciences , 28(2), 799–805. https://doi.org/10.1007/s40199-020-00358-5 https://doi.org/10.1007/s40199-020-00358-5

Babbar, M., & Gupta, T. (2022). Response of educational institutions to COVID-19 pandemic: An inter-country comparison. Policy Futures in Education , 20(4), 469–491. https://doi.org/10.1177/14782103211021937 https://doi.org/10.1177/14782103211021937

Bäckstrand, K. (2006). Multi-stakeholder partnerships for sustainable development: Rethinking legitimacy, accountability and effectiveness. European Environment , 16(5), 290–306. https://doi.org/10.1002/eet.425 https://doi.org/10.1002/eet.425

Ballard, M., Bancroft, E., Nesbit, J., Johnson, A., Holeman, I., Foth, J., … Palazuelos, D. (2020). Prioritising the role of community health workers in the COVID-19 response. BMJ Global Health , 5(6), e002550. https://doi.org/10.1136/bmjgh-2020-002550 https://doi.org/10.1136/bmjgh-2020-002550

Beisheim, M., & Simon, N. (2016). Multi-stakeholder partnerships for implementing the 2030 Agenda: Improving accountability and transparency . Analytical Paper for the 2016 ECOSOC Partnership Forum.

Bennett, B., & Carney, T. (2011). Review paper: Pandemic preparedness in Asia: A role for law and ethics? Asia Pacific Journal of Public Health , 23(3), 419–430. https://doi.org/10.1177/1010539511408411 https://doi.org/10.1177/1010539511408411

Biekart, K., & Fowler, A. (2018). Ownership dynamics in local multi-stakeholder initiatives. Third World Quarterly , 39(9), 1692–1710. https://doi.org/10.1080/01436597.2018.1450139 https://doi.org/10.1080/01436597.2018.1450139

Budd, J., Miller, B. S., Manning, E. M., Lampos, V., Zhuang, M., Edelstein, M., … McKendry, R. A. (2020). Digital technologies in the public-health response to COVID-19. Nature Medicine , 26(8), 1183–1192. https://doi.org/10.1038/s41591-020-1011-4 https://doi.org/10.1038/s41591-020-1011-4

Canals Lambarri, M. (2020). Learning from the COVID-19 pandemic: Concepts for good decision-making. RevistaMédica de Chile , 148(3), 418–420. https://doi.org/10.4067/s0034-98872020000300418 https://doi.org/10.4067/s0034-98872020000300418

Carrasco, S., Ochiai, C., & Okazaki, K. (2016). Disaster induced resettlement: Multi-stakeholder interactions and decision making following tropical storm Washi in Cagayan de Oro, Philippines. Procedia - Social and Behavioral Sciences , 218, 35–49. https://doi.org/10.1016/j.sbspro.2016.04.008 https://doi.org/10.1016/j.sbspro.2016.04.008

Centers for Disease Control and Prevention (CDC). (2020). Coronavirus Disease 2019 (COVID-19) . Centers for Disease Control and Prevention. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/index.html https://www.cdc.gov/coronavirus/2019-ncov/index.html

Cozzolino, A. (2012). Humanitarian logistics and supply chain management. In A. Cozzolino (Ed.), Humanitarian logistics: Cross-sector cooperation in disaster relief management (pp. 5–16). Berlin Heidelberg: Springer. https://doi.org/10.1007/978-3-642-30186-5_2 https://doi.org/10.1007/978-3-642-30186-5_2

Crispo, A., Bimonte, S., Porciello, G., Forte, C. A., Cuomo, G., Montagnese, C., … Cuomo, A. (2021). Strategies to evaluate outcomes in long-COVID-19 and post-COVID survivors. Infectious Agents and Cancer , 16(1), 62. https://doi.org/10.1186/s13027-021-00401-3 https://doi.org/10.1186/s13027-021-00401-3

Cruz, P. L. (2014). Cross-border governance on the U.S.–Mexico border: Institutional challenges and developments in health collaboration. Regions and Cohesion , 4(1), 53–71. https://doi.org/10.3167/reco.2014.040104 https://doi.org/10.3167/reco.2014.040104

Day, J. M., Melnyk, S. A., Larson, P. D., Davis, E. W., & Whybark, D. C. (2012). Humanitarian and disaster relief supply chains: A matter of life and death. Journal of Supply Chain Management , 48(2), 21–36. https://doi.org/10.1111/j.1745-493X.2012.03267.x https://doi.org/10.1111/j.1745-493X.2012.03267.x

Dayour, F., Adongo, C. A., Amuquandoh, F. E., & Adam, I. (2021). Managing the COVID-19 crisis: Coping and post-recovery strategies for hospitality and tourism businesses in Ghana. Journal of Hospitality and Tourism Insights , 4(4), 373–392. https://doi.org/10.1108/JHTI-08-2020-0150 https://doi.org/10.1108/JHTI-08-2020-0150

de Vries, M., Kenis, P., Kraaij-Dirkzwager, M., Ruitenberg, E. J., Raab, J., & Timen, A. (2019). Collaborative emergency preparedness and response to cross-institutional outbreaks of multidrug-resistant organisms: A scenario-based approach in two regions of the Netherlands. BMC Public Health , 19(1), 52. https://doi.org/10.1186/s12889-018-6376-7 https://doi.org/10.1186/s12889-018-6376-7

Dikid, T., Chaudhary, S., Goel, K., Padda, P., Sahu, R., Kumar, T., … Narain, J. P. (2020). Responding to COVID-19 pandemic: Why a strong health system is required. The Indian Journal of Medical Research , 151(2–3), 140. https://doi.org/10.4103/ijmr.IJMR_761_20 https://doi.org/10.4103/ijmr.IJMR_761_20

Djalante, R. (2012). Adaptive governance and resilience: The role of multi-stakeholder platforms in disaster risk reduction. Natural Hazards and Earth System Sciences , 12(9), 2923–2942. https://doi.org/10.5194/nhess-12-2923-2012 https://doi.org/10.5194/nhess-12-2923-2012

Dunlop, A. L., Logue, K. M., Vaidyanathan, L., & Isakov, A. P. (2016). Facilitators and barriers for effective academic-community collaboration for disaster preparedness and response. Journal of Public Health Management and Practice , 22(3), E20–E28. https://doi.org/10.1097/PHH.0b013e3182205087 https://doi.org/10.1097/PHH.0b013e3182205087

Dzinamarira, T., Mapingure, M. P., Rwibasira, G. N., Mukwenha, S., & Musuka, G. (2022). COVID-19: Comparison of the response in Rwanda, South Africa and Zimbabwe. MEDICC Review , 23, 15–20. https://doi.org/10.37757/mr2021.v23.n3.4 https://doi.org/10.37757/mr2021.v23.n3.4

Edwards, F. L., & Ott, J. S. (2021). Governments’ responses to the COVID-19 pandemic. International Journal of Public Administration , 44(11–12), 879–884. https://doi.org/10.1080/01900692.2021.1936964 https://doi.org/10.1080/01900692.2021.1936964

El-Jardali, F., Bou-Karroum, L., & Fadlallah, R. (2020). Amplifying the role of knowledge translation platforms in the COVID-19 pandemic response. Health Research Policy and Systems , 18(1), 58. https://doi.org/10.1186/s12961-020-00576-y https://doi.org/10.1186/s12961-020-00576-y

Faraj, S., & Xiao, Y. (2006). Coordination in fast-response organizations. Management Science , 52(8), 1155–1169. https://doi.org/10.1287/mnsc.1060.0526 https://doi.org/10.1287/mnsc.1060.0526

Faysse, N. (2006). Troubles on the way: An analysis of the challenges faced by multi-stakeholder platforms. Natural Resources Forum , 30(3), 219–229. https://doi.org/10.1111/j.1477-8947.2006.00112.x https://doi.org/10.1111/j.1477-8947.2006.00112.x

Ferretti, L., Wymant, C., Kendall, M., Zhao, L., Nurtay, A., Abeler-Dörner, L., … Fraser, C. (2020). Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing. Science , 368(6491), eabb6936. https://doi.org/10.1126/science.abb6936 https://doi.org/10.1126/science.abb6936

Fletcher, S. M., Thiessen, J., Gero, A., Rumsey, M., Kuruppu, N., & Willetts, J. (2013). Traditional coping strategies and disaster response: Examples from the South Pacific Region. Journal of Environmental and Public Health , 2013, 264503. https://doi.org/10.1155/2013/264503 https://doi.org/10.1155/2013/264503

Flores-Ramírez, R., Berumen-Rodríguez, A. A., Martínez-Castillo, M. A., Alcántara-Quintana, L. E., Díaz-Barriga, F., & Díaz de León-Martínez, L. (2021). A review of environmental risks and vulnerability factors of indigenous populations from Latin America and the Caribbean in the face of the COVID-19. Global Public Health , 16(7), 975–999. https://doi.org/10.1080/17441692.2021.1923777 https://doi.org/10.1080/17441692.2021.1923777

Freeman, R. E., Harrison, J. S., Wicks, A. C., Parmar, B. L., & De Colle, S. (2010). Stakeholder theory: The state of the art . Cambridge: Cambridge University Press. https://doi.org/10.1017/CBO9780511815768 https://doi.org/10.1017/CBO9780511815768

Fry, C. V., Cai, X., Zhang, Y., & Wagner, C. S. (2020). Consolidation in a crisis: Patterns of international collaboration in early COVID-19 research. PLoS One , 15(7), e0236307. https://doi.org/10.1371/journal.pone.0236307 https://doi.org/10.1371/journal.pone.0236307

Ghosh, A., Nundy, S., & Mallick, T. K. (2020). How India is dealing with COVID-19 pandemic. Sensors International , 1, 100021. https://doi.org/10.1016/j.sintl.2020.100021 https://doi.org/10.1016/j.sintl.2020.100021

Government of India (GOI). (2020). National Preparedness Survey on COVID-19: Responsesofdistrict collectors and IAS officers (2014–2018 batches) . G Department of Administrative Reforms and Public Grievances. Retrieved from https://darpg.gov.in/sites/default/files/COVID-19%20Impact%20Feedback%20Report.pdf https://darpg.gov.in/sites/default/files/COVID-19%20Impact%20Feedback%20Report.pdf

Grint, K. (2020). Leadership, management and command in the time of the Coronavirus. Leadership , 16(3), 314–319. https://doi.org/10.1177/1742715020922445 https://doi.org/10.1177/1742715020922445

Hayne, S. C., & Smith, C. A. P. (2005). The relationship between e-collaboration and cognition. International Journal of e-Collaboration (IJeC) , 1(3), 17–34. https://doi.org/10.4018/jec.2005070102 https://doi.org/10.4018/jec.2005070102

He, W., Zhang, Z. J., & Li, W. (2021). Information technology solutions, challenges, and suggestions for tackling the COVID-19 pandemic. International Journal of Information Management , 57, 102287. https://doi.org/10.1016/j.ijinfomgt.2020.102287 https://doi.org/10.1016/j.ijinfomgt.2020.102287

Hemmati, M. (2012). Multi-stakeholder processes for governance and sustainability: Beyond deadlock and conflict . New Delhi, India: Routledge. https://doi.org/10.4324/9781849772037 https://doi.org/10.4324/9781849772037

Holmes, E. A., O’Connor, R. C., Perry, V. H., Tracey, I., Wessely, S., Arseneault, L., … Bullmore, E. (2020). Multidisciplinary research priorities for the COVID-19 pandemic: A call for action for mental health science. The Lancet Psychiatry , 7(6), 547–560. https://doi.org/10.1016/S2215-0366(20)30168-1 https://doi.org/10.1016/S2215-0366(20)30168-1

Hu, H., Lei, T., Hu, J., Zhang, S., & Kavan, P. (2018). Disaster-mitigating and general innovative responses to climate disasters: Evidence from modern and historical China. International Journal of Disaster Risk Reduction , 28, 664–673. https://doi.org/10.1016/j.ijdrr.2018.01.022 https://doi.org/10.1016/j.ijdrr.2018.01.022

Hua, J., & Shaw, R. (2020). Corona virus (COVID-19) “Infodemic” and emerging issues through a data lens: The case of China. International Journal of Environmental Research and Public Health , 17(7), 2309. https://doi.org/10.3390/ijerph17072309 https://doi.org/10.3390/ijerph17072309

Janssen, M., Lee, J., Bharosa, N., & Cresswell, A. (2010). Advances in multi-agency disaster management: Key elements in disaster research. Information Systems Frontiers , 12(1), 1–7. https://doi.org/10.1007/s10796-009-9176-x https://doi.org/10.1007/s10796-009-9176-x

Jha, M. K., & Pankaj, A. K. (2021). Insecurity and fear travel as labour travels in the time of pandemic. In India’s migrant workers and the pandemic (pp. 177–190). New Delhi, India:Routledge. https://doi.org/10.4324/9781003246121-11 https://doi.org/10.4324/9781003246121-11

Jiang, Q. (2020). What small NGOs can deliver: A case study of a Canadian community-based project making fabric scrub caps for healthcare workers during the COVID-19 pandemic. International Social Work , 63(6), 851–856. https://doi.org/10.1177/0020872820959374 https://doi.org/10.1177/0020872820959374

Jillson, I. A., Clarke, M., Allen, C., Waller, S., Koehlmoos, T., Mumford, W., … Trant, A. (2019). Improving the science and evidence base of disaster response: A policy research study. BMC Health Services Research , 19(1), 274. https://doi.org/10.1186/s12913-019-4102-5 https://doi.org/10.1186/s12913-019-4102-5

Jones, L., & Hameiri, S. (2022). Explaining the failure of global health governance during COVID-19, International Affairs , 98(6), 2057–2076. https://doi.org/10.1093/ia/iiac231 https://doi.org/10.1093/ia/iiac231

Kringos, D., Carinci, F., Barbazza, E., Bos, V., Gilmore, K., Groene, O., … (2020). Managing COVID-19 within and across health systems: Why we need performance intelligence to coordinate a global response. Health Research Policy and Systems , 18(1), 80. https://doi.org/10.1186/s12961-020-00593-x https://doi.org/10.1186/s12961-020-00593-x

Kudtarkar, S. G. (2020). Resetting PPP in infrastructure model in India post-COVID-19 pandemic. The Indian Economic Journal , 68(3), 365–382. https://doi.org/10.1177/0019466220976678 https://doi.org/10.1177/0019466220976678

Lai, A. Y. (2012). Organizational collaborative capacity in fighting pandemic crises: A literature review from the public management perspective. Asia Pacific Journal of Public Health , 24(1), 7–20. https://doi.org/10.1177/1010539511429592 https://doi.org/10.1177/1010539511429592

Lavazza, A., & Farina, M. (2020). The role of experts in the Covid-19 pandemic and the limits of their epistemic authority in democracy. Frontiers in Public Health , 8, 356. https://doi.org/10.3389/fpubh.2020.00356 https://doi.org/10.3389/fpubh.2020.00356

Le, H. T., Mai, H. T., Pham, H. Q., Nguyen, C. T., Vu, G. T., Phung, D. T., … Ho, C. S. (2020). Feasibility of Intersectoral collaboration in epidemic preparedness and response at Grassroots levels in the threat of COVID-19 pandemic in Vietnam. Frontiers in Public Health , 8, 589437. https://doi.org//10.3389/fpubh.2020.589437 https://doi.org//10.3389/fpubh.2020.589437

Lee, J., Cho, H. S., & Shin, S. R. (2021). Nursing strategies for the post-COVID-19 era. International Nursing Review , 68(2), 149–152. https://doi.org/10.1111/inr.12653 https://doi.org/10.1111/inr.12653

Lee, S. M., & Lee, D. (2021). Opportunities and challenges for contactless healthcare services in the post-COVID-19 Era. Technological Forecasting and Social Change , 167, 120712. https://doi.org/10.1016/j.techfore.2021.120712 https://doi.org/10.1016/j.techfore.2021.120712

Levy, D. L. (2021). COVID-19 and global governance. Journal of Management Studies , 58(2), 562–566. https://doi.org/10.1111/joms.12654 https://doi.org/10.1111/joms.12654

Li, C.-H., Tan, C.-X., Wu, A.-H., & Gao, C.-Q. (2020). COVID-19: The role of community in China’s response. Journal of the Royal Society of Medicine , 113(7), 280–281. https://doi.org/10.1177/0141076820935344 https://doi.org/10.1177/0141076820935344

Marinelli, M. (2020). Emergency healthcare facilities: Managing design in a post-Covid-19 world. IEEE Engineering Management Review , 48(4), 65–71. https://doi.org/10.1109/EMR.2020.3029850 https://doi.org/10.1109/EMR.2020.3029850

Marston, C., Renedo, A., & Miles, S. (2020). Community participation is crucial in a pandemic. The Lancet , 395(10238), 1676–1678. https://doi.org/10.1016/S0140-6736(20)31054-0 https://doi.org/10.1016/S0140-6736(20)31054-0

McCullough, J. M., Eisen-Cohen, E., & Lott, B. (2020). Barriers and facilitators to intraorganizational collaboration in public health: Relational coordination across public health services targeting individuals and populations. Health Care Management Review , 45(1). Retrieved from https://journals.lww.com/hcmrjournal/Fulltext/2020/01000/Barriers_and_facilitators_to_intraorganizational.8.aspx . https://doi.org/10.1097/HMR.0000000000000203 https://journals.lww.com/hcmrjournal/Fulltext/2020/01000/Barriers_and_facilitators_to_intraorganizational.8.aspx https://doi.org/10.1097/HMR.0000000000000203

McDonald, S. M., & Sinha, R. (2008). Information communication technology: Reform of organisational crisis management during natural disasters. International Journal of Management Practice , 3(2), 131–149. Retrieved from https://www.researchgate.net/profile/Sean-Mcdonald-4/publication/247834224_Information_communication_technology_Reform_of_organisational_crisis_management_during_natural_disasters/links/58c45cce45851538eb87568e/Information-communication-technology-Reform-of-organisational-crisis-management-during-natural-disasters.pdf . https://doi.org/10.1504/IJMP.2008.018367 https://www.researchgate.net/profile/Sean-Mcdonald-4/publication/247834224_Information_communication_technology_Reform_of_organisational_crisis_management_during_natural_disasters/links/58c45cce45851538eb87568e/Information-communication-technology-Reform-of-organisational-crisis-management-during-natural-disasters.pdf https://doi.org/10.1504/IJMP.2008.018367

Meduri, Y. (2016). Multi-stakeholder participation in disaster recovery: A case study. Procedia Engineering , 159, 179–185. https://doi.org/10.1016/j.proeng.2016.08.153 https://doi.org/10.1016/j.proeng.2016.08.153

Memish, Z. A., Ebrahim, S. H., Kattan, R. F., Alharthy, A., Alqahtani, S. A., & Karakitsos, D. (2020). Leadership to prevent COVID-19: Is it the most important mitigation factor? Travel Medicine and Infectious Disease , 38, 101925. https://doi.org/10.1016/j.tmaid.2020.101925 https://doi.org/10.1016/j.tmaid.2020.101925

Mohseni, M., Azami-Aghdash, S., Mousavi Isfahani, H., Moosavi, A., & Fardid, M. (2021). Role of nongovernmental organizations in controlling COVID-19. Disaster Medicine and Public Health Preparedness , 16(5), 1705. https://doi.org/10.1017/dmp.2021.60 https://doi.org/10.1017/dmp.2021.60

Moradian, N., Ochs, H. D., Sedikies, C., Hamblin, M. R., Camargo, C. A., Martinez, J. A., … Rezaei, N. (2020). The urgent need for integrated science to fight COVID-19 pandemic and beyond. Journal of Translational Medicine , 18(1), 205. https://doi.org/10.1186/s12967-020-02364-2 https://doi.org/10.1186/s12967-020-02364-2

Moynihan, D. P. (2008). Combining structural forms in the search for policy tools: Incident command systems in U.S. crisis management. Governance , 21(2), 205–229. https://doi.org/10.1111/j.1468-0491.2008.00395.x https://doi.org/10.1111/j.1468-0491.2008.00395.x

Nolte, I. M., & Boenigk, S. (2013). A study of ad hoc network performance in disaster response. Nonprofit and Voluntary Sector Quarterly , 42(1), 148–173. https://doi.org/10.1177/0899764011434557 https://doi.org/10.1177/0899764011434557

Nowell, B., Steelman, T., Velez, A.-L. K., & Yang, Z. (2018). The structure of effective governance of disaster response networks: Insights from the field. The American Review of Public Administration , 48(7), 699–715. https://doi.org/10.1177/0275074017724225 https://doi.org/10.1177/0275074017724225

Obeng, E. A., Marfo, E., Owusu-Ansah, N., & Nantwi, G. (2014). Assessment of the effectiveness of multi-stakeholder dialogue . Tropenbos International, Wageningen, The Netherlands, 82.

Panigrahi, S. K., Majumdar, S., Galhotra, A., Kadle, S. C., & John, A. S. (2021). Community based management of COVID-19 as a way forward for pandemic response. Frontiers in Public Health , 8, 589772. https://doi.org/10.3389/fpubh.2020.589772 https://doi.org/10.3389/fpubh.2020.589772

Panneer, S., Kantamaneni, K., Pushparaj, R. R. B., Shekhar, S., Bhat, L., & Rice, L. (2021). Multistakeholder participation in disaster management—The case of the COVID-19 pandemic. Healthcare , 9(2), 203. https://doi.org/10.3390/healthcare9020203 https://doi.org/10.3390/healthcare9020203

Patuelli, A., Caldarelli, G., Lattanzi, N., & Saracco, F. (2021). Firms’ challenges and social responsibilities during Covid-19: A Twitter analysis. PLoS One , 16(7), e0254748. https://doi.org/10.1371/journal.pone.0254748 https://doi.org/10.1371/journal.pone.0254748

Paul, A., Nath, T. K., Mahanta, J., Sultana, N. N., Kayes, A. S. M. I., … Paul, S. (2021). Psychological and livelihood impacts of COVID-19 on Bangladeshi lower income people. Asia Pacific Journal of Public Health , 33(1), 100–108. https://doi.org/10.1177/1010539520977304 https://doi.org/10.1177/1010539520977304

Raychaudhuri, A. (2020). COVID-19 pandemic crisis and the way forward for India. COVID-19 , 9. Retrieved from https://aic.ris.org.in/sites/aic.ris.org.in/files/Publication/COVID-19%20Report%202020%20Final%201-9_section-min_compressed.pdf#page=34 https://aic.ris.org.in/sites/aic.ris.org.in/files/Publication/COVID-19%20Report%202020%20Final%201-9_section-min_compressed.pdf#page=34

Ryu, S., & Johansen, M. S. (2017). Collaborative networking, environmental shocks, and organizational performance: Evidence from hurricane Rita. International Public Management Journal , 20(2), 206–225. https://doi.org/10.1080/10967494.2015.1059915 https://doi.org/10.1080/10967494.2015.1059915

Satapathy, S., & Walia, A. (2007). Affected parents’ and other stakeholders’perception of a fire disaster management in India: A situational analysis. Disaster Management & Response , 5(4), 111–118. https://doi.org/10.1016/j.dmr.2007.08.002 https://doi.org/10.1016/j.dmr.2007.08.002

Sharma, A., Borah, S. B., & Moses, A. C. (2021). Responses to COVID-19: The role of governance, healthcare infrastructure, and learning from past pandemics. Journal of Business Research , 122, 597–607. https://doi.org/10.1016/j.jbusres.2020.09.011 https://doi.org/10.1016/j.jbusres.2020.09.011

Shoaf, K. I., Kelley, M. M., O’Keefe, K., Arrington, K. D., & Prelip, M. L. (2014). Enhancing emergency preparedness and response systems: Correlates of collaboration between local health departments and school districts. Public Health Report , 129 Suppl 4(Suppl 4), 107–113. https://doi.org/10.1177/00333549141296s414 https://doi.org/10.1177/00333549141296s414

Taylor, A. L., & Habibi, R. (2020). The collapse of global cooperation under the WHO International Health Regulations at the outset of COVID-19: Sculpting the future of global health governance. American Society of International Law Insights , 24, 15. Retrieved from https://www.asil.org/insights/volume/24/issue/15/collapse-global-cooperation-under-who-international-health-regulations. https://www.asil.org/insights/volume/24/issue/15/collapse-global-cooperation-under-who-international-health-regulations.

Tomasini, R. M., & Van Wassenhove, L. N. (2009). From preparedness to partnerships: Case study research on humanitarian logistics. International Transactions in Operational Research , 16(5), 549–559. https://doi.org/10.1111/j.1475-3995.2009.00697.x https://doi.org/10.1111/j.1475-3995.2009.00697.x

Trimurti, N., Endang, L., Hardi, W., & Hartuti, P. (2020, 2020/12/21). Multi-stakeholder participation challenges in local disaster management policies: A case from Bojonegoro District, Indonesia . Proceedings of the 6th International Conference on Social and Political Sciences (ICOSAPS 2020), Indonesia.

Twigg, J. (2001). Physician heal thyself?: The politics of disaster mitigation . London: Benfield Greig Hazard Research Center, University College.

Ullah, A., Pinglu, C., Ullah, S., Abbas, H. S. M., & Khan, S. (2021). The role of e-Governance in combating COVID-19 and promoting sustainable development: A comparative study of China and Pakistan. Chinese Political Science Review , 6(1), 86–118. https://doi.org/10.1007/s41111-020-00167-w https://doi.org/10.1007/s41111-020-00167-w

Verguet, S., Hailu, A., Eregata, G. T., Memirie, S. T., Johansson, K. A., & Norheim, O. F. (2021). Toward universal health coverage in the post-COVID-19 era. Nature Medicine , 27(3), 380–387. https://doi.org/10.1038/s41591-021-01268-y https://doi.org/10.1038/s41591-021-01268-y

Wang, C., Tee, M., Roy, A. E., Fardin, M. A., Srichokchatchawan, W., Habib, H. A., … Kuruchittham, V. (2021). The impact of COVID-19 pandemic on physical and mental health of Asians: A study of seven middle-income countries in Asia. PLoS One , 16(2), e0246824. https://doi.org/10.1371/journal.pone.0246824 https://doi.org/10.1371/journal.pone.0246824

Wangari, E. N., Gichuki, P., Abuor, A. A., Wambui, J., Okeyo, S. O., Oyatsi, H. T. N., … Kulohoma, B. W. (2021). Kenya’s response to the COVID-19 pandemic: A balance between minimising morbidity and adverse economic impact. AAS Open Research , 4, 3. https://doi.org/10.12688/aasopenres.13156.2 https://doi.org/10.12688/aasopenres.13156.2

Warner, J., Waalewijn, P., & Hilhorst, D. (2002). Public participation in disaster-prone watersheds: Time for multi-stakeholder platforms . Retrieved from https://library.wur.nl/WebQuery/wurpubs/fulltext/233664 https://library.wur.nl/WebQuery/wurpubs/fulltext/233664

WHO Coronavirus (COVID-19) Dashboard. (2023). May 25, 2023. Retrieved from https://covid19.who.int https://covid19.who.int

World Health Organization (WHO). (2020). COVID-19 strategic preparedness and response plan: Operational planning guidelines to support country preparedness and response . Retrieved from https://www.who.int/docs/default-source/coronaviruse/covid-19-sprp-unct-guidelines.pdf https://www.who.int/docs/default-source/coronaviruse/covid-19-sprp-unct-guidelines.pdf

Wosik, J., Fudim, M., Cameron, B., Gellad, Z. F., Cho, A., Phinney, D., … Tcheng, J. (2020). Telehealth transformation: COVID-19 and the rise of virtual care. Journal of the American Medical Informatics Association , 27(6), 957–962. https://doi.org/10.1093/jamia/ocaa067 https://doi.org/10.1093/jamia/ocaa067

Zhou, C., Su, F., Pei, T., Zhang, A., Du, Y., Luo, B., … Xiao, H. (2020). COVID-19: Challenges to GIS with Big Data. Geography and Sustainability , 1(1), 77–87. https://doi.org/10.1016/j.geosus.2020.03.005 https://doi.org/10.1016/j.geosus.2020.03.005

Sigamani Panneer, is a Professor, Centre for the Study of Law and Governance, Jawaharlal Nehru University, New Delhi, India and D. Litt. Scholar, Department of Social Work, Assam University, Silchar. He can be contacted at [email protected].

Subhabrata Dutta is a Professor, Department of Social Work, Assam University, Silchar. He can be contacted at [email protected].

Lekha D. Bhat, is an Assistant Professor, Department of Epidemiology and Public Health, Central University of Tamil Nadu, Thiruvarur, India. She can be contacted at [email protected].

Prakash Chand Kandpal, is a Professor, Centre for the Study of Law and Governance, Jawaharlal Nehru University, New Delhi, India. He can be contacted at [email protected].

Robert Ramesh Babu P, is an Assistant Professor, PG Department of Social Work, Don Bosco College, Dharmapuri, India. He can be contacted at [email protected]; [email protected].

Rubavel M., PhD, Consultant UNDP, Bengaluru, Karnataka. He can be contacted at [email protected].

Vigneshwaran Subbiah Akkayasamy, is an Assistant Professor, Department of Sociology and Social Work, School of Social Sciences, CHRIST (Deemed to be University), Bangalore Central Campus, India. He can be contacted at [email protected].

Harvard-Style Citation

Panneer, S , Dutta, S , Bhat, L , Kandpal, P , Babu P, R , M, R & Akkayasamy, V. (2024) 'Multistakeholder Participation, Collaboration, and Networking in Disaster Risk Reduction and Pandemic Management: Insights and Future Policy Framework', Social Development Issues . 46(2) doi: 10.3998/sdi.5989

Show: Vancouver Citation Style | APA Citation Style

Vancouver-Style Citation

Panneer, S , Dutta, S , Bhat, L , Kandpal, P , Babu P, R , M, R & Akkayasamy, V. Multistakeholder Participation, Collaboration, and Networking in Disaster Risk Reduction and Pandemic Management: Insights and Future Policy Framework. Social Development Issues. 2024 5; 46(2) doi: 10.3998/sdi.5989

Show: Harvard Citation Style | APA Citation Style

APA-Style Citation

Panneer, S Dutta, S Bhat, L Kandpal, P Babu P, R M, R & Akkayasamy, V. (2024, 5 17). Multistakeholder Participation, Collaboration, and Networking in Disaster Risk Reduction and Pandemic Management: Insights and Future Policy Framework. Social Development Issues 46(2) doi: 10.3998/sdi.5989

Show: Harvard Citation Style | {% trans 'Vancouver Citation Style' %}

Non Specialist Summary

This article has no summary

An official website of the United States government

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

• Publications
• Account settings

Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now .

• Advanced Search
• Journal List
• Elsevier - PMC COVID-19 Collection

Effects of COVID-19 pandemic in daily life

Dear Editor,

COVID-19 (Coronavirus) has affected day to day life and is slowing down the global economy. This pandemic has affected thousands of peoples, who are either sick or are being killed due to the spread of this disease. The most common symptoms of this viral infection are fever, cold, cough, bone pain and breathing problems, and ultimately leading to pneumonia. This, being a new viral disease affecting humans for the first time, vaccines are not yet available. Thus, the emphasis is on taking extensive precautions such as extensive hygiene protocol (e.g., regularly washing of hands, avoidance of face to face interaction etc.), social distancing, and wearing of masks, and so on. This virus is spreading exponentially region wise. Countries are banning gatherings of people to the spread and break the exponential curve. 1 , 2 Many countries are locking their population and enforcing strict quarantine to control the spread of the havoc of this highly communicable disease.

COVID-19 has rapidly affected our day to day life, businesses, disrupted the world trade and movements. Identification of the disease at an early stage is vital to control the spread of the virus because it very rapidly spreads from person to person. Most of the countries have slowed down their manufacturing of the products. 3 , 4 The various industries and sectors are affected by the cause of this disease; these include the pharmaceuticals industry, solar power sector, tourism, Information and electronics industry. This virus creates significant knock-on effects on the daily life of citizens, as well as about the global economy.

Presently the impacts of COVID-19 in daily life are extensive and have far reaching consequences. These can be divided into various categories:

• • Challenges in the diagnosis, quarantine and treatment of suspected or confirmed cases
• • High burden of the functioning of the existing medical system
• • Patients with other disease and health problems are getting neglected
• • Overload on doctors and other healthcare professionals, who are at a very high risk
• • Overloading of medical shops
• • Requirement for high protection
• • Disruption of medical supply chain
• • Slowing of the manufacturing of essential goods
• • Disrupt the supply chain of products
• • Losses in national and international business
• • Poor cash flow in the market
• • Significant slowing down in the revenue growth
• • Service sector is not being able to provide their proper service
• • Cancellation or postponement of large-scale sports and tournaments
• • Avoiding the national and international travelling and cancellation of services
• • Disruption of celebration of cultural, religious and festive events
• • Undue stress among the population
• • Social distancing with our peers and family members
• • Closure of the hotels, restaurants and religious places
• • Closure of places for entertainment such as movie and play theatres, sports clubs, gymnasiums, swimming pools, and so on.
• • Postponement of examinations

This COVID-19 has affected the sources of supply and effects the global economy. There are restrictions of travelling from one country to another country. During travelling, numbers of cases are identified positive when tested, especially when they are taking international visits. 5 All governments, health organisations and other authorities are continuously focussing on identifying the cases affected by the COVID-19. Healthcare professional face lot of difficulties in maintaining the quality of healthcare in these days.

Declaration of competing interest

None declared.

• Open access
• Published: 08 May 2024

The digital transformation in pharmacy: embracing online platforms and the cosmeceutical paradigm shift

• Ahmad Almeman   ORCID: orcid.org/0000-0002-6521-9463 1  

Journal of Health, Population and Nutrition volume  43 , Article number:  60 ( 2024 ) Cite this article

726 Accesses

3 Altmetric

Metrics details

In the face of rapid technological advancement, the pharmacy sector is undergoing a significant digital transformation. This review explores the transformative impact of digitalization in the global pharmacy sector. We illustrated how advancements in technologies like artificial intelligence, blockchain, and online platforms are reshaping pharmacy services and education. The paper provides a comprehensive overview of the growth of online pharmacy platforms and the pivotal role of telepharmacy and telehealth during the COVID-19 pandemic. Additionally, it discusses the burgeoning cosmeceutical market within online pharmacies, the regulatory challenges faced globally, and the private sector’s influence on healthcare technology. Conclusively, the paper highlights future trends and technological innovations, underscoring the dynamic evolution of the pharmacy landscape in response to digital transformation.

Introduction

Digital technology is driving a massive shift in the worldwide pharmacy industry with the goal of improving productivity, efficiency, and flexibility in healthcare delivery. In the pharmacy industry, implementing digital technologies like automation, computerization, and robotics is essential to cutting expenses and enhancing service delivery​​ [ 1 ]. With a predicted 14.42% annual growth rate, the digital pharmacy market is expanding significantly and is expected to reach a market volume of about $35.33 billion by 2026. This expansion reflects the pharmacy industry’s growing reliance on and promise for digital technologies​ [ 2 ].

Pharmacy services have always been focused on face-to-face communication and paper-based procedures. However, the drive for more effective, transparent, and patient-centered healthcare is clear evidence of the growing need for digital transformation. Breakthroughs like mobile communications, cloud computing, advanced analytics, and the Internet of Things (IoT) are reshaping the healthcare sector. These breakthroughs have the potential to greatly improve patient care and service delivery, as demonstrated in other industries including banking, retail, and media [ 3 ].

In the pharmacy industry, a number of significant factors are hastening this digital transition. Important concerns include the desire for cost-effectiveness, enhanced patient care, and more transparency and efficiency in medication development and manufacture. This change has been made even more rapid by the COVID-19 pandemic, which has highlighted the necessity for digital solutions to address the difficulties associated with providing healthcare in emergency situations [ 4 ].

In terms of specific technologies being adopted, artificial intelligence (AI) and machine learning are playing a pivotal role. The McKinsey Global Institute estimates that AI in the pharmaceutical industry could generate nearly $100 billion annually across the U.S. healthcare system. The use of AI and machine learning enhances decision-making, optimizes innovation, and improves the efficiency of research and clinical trials. This results in more effective patient care and a more streamlined drug development process​ [ 5 ].

The digital transformation in the pharmacy sector represents a pivotal shift in the delivery and experience of healthcare services. This evolution is more than a transient trend; it’s a fundamental alteration in the healthcare landscape [ 6 ]. The adoption of digital technologies is reshaping aspects of healthcare, including patient engagement and medication adherence, leading to enhanced healthcare outcomes. Research indicates that digital tools in pharmacy practices have resulted in more individualized and efficient patient care. Telehealth platforms, exemplified by companies like HealthTap, are being increasingly incorporated by pharmacies to augment patient care via technological solutions. The contribution of digital health technology to medication adherence is notable, employing a variety of tools such as SMS, mobile applications, and innovative devices like virtual pillboxes and intelligent pill bottles. These advancements are pivotal in addressing the critical issue of medication nonadherence in healthcare. Furthermore, digital health tools are empowering pharmacists with expanded clinical responsibilities, particularly in the management of chronic diseases like diabetes, where apps and smart devices provide essential features such as blood glucose tracking and medication reminders. This comprehensive integration of digital health into pharmacy practice signifies a transformative era in healthcare delivery and patient management [ 7 ].

Online platforms are being used increasingly by the pharmaceutical sector and educational institutions to improve efficiency, flexibility, and accessibility. The telepharmacy program at CVS Pharmacy is an example of how telepharmacy services, which provide remote counseling and prescription verification, bring pharmaceutical care to underprivileged communities [ 8 ]. Prescription accuracy and drug management are enhanced by e-prescribing software like Epic’s MyChart and digital health apps like Medisafe [ 9 ; 10 ]. Blockchain technology is also being investigated for transparent and safe supply chain management. Continuous learning and professional networking are made possible in education by Virtual Learning Environments (VLEs) like Moodle [ 11 ], simulation software like SimMan 3G Plus [ 12 ], Continuing Professional Development (CPD) platforms like the American Pharmacists Association [ 13 ], and online conference platforms, as shown in Fig.  1 . While these platforms offer significant benefits like enhanced access and cost-effectiveness, they also present challenges, including addressing the digital divide and ensuring the quality and credibility of online services to maintain professional standards and patient safety.

In this review, we summarized the digital transformation in the pharmacy sector, emphasizing the integration of online platforms and the emerging significance of cosmeceuticals. We discussed the global shift towards digital healthcare, including telehealth and online pharmacy services, and how these changes have been accelerated by the COVID-19 pandemic. The paper also examined the impact of digital technologies on pharmacy practice and education, with a focus on telepharmacy services, e-prescribing software, and digital health apps. Additionally, it addresses the challenges and opportunities presented by this transformation, including regulatory and safety concerns, and the need for continuous professional development in the digital era.

Comprehensive overview of different platforms in the pharmaceutical industry and education illustrating purposes and exemplary cases

The global impact of online pharmacy platforms

In recent years, the landscape of pharmacy practice and education has undergone a significant transformation, driven by technological advancements and catalyzed by the global COVID-19 pandemic. A study highlighting the increasing consumer trust in online medication purchases pre, during, and post-pandemic reveals a shift in consumer behavior towards online pharmacies [ 14 ]. This trend underscores a greater reliance on these platforms, where the perceived benefits significantly outweigh the perceived risks, indicating a positive reception and growing trust in digital healthcare solutions.

The adoption of telehealth, including telepharmacy, exemplifies this shift. In the United States, patient adoption of telehealth services surged from 11% in 2019 to 46%, with healthcare providers expanding their telehealth visits [ 15 ]. This shift is a reflection of how adaptable the healthcare sector is to digital platforms and how customer acceptance is increasing. The epidemic has also served as a catalyst, hastening the creation and uptake of online telepharmacy services throughout the world. The “new normal” has forced the addition of new platforms to support established sources of health information. The creation and evaluation of an online telepharmacy service in the Philippines during the pandemic serves as an example of this, demonstrating how quickly the global pharmacy industry adopted digital solutions. These services are essential for providing and elucidating pharmaceutical information within the context of primary healthcare delivery; they are not merely supplementary [ 16 ].

Simultaneously, pharmacist-led companies such as MedEssist and MedMehave, innovated digital platforms to facilitate services like flu shots or COVID-19 tests, reflecting a move towards customer-centric, digital-first services [ 17 ]. This transition enhances convenience and access to care but also introduces significant regulatory challenges. As the growth of online medicine sales disrupts traditional pharmacy markets, navigating these challenges becomes crucial for maintaining patient safety, quality standards, and fostering a trustworthy online healthcare environment [ 18 ].

Parallel to the practice changes, educational platforms for pharmacy have also evolved, especially under the impetus of the pandemic. These platforms have integrated a mix of traditional and student-centered teaching methodologies, including remote didactic lectures and on-site experiential training. The implementation of blended learning approaches, which combine remote lectures with on-site laboratory classes, reflects a broader educational trend towards hybrid models. This approach aims to leverage the advantages of both online and traditional methods, offering a more flexible and potentially more effective educational experience [ 19 ].

It takes more than just implementing new tools to integrate educational technology into pharmacy education, it also requires understanding how these technologies affect instruction and student learning. To effectively improve the educational experience, their utilization must have a purpose. There is an increasing amount of scholarly interest in this field, as evidenced by systematic reviews of the effects of new technologies on undergraduate pharmacy teaching and learning [ 20 ]. These digital platforms will probably become more significant in the future of pharmacy education, helping to mold the profession and guaranteeing that pharmacists are equipped to fulfill the ever-changing demands of the healthcare system. This development is indicative of a larger trend in the healthcare industry toward a more flexible, patient-focused, and technologically advanced environment [ 21 ].

Digital transformation in global healthcare

The recent advancements in digital transformation within global healthcare are significantly reshaping the landscape of healthcare and pharmacy services. These transformations are largely driven by the integration of digital technologies, which are redefining the tools and methods used in health, medicine, and biomedical science, ultimately aiming to create a healthier future for people worldwide [ 22 ]. In a 2018 report [ 23 ], Amazon’s potential entry into the $500 billion U.S. pharmacy market, the second-largest retail category, through mail-order and online pharmacies was highlighted as a significant industry disruptor. With licenses in at least 12 states in the US and a strategy focused on bypassing middlemen, Amazon’s historical success positions it to transform the pharmacy landscape, promising enhanced efficiency and cost savings for consumers.

One of the critical areas identified in recent research is the establishment of five priorities of e-health policy making: strategy, consensus-building, decision-making, implementation, and evaluation. These priorities emerged from stakeholders’ perceptions and are crucial for the effective integration and adoption of digital health technologies​ [ 24 ]. This holistic approach is increasingly relevant for scholars and practitioners, suggesting a focus on how multiple stakeholders implement digital technologies for management and business purposes in the healthcare sector [ 25 ]​​. The deployment of technological modalities, encompassed within five distinct clusters, can facilitate the development of a digital transformation model. This model ensures operational efficiency through several dimensions: enhanced operational efficacy by healthcare providers, the adoption of patient-centered methodologies, the integration of organizational factors and managerial implications, the refinement of workforce practices, and the consideration of socio-economic factors [ 25 ].

Studies focusing on value creation through digital means suggest healthcare as a consumer-centric realm ripe for center-edge transformations, characterized by self-service and feedback cycles. These transformations are vital in addressing inherent tensions between patients and physicians, steering the focus towards value co-creation and service-dominant logic [ 26 ]. Participatory design and decision-making approaches are emphasized for enhancing health information technology’s performance and institutional healthcare innovation. Such approaches are particularly crucial in developing national electronic medical record systems and improving chronic disease treatment through electronic health records. Additionally, telehealth research integrates patients’ perceptions, contributing to the understanding of technology, bureaucracy, and professionalism within healthcare [ 27 ].

The impact of health information technology (HIT) on operational efficiencies is profound. Empirical studies, such as those by Hong and Lee [ 28 ], Laurenza et al. [ 29 ], and Mazor et al. [ 30 ], demonstrate positive correlations between HIT and patient satisfaction, quality of care, and operational efficiency. However, challenges remain, as Rubbio et al. [ 31 ] highlight deficiencies in resilience-oriented practices for patient safety. Organizational and managerial factors in digital healthcare transformation also receive significant attention. Hikmet et al. [ 32 ] and Agarwal et al. [ 33 ] investigate the role of organizational variables and barriers in HIT adoption, whereas Cucciniello et al. [ 34 ] delve into the interdependence between implementing electronic medical records (EMR) systems and organizational conditions. Further, Eden et al. [ 35 ] and Huber and Gärtner [ 36 ] explore workforce adaptations and the implications of health information systems in hospitals that can increases transparency of work processes and accountability. Lastly, examining healthcare financialization and digital division provides an international perspective, contrasting the regulated environment in the EU with the US’s use of online medical crowdfunding as a potential solution to reduce bankruptcy [ 37 ; 38 ]. Collectively, these studies suggest a comprehensive model where stakeholders leverage digital transformation for management, enhancing operational efficiency in healthcare service providers.

Marques and Ferreira [ 39 ] performed a systematic literature review of digital transformation in healthcare, spanning the period from 1973 to 2018. Utilizing the SMARTER (Simple Multi-attribute Rating Technique Exploiting Ranks) method, 749 potential articles were analyzed, culminating in the prioritization and selection of 53 articles for detailed examination. The literature was organized into seven thematic areas: (1) Integrated management of IT in healthcare, (2) Medical images, (3) Electronic medical records, (4) IT and portable devices in healthcare, (5) Access to e-health, (6) Telemedicine, and (7) Privacy of medical data. It was observed that the predominant focus of research resides in the domains of integrated management, electronic medical records, and medical images. Concurrently, emerging trends were identified, notably the utilization of portable devices, the proliferation of virtual services, and the escalating concerns surrounding privacy. See Fig.  2 for visual representation of multifaceted digital transformation in healthcare.

Visual representation of multifaceted digital transformation in healthcare: a synthesis of provider-patient dynamics, HIT impact, and strategic management. HIT; health information technology, HC; healthcare, EMR; electronic medical records. IT; information technology, Pt.; patient

Telehealth and online pharmacy advancements in pandemic management

In the realm of online pharmacies and telehealth, digital health technologies have been instrumental in managing the COVID-19 pandemic through surveillance, contact tracing, diagnosis, treatment, and prevention. These technologies ensure that healthcare, including pharmacy services, is delivered more effectively, addressing the challenges of accessibility and timely care. The role of telemedicine and e-pharmacies, in particular, has been emphasized in improving access to care worldwide. By enabling remote consultations and drug delivery, these platforms are making healthcare more accessible, especially in regions where traditional healthcare infrastructure is limited or overstretched [ 40 ].

The Canadian Virtual Care Policy Framework advocates for the swift adoption and integration of virtual care, propelled by the COVID-19 pandemic. It emphasizes enhancing access and quality, ensuring equity and privacy, and devising appropriate remuneration models, employing a collaborative, patient-centered approach while addressing digital disparities. During the COVID-19 pandemic, Canadian provinces and territories rapidly adopted virtual health care, leading to 60% of visits being virtual by April 2020, up from 10 to 20% in 2019. However, these implementations were often temporary and not fully integrated into healthcare systems. By August 2020, virtual visits decreased to 40%, with variations across regions, while provinces and territories used temporary billing codes for these services. The framework’s “Diagnostique” provides a thorough analysis of policy enablers and strategies for virtual care, underscoring the need for comprehensive policy and partnership engagement [ 41 ]. In the context of digital transformation in pharmacy, the Hospital News article outlines the application and infrastructure of telepharmacy services in Canada, highlighting the geographical challenges and the early adoption of telepharmacy in certain regions since 2003. It notes the use of various technologies like Medication Order Management, Videoconferencing, and Remote Camera Verification. Although lacking specific quantitative data, the article underscores the necessity for expanded telepharmacy services to ensure uniform care quality across diverse locations [ 42 ].

Similarly, Telehealth offers extensive resources for patients and providers in the United States, emphasizing programs like the Affordable Connectivity Program and Lifeline to facilitate access. The Health Resources and Services Administration enhances telehealth through support services, research, and technical assistance, reflecting a significant outreach impact [ 43 ]. The Office for the Advancement of Telehealth (OAT) under Health Resources and Services Administration (HRSA) works to improve access to quality health care through integrated telehealth services in the US. It supports direct services, research, and technical assistance, with over 6,000 telehealth technical assistance requests sent to Telehealth Resource Centers and approximately 22,000 patients served [ 44 ].

Internationally, In the UK, the National Health Service (NHS) spearheads digital health and care, providing significant innovation opportunities through vast data management. Support for digital health spans various stages, from discovery with organizations like Biotechnology and Biological Sciences Research Council (BBSRC) and Intelligent Data Analysis (IDA) research group, to development with networks such as Catapults and CPRD, and delivery with entities like the Academic Health Science Networks (AHSNs) and DigitalHealth.London. Regulatory bodies like the Medicines and Healthcare products Regulatory Agency (MHRA) and NICE ensure safety and efficacy. The collaborative ecosystem involves academic, healthcare, and industry stakeholders, aiming to enhance health and care services through technology and innovation [ 45 ].

In Australia, the government’s investment of over $4 billion into COVID-19 telehealth measures has facilitated universal access to quality healthcare. This initiative has provided over 85 million telehealth services to more than 16 million patients, with approximately 89,000 healthcare providers engaging in this service delivery. From 1 January 2022, telehealth services, initially introduced in response to COVID-19, will become an ongoing part of Medicare. This will allow eligible patients across Australia continued access to general practice (GP), nursing, midwifery, and allied health services via telehealth, deemed clinically appropriate by the health professional [ 46 ].

European nations such as the Netherlands, Austria, and Italy are at the forefront of implementing cross-organizational patient records, significantly enhancing telehealth communication and facilitating cross-border healthcare. The role of strong government support in advancing telehealth is pivotal. Ursula von der Leyen, the President of the European Commission, has been a prominent advocate for eHealth. She proposed the establishment of a European Health Data Space to streamline health data exchange across member states. France, a leader in telehealth legislation for nearly a decade, has pioneered a public funding scheme for tele-expertise at a national scale. Despite these advancements, challenges like legislative barriers and the lack of consistent political direction continue to impede progress in the telehealth domain​ [ 47 ].

The Asia-Pacific region anticipates a surge in telehealth adoption driven by digital demand and pandemic-induced behavioral changes, while South East Asia exhibits widespread telehealth growth across healthcare aspects [ 48 ]. The telehealth adoption across the Asia-Pacific region has shown remarkable growth between 2019 and 2021 and is projected to continue rising by 2024. China’s adoption nearly doubled to 47% and is expected to reach 76%. Indonesia’s usage more than doubled to 51%, with a forecast of 72%. Malaysia and the Philippines both anticipate reaching a 70% adoption rate, increasing from 30% to 29%, respectively. India’s adoption is projected to more than double to 68%, while Singapore, which had a significant increase from 5 to 45%, is expected to achieve a 60% adoption rate. This trend indicates a robust uptake of telehealth services in the region [ 48 ].

Global telemedicine and E-pharmacy policy dynamics

In the context of telemedicine and e-pharmacy regulations within South East Asia, a notable distinction emerges with Singapore, Malaysia, and Indonesia being the only countries to have formalized legal frameworks governing both telemedicine practices and the dissemination of electronic information. In these countries, tele-consultation is restricted to patients already under the care of healthcare practitioners or as part of ongoing treatment, specifically in Singapore and Malaysia. Additionally, for scenarios requiring more intensive medical intervention, such as new referrals, emergency cases, or invasive procedures, both Malaysia and Indonesia mandate physical presence and face-to-face consultations, emphasizing a cautious and regulated approach to remote healthcare. In Malaysia, the regulations further stipulate that online prescriptions, excluding narcotics and psychotropic substances, are permissible solely under the continuation of care model, reflecting a judicious use of digital prescription services [ 49 ].

In Central and Eastern Europe (CEE), telemedicine has experienced substantial growth, primarily catalyzed by the COVID-19 pandemic, which necessitated rapid advancements in technology and alterations in healthcare practices. The region’s robust digital infrastructure, coupled with the innovative drive of local companies and the challenges posed by an aging demographic, has significantly contributed to this expansion. According to the European Commission’s Market Study on Telemedicine, the global telemedicine market was projected to grow annually by 14% by 2021, a rate that was likely surpassed due to the pandemic’s impact. More specifically, the Europe Telehealth Market, valued at US $6,185.4 million in 2019, is anticipated to witness an annual growth rate of 18.9% from 2020 to 2030. This trend underscores the increasing reliance on and potential of telemedicine in addressing healthcare needs in the CEE region [ 50 ].

In the Middle East, telehealth and telepharmacy, have seen varied degrees of adoption and progress. Despite attempts to reform healthcare delivery in the region, the progress of telemedicine has been somewhat slow, with certain expectations yet to be fully realized. However, there has been notable development in the use and adoption of these technologies [ 51 ]​. In a survey comparing the utilization of digital-health applications in Saudi Arabia and the United Arab Emirates (UAE), it was observed that a higher percentage of Saudi participants have utilized online pharmacy services (48%) compared to the UAE (36%). Conversely, awareness of teleconsultation services without prior use was higher in the UAE (43%) than in Saudi Arabia (35%). Retention data indicates that a significant proportion of users in both countries continue to engage with these services, with 80% of Saudi participants and 71% of UAE participants using teleconsultations at varying frequencies. Notably, a substantial majority of users in Saudi Arabia reported regular use of online pharmacies (90%), slightly higher than the UAE (78%), reflecting robust ongoing engagement with these digital health modalities. Notably, consumer adoption of telehealth products is primarily driven by time savings (48%) and convenience (47%), with 24-hour accessibility and efficacy both influencing 34% of users. Affordability and personal recommendations are also notable factors, while a wide range of options and quality are lesser but relevant considerations [ 52 ].

In response to the COVID-19 pandemic, a cross-sectional study was conducted among 391 licensed community pharmacists in the United Arab Emirates to assess the adoption and impact of telepharmacy services. The study revealed a predominant use of telepharmacy services, particularly via phone (95.6%) and messaging applications (80.0%). The findings highlighted that pharmacies with more pharmacists and those operating as part of a group or chain were more likely to implement a diverse range of telepharmacy services. The study identified significant barriers to telepharmacy adoption in individual pharmacies, including limited time, inadequate training, and financial constraints. There was a noticeable shift in service provision during the lockdown, with an increased reliance on telepharmacy, especially among pharmacies serving 50–100 patients per day. However, a reduction in services such as managing mild diseases and selling health products was observed during the lockdown period. The study concluded that telepharmacy played a pivotal role in supporting community pharmacies during the pandemic, with its expansion facilitated by the UAE’s advanced internet infrastructure, supportive health policies, and widespread digital connectivity [ 53 ]. Collectively, these insights reflect a global shift towards integrating and enhancing telehealth services as a response to emerging healthcare needs and technological advancements.

Unni et al. [ 54 ] provided an extensive review of telepharmacy initiatives adopted globally during the COVID-19 pandemic. Predominantly, virtual consultations were utilized to enable at-risk patients and others to remotely access pharmacists, thereby monitoring chronic illnesses, optimizing medication usage, and providing educational support [ 55 ]. Home delivery of medicines was widely implemented to decrease the necessity for in-person visits and mitigate exposure risks [ 56 ]. Additionally, patient education was prioritized to ensure effective management of health conditions from a distance [ 57 ]. Notably, a network of hospitals in China developed cloud-pharmacy care, allowing patients to consult pharmacists via text and the internet, while Spain utilized information and communication technologies for remote pharmaceutical care [ 58 ; 59 ]. Zero-contact pharmaceutical care, introduced in China, facilitated online medication consultations, eliminating direct contact [ 60 ]. The Kingdom of Saudi Arabia and other regions adapted new e-tools and teleprescriptions to enhance service accessibility [ 61 ]. The U.S. focused on credentialing pharmacists for telehealth to ensure competent service provision, and New Zealand implemented hotline numbers for phone consultations to further reduce physical visits [ 62 ; 63 ]. These initiatives reflect a significant shift towards innovative, technology-driven solutions in pharmaceutical care during a global health crisis. Refer to Fig.  3 for a graphical depiction of the worldwide distribution and applications of telepharmacy initiatives.

The global distribution of telepharmacy programs with an analysis of geographical distribution, technological applications, and associated benefits

Tracing the Private Sector’s Impact on Healthcare’s Technological Transformation

The role of the private sector in the fourth industrial revolution.

The World Economic Forum underscores the private sector’s leading role in digital inclusion and the acceleration of actions pertinent to the Fourth Industrial Revolution. This revolution affects economies, industries, and global issues profoundly, indicating the private sector’s critical role in driving technological advancements and digital platforms that deliver impactful healthcare solutions [ 64 ].

Mapping digital transformation in healthcare

A comprehensive analysis performed by Dal Mas et al. [ 65 ] meticulously maps the intricate terrain of digital transformation in healthcare, spotlighting the private sector’s instrumental role. Initially, the investigation encompassed an extensive array of diverse studies, leading to the identification of five main areas of digital technologies: smart health technologies, data-enabled and data collection technologies, Industry 4.0 tools and technologies, cognitive technologies, and drug & disease technologies. These domains frame the future research pathways, primarily steered by the private sector’s innovative drive. A significant proportion of the literature addresses healthcare broadly, suitable for both private and public sectors, yet a notable segment specifically focuses on the private sector’s endeavors, with a pronounced emphasis on the pharmaceutical domain [ 66 ; 67 ].

Public-private partnerships in healthcare delivery

The highlighted technologies, including digital platforms and telemedicine, exemplify the private sector’s trailblazing contributions to digital healthcare advancements. For instance, public-private partnerships (PPP) in India have emerged as a pivotal model for realizing universal healthcare (UHC), especially against the backdrop of acute healthcare shortages and urban-rural divides. Notably, mega PPP projects have successfully deployed technology-enabled remote healthcare (TeRHC), demonstrating its feasibility and impact in reaching isolated communities. These initiatives, overcoming various challenges, serve as a compelling example for global adoption, underscoring the transformative role of PPP in healthcare delivery [ 68 ].. Furthermore, a considerable majority of the literature in telemedicine underscores the necessity for profound research implications, yet a significant minority suggests policy implications [ 69 ; 70 ], reflecting a complex synergy between the private and public sectors in sculpting the digital healthcare framework [ 71 ]. This synthesis underscores the private sector’s critical influence in propelling the digital transformation in healthcare, charting a course that progressively fuses technological innovation with healthcare provision.

A study highlights Indonesia’s strategic initiatives to capitalize on telehealth business opportunities, driven by the Ministry of Research and Technology’s robust support for Technology-Based Start-up Company schemes [ 72 ]. With a demographic boon of 298 million from 2020 to 2024, escalating non-communicable diseases (71%), and a growing base of 222.4 million JKN participants, the stage is set for transformative growth. Despite a critical shortage of health workers (0.4 doctors per 1000 population), the enthusiasm for telemedicine is evident, with 71% satisfaction in hospital telemedicine and 32 million active telehealth users. The Ministry’s foresight in fostering technology start-ups, exemplified by the TEMENIN platform with its 11 health platforms, is steering Indonesia towards a future where high-quality healthcare is accessible and sustainable.

Lab@AOR: a model for PPPs in healthcare sector

The “Lab@AOR” initiative stands as a paradigmatic example of PPPs effectuating digital transformation within the healthcare sector. This strategic collaboration, between the University Hospital of Marche and Loccioni [ 73 ], a private entity, underscores the capacity of PPPs to navigate intricate challenges, stimulate international cooperation, and contribute to the development of sustainable, patient-centric healthcare solutions. Specifically, Lab@AOR was instituted to confront the nuanced challenges associated with the robotization of healthcare service delivery, highlighting the initiative’s role in fostering technological advancement through public and private sector synergy [ 74 ]. The project illustrates the evolution of Lab@AOR through three main phases: the pioneering stage, where groundwork for collaboration was laid; the nurturing stage, where collaborative exchanges were fostered; and the harvesting stage, wherein the potential of the PPP was fully unleashed. In the pioneering stage, Lab@AOR focused on a critical healthcare service component: the in-hospital preparation of medications for oncological patients. The University Hospital of Marche identified a need for innovation to improve service quality, efficiency, and safety, while Loccioni sought a real-life setting to test and refine its robotized system, APOTECAchemo [ 75 ]. This convergence of needs led to a symbiotic partnership aiming to enhance healthcare delivery through technological advancement.

During the nurturing stage, the partnership expanded the scope of APOTECAchemo to include non-oncological medications and developed additional tools like APOTECAps for manual preparation support. This phase was characterized by intensive collaboration, knowledge sharing, and continuous innovation, demonstrating the dynamic capability of the PPP to adapt and evolve in response to emerging healthcare challenges. The harvesting stage marked the international expansion of Lab@AOR, transforming it from a local initiative to an international community focused on leveraging digitalization and robotization to improve care quality and patient-centeredness. The PPP’s growth was catalyzed by its open perspective and inclusive approach, engaging entities from various cultural and institutional contexts, and fostering a network of 31 nodes across 19 countries and 3 continents.

Advancements in telehealth business models and frameworks

In their investigative study, Velayati et al. [ 76 ] delved into the articulation of emergent business models in telehealth and scrutinized the deployment of established frameworks across a variety of telehealth segments. The research spanned an extensive range of sectors, notably telemonitoring, telemedicine, mobile health, and telerehabilitation, alongside telehealth more broadly. The scope further extended to encompass niche areas such as assisted living technologies, sensor-based systems, and specific fields like mobile teledermoscopy, teleradiology, telecardiology, and teletreatment, presenting a thorough analysis of the telehealth landscape. Within the telemedicine and telehealth services sector, Barker et al. [ 77 ] introduced the Arizona Telemedicine Program (ATP) Model, a quintet-layer approach aimed at efficiently distributing telemedicine services throughout Arizona. Complementing this, Lee and Chang [ 78 ] proposed a four-component model specifically tailored for mobile health (mHealth) services pertaining to chronic kidney disease, focusing on offering a cost-effective platform for disease support and management. In the realm of telemonitoring, Dijkstra et al. [ 79 ] utilized the Freeband Business Blueprint Method (FBBM), which includes service, technological, organizational, and financial domains, to facilitate multiple telemonitoring services. Furthermore, the systemic and economic differences were explored in care coordination through Business to customer (B2C) and business (B2B) models for telemonitoring patients with chronic diseases, with the B2C model’s economic advantages were highlighted [ 80 ].

General telemedicine frameworks also received attention. Lin et al. [ 81 ] constructed a six-component framework analyzing major telemedicine projects in Taiwan, while Peters et al. [ 82 ] developed the CompBizMod Framework in Germany, encompassing value proposition, co-creation, communication and transfer, and value capture, designed to evaluate and enhance competitive advantages in telemedicine. In the specialized field of telecardiology, a comprehensive nine-component sustainable business model was crafted to facilitate mutual benefits for service providers and patients. This model emphasizes the importance of a holistic approach in ensuring the longevity and effectiveness of healthcare delivery within this domain [ 83 ]. Meanwhile, Mun et al. [ 84 ] presented a suite of five teleradiology business models aimed at providing effective, high-quality, and cost-efficient diagnoses.

The teletreatment sector saw innovative models from Kijl et al. [ 85 ], who designed a model for treating patients with chronic pain, focusing on the interrelation of components in the value network and the role of information technology. Complementarily, Fusco and Turchetti [ 86 ] introduced four models for telerehabilitation post-total knee replacement, emphasizing partnerships between care units and equipment suppliers to reduce costs and waiting lists. The mHealth and assisted living technology sector witnessed the introduction of a wearable biofeedback system model by Hidefjäll and Titkova [ 87 ], which employed Alexander Osterwalder’s Business Model Canvas and focused on a comprehensive commercialization process. Additionally, Oderanti and Li [ 88 ] presented a seven-component sustainable business model for assisted living technologies, aimed at encouraging older individuals to invest in eHealth services while reducing the pressure on health systems. These diverse clusters and models reflect the multifaceted nature of telehealth, each tailoring its approach to meet the unique demands of its domain. They collectively aim to optimize service delivery, stakeholder involvement, cost efficiency, and patient care quality, marking significant strides in the ongoing evolution of digital healthcare.

Challenges and biases in healthcare technology

One key aspect is the emergence of novel medical technologies and their potential biases. These biases are often a result of insufficient consideration of patient diversity in the development and testing phases. For example, disparities in the performance of medical devices like pulse oximeters among different racial groups have been observed, potentially due to a lack of diverse representation in clinical trials. This indicates a tendency for the development of healthcare technologies that may not adequately serve all patient populations [ 89 ]. A study on the profitability and risk-return comparison across health care industries highlights the use of return on equity (ROE) as a measure of profitability from a shareholder’s perspective. This measure combines profit margin, asset utilization, and financial leverage. The study analyzed financial data of publicly traded healthcare companies, providing insights into the financial dynamics of the healthcare sector. It revealed that while companies like Pfizer Inc. and UnitedHealth Group reported similar profitability, they had substantial differences in profit margin and asset utilization, indicating diverse financial strategies within the healthcare sector. This study underscores the complexity of financial performance in healthcare, where profitability measures need to be balanced with risk assessment and the broader impact on healthcare provision​ [ 90 ].

Additionally, an article discusses the benefits, pitfalls, and potential biases in healthcare AI. It emphasizes that as the healthcare industry adopts AI, machine learning, and other modeling techniques, it is seeing benefits for both patient outcomes and cost reduction. However, the industry must be mindful of managing the risks, including biases that may arise during the implementation of AI. Lessons from other industries can provide a framework for acknowledging and managing data, machine, and human biases in AI. This perspective is crucial in understanding how the integration of advanced technologies in healthcare can be influenced by the drive for profitability and efficiency, possibly at the expense of equitable and patient-centered care [ 91 ; 92 ].

Cosmeceuticals in the online pharmacy market

Cosmeceuticals, a term derived from the combination of cosmetics and pharmaceuticals, refer to a category of products that are formulated to provide both aesthetic improvements and therapeutic benefits. These products, typically applied topically, are designed to enhance the health and beauty of the skin, going beyond the mere cosmetic appearance. The exploration of cosmeceuticals in the online pharmacy market reveals a multifaceted and rapidly expanding industry. Bridging the gap between cosmetics and pharmaceuticals, they form a significant portion of the skincare industry. Cosmeceuticals are formulated from various ingredients, with their main categories being constantly discussed and analyzed in the scientific community [ 93 ]. They have taken a considerable share of the personal care industry globally, constituting a significant part of dermatologists’ prescriptions worldwide [ 94 ]. This surge is further fueled by increasing consumer demand for effective and safe products, including anti-aging skincare cosmeceuticals, a need which has been intensified by concerns over pollution, climate change, and the COVID-19 pandemic [ 95 ].

The global cosmeceuticals market is experiencing robust growth. Valued at USD 56.78 billion in 2022, it’s projected to expand to USD 95.75 billion by 2030, with a compound annual growth rate (CAGR) of 7.45%. This growth trajectory is propelled by the innovative integration of bioactive ingredients known for their medical benefits​ [ 96 ]. Another report confirms this upward trend, indicating the market was worth $45.56 billion in 2021 and is on a path of significant growth to USD 114 billion by 2030. The global disease burden is significantly impacted by various skin diseases, with dermatitis, psoriasis, and acne vulgaris among the most prevalent, contributing 0.38%, 0.19%, and 0.29% respectively. The pervasive nature of these conditions drives a substantial demand for effective treatments, propelling the integration of cosmeceuticals into the online pharmacy market. This integration not only offers convenient access to a range of therapeutic skincare products but also caters to the rising consumer inclination towards self-care and preventive healthcare. As a result, the online availability of cosmeceuticals is not just addressing the immediate needs of individuals suffering from skin conditions but is also reshaping the landscape of personal healthcare by making specialized treatments more accessible and customizable [ 97 ]. See Fig.  4 .

The left panel presents the market share distribution for key segments in the cosmeceuticals industry in 2021, including Skin Care Segment, and Supermarket & Specialty Stores, for Asia Pacific Revenue, with percentages for each category. The right panel displays the market value progression over time from 2021 to the projected value in 2030, with bold numbers indicating the value in billion USD for each year. The lower horizontal bar chart depicts the percentage contribution of various skin diseases to the global disease burden

Several factors are contributing to this expansion of the cosmeceuticals market. The market is driven by innovation in natural ingredients and a significant penetration of internet, smartphone, and social media applications, which attract potential consumer populations and reflect constantly changing consumer behavior [ 98 ]​​. The cosmeceuticals market’s robust CAGR and revenue share, especially in regions like Asia Pacific, further signify its burgeoning presence and potential within the global market [ 99 ]​. Integration into online pharmacies is a key aspect of this market’s evolution, offering easier access to these products for a wider customer base. As the market continues to grow, it’s anticipated that the blend of cosmeceuticals with online pharmaceutical platforms will become increasingly seamless, offering consumers a diverse range of accessible, effective, and beneficial skincare and health products. This integration is likely to be driven by the growing trend of e-commerce and digitalization in healthcare and personal care sectors.

The landscape of online pharmacies, particularly concerning cosmeceuticals, is evolving. While the overall penetration for non-specialty drugs in mail-order and online pharmacies is low, they represent a significant portion of specialty prescription revenues at 37%. Despite this, only 13% of consumers consider these as their primary pharmacy choice, indicating a growing but still emerging market​​​​. Strategies are in place to enhance the market appeal of these pharmacies, focusing on speed, convenience, and personalized experiences, such as video telehealth visits, to attract a broader consumer base [ 100 ].

The dissertation “L’Oréal Portugal: A Digital Challenge for the Active Cosmetics Division” authored by Ascenso [ 101 ] provides an in-depth examination of the impact of digital evolution on the Portuguese cosmeceutical sector and its implications for L’Oréal, a significant cosmetics company. It posits that while L’Oréal has foundational digital competencies, the rapidly evolving digital landscape presents a broad spectrum of potential risks and opportunities. The study details the operations of L’Oréal’s Active Cosmetics Division, which manages brands predominantly sold in pharmacies and parapharmacies, and explores the potential repercussions of digitalization on L’Oréal Portugal’s strategic and operational frameworks. Furthermore, the thesis highlights the expanding role of e-pharmacies and the need for legal reforms to facilitate their operation. It discusses the prevalent trends in the cosmetic industry, such as the increasing demand for natural, male-focused, and environmentally friendly products. The dissertation scrutinizes L’Oréal’s strategic pillars, including innovation, acquisition, and regional growth, emphasizing the need for the company to integrate advanced technologies and recalibrate its business methodologies in light of digital progression [ 101 ]. Although L’Oréal has initiated some digital strategies targeting consumers and pharmacies, there’s a recognized need for an intensified focus on digital marketing aimed at clients. An exploratory attempt by L’Oréal to implement an online ordering platform for pharmacies did not meet success, indicating possible industry unreadiness for such advancements. This case study serves as a critical examination of how traditional companies in the pharmaceutical and cosmetics sectors must adapt to the digital age’s challenges and opportunities [ 101 ].

In a collaborative endeavor with L’Oréal, an associated digital agency provided a comprehensive suite of services that encompasses the full management of social media pages, the development of e-commerce websites, the establishment of Customer Relationship Management (CRM) platforms tailored for pharmacies, and the execution of digital campaigns leveraging QR codes, SMS marketing, and newsletters. These digital tools confer a competitive edge, facilitating a deeper comprehension of consumer behavior and the potential to augment value extraction from customer interactions. For the laboratories, particularly those associated with cosmetics, the advantages are twofold: an increase in sell-out figures, thereby enhancing direct sales to end consumers, and a boost in sell-in metrics, reflecting a rise in transactions to pharmacies or wholesalers. The online ordering feature, as noted by João Roma, a manager at La Roche-Posay, could result in a cacophony of processes if laboratories were to individually develop distinct methods. He advocates for the utilization of pre-existing platforms, such as the established e-learning infrastructure, to spearhead ventures into the online marketplace [ 101 ].

A survey conducted specifically for L’Oréal’s e-learning platform, cosmeticaactiva.pt [ 102 ], across the Portuguese landscape garnered responses from 324 participants, comprising 71% general pharmacists, 13% technical assistants, 8% directors, 7% individuals responsible for procurement from laboratories, and 2% beauty/cosmetic advisors. The findings from this survey underscore the pervasive adoption of digital tools within the pharmacy sector: 82% of respondents affirmed the presence of their pharmacies on social media platforms, 80% reported the use of basic management software, 64% indicated the deployment of advanced management systems, 61% were conversant with online ordering systems directed at laboratories, 38% utilized a store locator, 28% had an established website presence, and a smaller segment of 12% offered online shopping facilities.

Another survey conducted within this study to evaluate the significance of dermocosmetic products in pharmacies yielded a mean importance rating of 4.38 out of 5, indicating that a majority of pharmacists consider these products to be highly important to their business operations. Factors critical to the differentiation of a proficient laboratory/supplier were innovation and cost-effectiveness, with mean scores of 1.9 and 2.7 respectively, on a scale from 1 (most important) to 5 (least important). A substantial majority of pharmacists, amounting to 81.8%, perceive their pharmacies as beacons of innovation and modernity. Detailed interviews elucidated that digital tools are indispensable in augmenting sales for cosmeceutical products by catalyzing demand—a dynamic not feasible with medicinal products. These tools are paramount in managing customer loyalty, facilitating enhanced communication with existing clients via online and mobile channels. Despite the challenges posed by digitalization, particularly in the realms of logistics and human resources, the management at L’Oréal is well-equipped to swiftly adapt to the evolving business landscape, as evidenced by the proactive adoption and integration of these digital strategies [ 101 ] as illustrated in Fig.  5 .

Results from Ascenso [ 101 ] survey assessing digital challenges for L’Oréal in the Portuguese cosmeceutical sector. Digital Tools Usage in Pharmacies (upper left) : the bar chart showing the percentage of respondents using various digital tools in pharmacies. Suppliers’ Choosing Factors (upper right) : the bar chart displaying the mean scores of factors that distinguish a good laboratory/supplier. General Pharmacists Opinion (lower left) : A line chart illustrating the mean ratings of pharmacists’ opinions on whether the pharmaceutical sector is modern, changing, conducive to innovations, adapted to consumer needs, and more developed than other sectors. Importance of Digital Development Tools for Pharmacies (lower right) : A vertical bar chart demonstrating the mean scores for the importance of different digital development tools for pharmacies

The digital transformation strategies, exemplified by companies like L’Oréal, extend beyond the mere targeting of end consumers, encompassing the perspectives of various stakeholders, including retailers. This broadened focus reflects a holistic and integrated approach to digital marketing and customer engagement, indicative of a larger trend within the market. The significance of digital channels in facilitating comprehensive customer interaction and brand development is increasingly recognized. The distinction of organizations such as L’Oréal in their digital initiatives highlights the competitive advantage that can be garnered through innovative digital strategies.

The receptiveness of industry professionals, such as pharmacists, to emerging digital trends, along with the readiness of companies to engage in non-face-to-face sales models, marks a paradigm shift in traditional sales and distribution methods. This shift is reflective of a broader market trend where digital platforms are becoming integral to the customer journey. Furthermore, the potential for online sales in specialized sectors, such as dermocosmetics, and the benefits that organizations derive from the technological advancement of their client base, underscore an escalating acknowledgment of e-commerce and digital tools as crucial elements of a business strategy. This trend, with L’Oréal as a prime example, emphasizes the broader market movement towards digital transformation, not merely as an option but as a necessity for maintaining relevance and competitiveness in an ever-evolving market landscape.

The global regulatory landscape for cosmeceuticals

Sophisticated regulatory legislation and enforcement mechanisms characterize many developed countries such as the USA, EU Member States, Canada, and Japan. These nations, along with influential organizations like the World Health Organization (WHO), significantly shape international market rules and regulations due to their market size and regulatory capacity [ 103 ]. The WHO is particularly noted for its crucial role in setting global standards, with a focus on developing and promoting international standards related to food, biological, pharmaceutical, and similar products [ 104 ]. In contrast to pharmaceuticals, the cosmetic industry necessitates a more advanced international regulatory framework due to consumers’ extensive exposure to these products. The distinction between cosmetics and pharmaceuticals varies significantly across different countries, with the USA employing a voluntary registration system for cosmetics and the EU and Japan requiring mandatory product filings prior to marketing [ 105 ]. Concerns over the safety of pharmaceutical and cosmetic products are highlighted, with an increasing consumer focus on “natural, ecological, and clean” products [ 106 ]. However, the lack of a regulatory framework for these categories underscores the need for more advanced regulations to mitigate health risks.

Intergovernmental cooperation is emphasized, with the US and EU portrayed as dominant players in the pharmaceutical and cosmetic industries, respectively. Regulatory capacity, which is essential for defining, implementing, and monitoring market rules, varies among countries and markets. This capacity depends on several factors, including staff expertise, statutory sanctioning authority, and the degree of centralization of regulatory authority [ 103 ]. The regulatory systems of the EU and US are explored, focusing on their unique approaches to medicine authorization and regulation. The European Medicines Agency (EMA) in the EU and the Food and Drug Administration (FDA) in the US serve as pivotal regulatory bodies [ 107 ; 108 ]. The EMA’s centralized procedure and the FDA’s premarket approval process are detailed, along with subsequent postmarket regulatory procedures. For instance, EU and US cosmetic regulations are compared, revealing differences in their approaches and the evolution of the EU’s regulatory landscape through various amendments and directives. In particular, directive 76/768/EC has been superseded by Regulation (EC) N° 1223/2009, serving as the principal regulatory framework for finished cosmetic products in the EU market. This regulation enhances product safety, optimizes the sector’s framework, and eases procedures to promote the internal cosmetic market. Incorporating recent technological advancements, including nanomaterials, it maintains an internationally acknowledged regime focused on product safety without altering existing animal testing prohibitions [ 109 ].

The Eurasian Economic Union’s (EAEU) regulatory framework for medicines and medical devices is detailed, including the legal framework established for regulating the circulation of these products. The conformity assessment methods, such as the EAC Declaration and the State Registration process, are required for manufacturers to demonstrate their products’ compliance with the standards [ 110 ]. Armenia is also part of the EAEU’s legal framework, which aims to unify regulations for the production and registration of pharmaceuticals and medical products by 2025. This unification is expected to reduce administrative costs for manufacturers and improve medicinal products for patients. Despite significant developments in the cosmetics industry, Armenia does not have an extensive regulatory framework for it. Prior to joining the EAEU, the only regulation concerning cosmetic products was the Order of the Minister of Health of the Republic of Armenia on “Hygiene Requirements of the Production and Safety of Perfume-Cosmetic Products.” Since joining the EAEU, Armenia has unified its national legislation with EAEU regulations, but there are challenges and gaps in the direct applicability of the EAEU’s technical regulations in the country [ 111 ].

In the context of the necessity for clear regulatory framework stems from two reasons. Firstly, cosmeceuticals - products straddling cosmetics and drugs - demand intensified regulatory attention. Examples include the 2007 FDA seizure of Jan Marini’s Age Intervention Eyelash, which contained the drug ingredient bimatoprost, and products boasting human stem cell cultured media, which claim rejuvenating effects but may pose safety risks due to minimal oversight [ 112 ]. A noted 1450% increase in FDA warnings (from 4 to 62 letters) between 2007 and 2011 and 2012–2017, with 8 targeting stem cell ingredient promotions, underscores the growing concern [ 113 ]. The FDA’s limited capacity to identify and assess potential drug-adulterated cosmetics raises concerns.

The second aspect focuses on the necessity for a more comprehensive and unbiased scientific and medical perspective in the FDA’s ingredient review process. The Personal Care Products Safety Act proposes a balanced committee formation including industry, consumer, and medical representatives, yet advocates for the inclusion of specialized professionals like chemists, dermatologists, toxicologists, and endocrinologists. Specific ingredients like diazolidinyl urea and quarternium-15, although effective antimicrobials, are flagged for potential skin allergy risks and formaldehyde release. The preservative 4-methylisothiazolinone, banned in Europe for rinse-off products, is noted for increasing allergic contact dermatitis cases in the US [ 114 ]. The lag in US cosmetic regulation compared to the EU is acknowledged, with the Personal Care Products Safety Act considered a significant advancement, albeit in need of further refinement [ 115 ].

The importance of consumer safety in the global regulatory landscape for cosmeceuticals, particularly for products that blur the line between cosmetics and pharmaceuticals, is a critical issue due to several key factors. Firstly, the cosmeceutical market is expanding rapidly, driven by new ingredients promising various skincare benefits like anti-aging and photoprotection. This growth necessitates clear regulatory guidelines to ensure that these products are safe and their claims are clinically proven. The FDA, for instance, differentiates between cosmetics and cosmeceuticals based on their intended use, particularly if a product is marketed as a cosmetic but functions in a way that affects the structure of the human body, classifying it as a cosmeceutical [ 116 ].

Secondly, the legal and regulatory distinctions between drugs and cosmetics are significant. Drugs are subject to FDA approval based on their intended use in treating diseases or affecting the body’s structure or function, whereas cosmetics are not. This difference becomes crucial when products are marketed with drug-like claims but are not regulated as drugs, potentially leading to consumer safety issues. For example, botanical cosmeceuticals, which contain natural ingredients like herbal extracts, need thorough evaluation to ensure consistency in therapeutic effects [ 117 ]. Additionally, cosmeceutical manufacturers must be careful with marketing and advertising claims to avoid legal implications. Misleading claims can lead to lawsuits and regulatory actions, as seen in past cases where companies faced consequences for unfounded product claims. Moreover, the FDA advises cosmeceutical manufacturers to follow Good Manufacturing Practices (GMP) to reduce the risk of misbranding or mislabeling. These guidelines include production practices and specific warning statement guidelines, emphasizing the importance of substantiating the safety of these products [ 118 ].

The global regulatory landscape for online pharmacy

Online pharmacies pose various risks to consumers, including the potential health hazards from counterfeit or substandard medications and the inappropriate use of prescription drugs. The regulatory landscape for these pharmacies varies significantly across nations, with some countries like the United States implementing specific laws, while others, such as France, have instituted outright bans [ 119 ]. The European Union, for instance, has implemented a mandate effective from 1 July 2015, which requires member states to adhere to legal provisions for a common logo specific to online pharmacies. This is coupled with an obligation for national regulatory authorities to maintain a registry of all registered online medicine retailers, as detailed by the European Medicines Agency [ 120 ]. Furthermore, the sale of certain medications online within the EU is permissible, contingent upon the registration of the pharmacy or retailer with respective national authorities​ [ 121 ]. Additionally, the Council of Europe’s MEDICRIME Convention introduces an international treaty that criminalizes the online sale of counterfeit medicinal products, enforcing prosecution irrespective of the country in which the crime is perpetrated [ 122 ].

Switzerland presents a unique stance, where Swissmedic strongly advises against the online purchase of medicines due to the high risk of illegal sourcing and poor quality. However, Swiss mail-order pharmacies with a valid cantonal license to operate a mail-order business are exempted from this advisory​ [ 123 ]. The Swiss Mail-Order Pharmacists Association and its affiliates, such as Zur Rose AG and MediService AG, actively advocate for a modern and equitable regulation of mail-order medicine sales​ [ 124 ]. The legislative framework is further bolstered by the Federal Act on Medicinal Products and Medical Devices, which regulates therapeutic products to guarantee their quality, safety, and efficacy​ [ 125 ]. In the Middle East, community pharmacy practice is predominantly governed by national Ministries of Public Health or equivalent governmental entities, with most community pharmacies being privately owned​ [ 126 ]. The region’s involvement in the Global Cooperation Group, which encompasses various international regulatory bodies like the EMA and USFDA, signifies a collaborative approach towards drug regulatory affairs in the MENA region [ 127 ]. Despite these advances in regulatory collaboration, it is notable that currently no specific regulations have been detected for online purchases from online pharmacies in the Middle East, highlighting a significant area for potential regulatory development. Furthermore, a notable transition is observed in pharmacy education across several Middle Eastern nations, with an inclination towards introducing Pharm.D degrees to replace traditional pharmacy degrees, reflective of evolving educational standards in the pharmaceutical field [ 128 ]. This shift in education parallels the need for updated regulatory frameworks, especially in the context of the burgeoning online pharmacy sector.

Furthermore, Australia permits the sale of both Prescription-Only Medicines (POMs) and Over-the-Counter (OTC) medications online, provided that brick-and-mortar pharmacies comply with all relevant laws and practice standards [ 129 ]. In contrast, South Korea maintains a stringent stance, prohibiting the online sale of both POMs and OTC medicines, with sales confined exclusively to physical stores registered with the Regulatory Authority (RA) [ 130 ]. China, Japan, Russia, Singapore, and Malaysia exhibit a more selective regulatory framework. China and Russia allow the online sale of OTC medicines only, with China imposing additional restrictions on third-party e-commerce platforms and Russia having introduced a draft law in December 2017 to formalize this practice [ 131 ; 132 ]. Japan permits the online sale of certain OTC medicines, explicitly excluding specific substances such as fexofenadine and loratadine [ 133 ]. Similarly, Singapore and Malaysia endorse the online sale of specific OTC medicines only, adopting a “buyers beware” approach to caution consumers about the associated risks [ 134 ; 135 ]. Lastly, the legal landscapes in India and Indonesia remain ambiguous. India’s RA has effectively banned the online sale of medicinal products, yet this prohibition lacks legislative backing. Indonesia, too, grapples with unclear regulations, leaving the legal status of online pharmacies indeterminate [ 136 ].

In response to these risks, several initiatives have been developed to guide and certify online pharmacies. In the United States, LegitScript offers certification to online pharmacies that comply with criteria such as appropriate licensing and registration [ 137 ]. Similarly, the Verified Internet Pharmacy Practice Sites (VIPPS) program, accredited by the National Association of Boards of Pharmacy, ensures pharmacies adhere to licensing requirements in the states where they dispense medications [ 138 ]. Internationally, the Health On the Net Foundation has introduced the HONcode, an ethical standard for health websites globally. This code certifies sites that provide transparent and qualified information. However, due to the absence of international harmonization, the HONcode’s certification is limited to US and Canadian pharmacies verified by VIPPS [ 139 ]. The lack of a harmonized international approach presents significant challenges. Consumers do not have access to a comprehensive, global repository of all certified pharmacies. The diverse certification schemes are not well articulated or interconnected, leading to consumer unawareness about their significance or existence. Moreover, enforcing standards across different legal jurisdictions is complex without a unified agreement. To enhance consumer protection, it is imperative to develop and promote a standardized, minimal international code of conduct for online pharmacies. Such a code would unify requirements and allow all initiatives to clarify their roles under a common framework. Adequate oversight in the borderless online pharmacy market can only be achieved through collaborative efforts. To visualize the infographic of the global regularity landscape for the online pharmacy see Fig.  6 .

Comprehensive representation of the regulatory landscape for global online pharmacies, detailing international and national initiatives, certification programs, and conventions aimed at minimizing risks associated with the purchase of medications via online platforms

Technological innovations and Future trends in global pharmacy

The global pharmacy sector is undergoing a transformative shift, driven by the rapid advancement of technological innovations. As the world becomes increasingly digital, the integration of cutting-edge technologies like Artificial Intelligence (AI) and blockchain is setting the stage for a new era in pharmaceutical care and management. These advancements promise to revolutionize the industry by enhancing efficiency, accuracy, and security, ultimately leading to improved patient outcomes and a more streamlined healthcare experience [ 140 ].

Walgreens, in partnership with Medline, a telehealth firm, has developed a platform for patient interaction with healthcare professionals via video chat. AI’s role extends to inventory management in retail pharmacies, allowing pharmacists to predict patient needs, stock appropriately, and use personalized software for patient reminders. Although not all inventory management software in retail pharmacies utilizes AI, some, like Blue Yonder’s software developed for Otto group, demonstrate the potential of AI in predicting product sales with high accuracy, thus enhancing supply chain efficiency [ 141 ; 142 ]. At the University of California San Francisco (UCSF) Medical Center, robotic technology is employed to improve patient safety in medication preparation and tracking. This technology has prepared medication doses with a notable error-free record and surpasses human capabilities in accuracy and efficiency. It prepares both oral and injectable medicines, including chemotherapy drugs, freeing pharmacists and nurses to focus on direct patient care. The automated system at UCSF receives electronic medication orders, with robotics handling the picking, packaging, and dispensing of individual doses. This system also assembles medications on bar-coded rings for 12-hour patient intervals and prepares sterile preparations for chemotherapy and intravascular syringes [ 143 ].

In the realm of global pharmacy, blockchain technology emerges as a pivotal force, driving advancements across various facets of healthcare and pharmaceuticals. At the forefront of its application is the enhancement of supply chain transparency [ 144 ]. Blockchain’s immutable ledger ensures the provenance and legitimacy of medical commodities, offering an unprecedented level of visibility from manufacturing to distribution. This is particularly vital in areas plagued by counterfeit drugs, where systems like MediLedger are instrumental in verifying the legality and essential details of medicines [ 145 ].

The utility of blockchain extends to the implementation of smart contracts — scripts processed on the blockchain that bolster transparency in medical studies and secure patient data management [ 146 ]. These contracts find extensive use in advanced medical settings, as evidenced by a blockchain-based telemonitoring system for remote patients and Dermonet, an online platform for dermatological consultation [ 147 ].

Furthermore, blockchain is revolutionizing patient care through patient-centric Electronic Health Records (EHRs). By decentralizing EHR maintenance, blockchain empowers patients with secure access to their historical and current health records [ 148 ]. Prototypes like MedRec and systems such as MeD Share exemplify how blockchain can provide complete, permanent access to clinical documents and facilitate the sharing of medical data between untrusted parties, respectively, ensuring high information authenticity and minimal privacy risks [ 149 ; 150 ]. In verifying medical staff credentials, blockchain again proves invaluable. Systems like ProCredEx, based on the R3 Corda blockchain protocol, streamline the credentialing process, offering rapid verification while allowing healthcare entities to leverage their existing data for enhanced transparency and assurance about medical staff experience [ 151 ].

The integration of blockchain with Internet of Things devices for remote monitoring marks another leap forward, significantly bolstering data security. By safeguarding the integrity and privacy of patient data collected by these devices, blockchain mitigates the risk of tampering and ensures that only authorized parties can access sensitive information [ 152 ]. Besides, a blockchain-based drug supply chain initiative, PharmaChain, utilizes AI for approaches against drug counterfeit and ensures the drug supply chain is more traceable, visible, and secure. For online pharmacies, this means a more reliable supply chain and assurance of drug authenticity, crucial for maintaining trust and safety [ 153 ].

In response to the COVID-19 pandemic, the PharmaGo platform has emerged as an innovative solution in Sri Lanka, revolutionizing the delivery of pharmacy services. As traditional pharmacies grapple with the challenges of meeting all customer needs in one location, PharmaGo addresses this by providing a comprehensive online pharmaceutical service. It allows customers to access a wide range of medications through a single platform, reducing the need to visit multiple pharmacies. Utilizing image processing technology, pharmacy owners can accurately identify prescribed medicines, while the system’s predictive analytics forecasts future drug demands, enhancing stock management. Additionally, PharmaGo’s AI-powered medical chatbot offers real-time guidance, ensuring a seamless and efficient customer experience. This platform represents a significant advancement in healthcare accessibility and pharmacy service delivery in the pandemic era [ 154 ]. In the same context, ontology-based medicine information system, enhancing search relevance through a chatbot interface was presented by Amalia et al. [ 155 ]. Addressing conventional search engines’ limitations in interpreting data relationships, it employs semantic technology to represent metadata informatively. The ontology as a knowledge base effectively delineates disease-medicine relationships, with evaluations indicating a 90% response validity from the chatbot, offering a robust reference for medical information retrieval and its semantic associations.

Future trends for the digital transformation of in the pharmaceutical sector

Future trends for the digital transformation of pharmacies globally are heavily influenced by the transformative impact of digital technologies on healthcare delivery. The integration of telemedicine, electronic health records, and mobile health applications is pivotal in enhancing patient care. These technologies are instrumental in improving data sharing and collaboration among healthcare professionals, increasing the efficiency of healthcare services. Additionally, they offer significant potential for personalized medicine through data analytics and play a crucial role in patient engagement and self-management of health. The importance of these technologies in creating a more connected and efficient healthcare system is underscored, marking a significant shift in the global healthcare landscape [ 156 ].

In the pharmaceutical sector, the COVID-19 pandemic has catalyzed a significant shift towards Pharmaceutical Digital Marketing (PDM), particularly for over-the-counter drugs. This shift focuses on utilizing online pharmacies and digital platforms for targeted advertising, directly reaching consumers. The trend towards purchasing OTC drugs online has grown, driven by the convenience and efficiency of digital channels. While PDM faces challenges like regulatory constraints and the need for digital proficiency, it offers substantial opportunities in enhancing customer engagement and precise marketing. The future of PDM is poised to be more consumer-centric, integrating advanced technologies like AI, and emphasizing personalized marketing strategies to strengthen brand engagement and customer interaction [ 157 ].

Artificial intelligence holds immense potential to revolutionize the field of pharmacy, offering numerous benefits that can significantly enhance efficiency and patient care. One of the primary applications of AI in this sector is the automation of routine tasks. By utilizing AI, pharmacies can automate critical processes such as prescription processing, checking for drug interactions, and managing inventory. This automation not only streamlines operations but also minimizes the likelihood of human error, thereby increasing the overall efficiency of pharmacies [ 158 ].

Furthermore, AI can play a pivotal role in personalized medication management. This is particularly beneficial for patients with chronic conditions such as diabetes who require careful management of their insulin dosages, as fluctuations in blood sugar levels can lead to serious complications. AI systems can monitor patients continuously, provide timely reminders for medication intake, and dynamically adjust treatment plans based on individual health data. Such personalized management ensures that patients receive optimal care tailored to their specific needs, potentially improving treatment outcomes. Incorporation of AI into electronic health records presents another significant advancement. By integrating AI with EHRs, healthcare providers can access real-time patient data. This integration empowers healthcare professionals to make more informed care decisions, enhancing the quality of patient care. Moreover, it significantly reduces the likelihood of medication errors, a critical concern in healthcare.

Likewise, AI’s capability to analyze extensive patient data is invaluable. It can identify patterns and trends in medication adherence, detect potential drug interactions, and pinpoint adverse drug reactions. These insights are crucial for healthcare professionals and researchers. By understanding these patterns, they can develop more effective medication adherence strategies and support systems, contributing to better patient outcomes and advancing the overall field of pharmaceutical care.

In the expansive realm of chemical space, the pharmaceutical industry faces the continual challenge of identifying new active pharmaceutical ingredients (APIs) for diverse diseases [ 159 ]. High throughput screening (HTS), despite its advancements in recent decades, remains resource-intensive and often yields unsuitable hits for drug development. The failure rate of investigational compounds remains high, with a study citing only a 6.2% success rate for orphan drugs progressing from phase I to market approval [ 160 , 161 ].

Machine learning presents a transformative approach to this challenge. It offers an alternative to manual HTS through in silico methodologies. ML-driven drug discovery boasts several advantages: it operates continuously, surpasses the capacity of manual methods, reduces costs by decreasing the number of physical compounds tested, and early identifies negative characteristics of compounds, such as off-target effects and sex-dependent variability [ 162 ].

A substantial advancement in the realm of machine learning has emerged from major pharmaceutical entities, notably AstraZeneca, in conjunction with research institutions. This progress is evidenced by the development of an innovative algorithm that demonstrates both time efficiency and effectiveness in the sphere of drug discovery. The recent introduction of this algorithm significantly enhances the process of determining binding affinities between investigational compounds and therapeutic targets. It surpasses traditional in silico methods in terms of performance. The application of this algorithm underscores the remarkable potential of machine learning in accelerating the identification and development of novel therapeutic agents [ 163 ].

Moreover, the proficiency of machine learning in managing vast and intricate datasets has rendered it indispensable in research focused on cancer targets, utilizing diverse and extensive datasets. This approach is fundamental in numerous drug discovery initiatives, especially those targeting various forms of cancer. A wide array of ML techniques, ranging from supervised to unsupervised learning, are employed to discern chemical attributes that are indicative of potential therapeutic efficacy against a spectrum of cancer targets. This methodology is crucial in identifying novel compounds that could be effective in cancer treatment, leveraging the rich and complex data available in oncological research [ 164 ].

The digital transformation in the pharmacy sector is significantly reshaping healthcare delivery, driven by the integration of cutting-edge technologies like Artificial Intelligence and blockchain. This transformation is marked by a substantial growth in the digital pharmacy market, with a projected annual growth rate of 14.42%, leading to a market volume of approximately $35.33 billion by 2026​​.

One major aspect of this transformation is the growing reliance on online pharmacy platforms, largely influenced by the COVID-19 pandemic. Consumer trust in online medication purchases has significantly increased, indicating a shift towards digital healthcare solutions. The adoption of telehealth services, including telepharmacy, has surged, with patient adoption in the United States increasing from 11% in 2019 to 46%. This shift towards digital-first services enhances convenience and access to care but also introduces regulatory challenges, particularly in maintaining patient safety and quality standards in the rapidly evolving online healthcare environment​​.

The cosmeceuticals market, a segment within online pharmacies, is experiencing robust growth. Cosmeceuticals, which bridge the gap between cosmetics and pharmaceuticals, have become a significant part of the skincare industry. The market, valued at USD 56.78 billion in 2022, is projected to expand to USD 95.75 billion by 2030. This expansion is driven by factors like innovation in natural ingredients and significant penetration of internet, smartphone, and social media applications. Despite the growth, the overall penetration for non-specialty drugs in mail-order and online pharmacies remains low, representing a significant portion of specialty prescription revenues. The evolving landscape of online pharmacies in the cosmeceuticals sector reflects a trend towards more accessible and customizable personal healthcare solutions​​.

Technological innovations are setting the stage for a new era in pharmaceutical care and management. AI’s role extends to areas like inventory management in retail pharmacies, where it predicts patient needs and enhances supply chain efficiency. Blockchain technology enhances supply chain transparency and legitimizes medical commodities, especially crucial in areas affected by counterfeit drugs. Blockchain also plays a vital role in patient-centric Electronic Health Records and telemonitoring systems. For instance, PharmaGo, an innovative platform developed in response to the pandemic, provides a comprehensive online pharmaceutical service, demonstrating the significant advancements in healthcare accessibility and pharmacy service delivery​​.

These technological advancements are instrumental in improving data sharing and collaboration among healthcare professionals. They offer significant potential for personalized medicine through data analytics, playing a crucial role in patient engagement and self-management of health. The future trends in the pharmaceutical sector, particularly influenced by the COVID-19 pandemic, indicate a shift towards Pharmaceutical Digital Marketing (PDM) and a more consumer-centric approach. AI’s potential in revolutionizing pharmacy includes automation of routine tasks, personalized medication management, real-time patient data access, and the identification of patterns in medication adherence and potential drug interactions​​.

Data availability

No datasets were generated or analysed during the current study.

Hole G, Hole AS, McFalone-Shaw I. Digitalization in pharmaceutical industry: what to focus on under the digital implementation process? Int J Pharmaceutics: X. 2021;3:100095.

CAS   Google Scholar  

Shambhavi. Digital Pharmacy on the rise: transforming the Pharma Sector. Brillio.com; Oct. 2022.

Champagne HA, Leclerc D. O., The road to digital success in pharma [Internet]. https://www.mckinsey.com/industries/life-sciences/our-insights/the-road-to-digital-success-in-pharma# ~:text=Mobile%20communications%2 C%20the%20cloud%2 C%20advanced,media%2 C%20retail%2 C%20and%20banking%20industries, August 1, 2015.

COVID-19 accelerated. digital transformation of the pharma industry by five years: Poll, Available from: http://www.pharmaceutical-technology.com/news/covid-19-accelerated-digital-transformation-of-the-pharma-industry-by-five-years-poll/#:~:text=Digital%20transformation%20in%20the%20pharmaceutical,powerful%20analytics%20than%20ever%20before?cf-view&acf-closed , March 9, 2021.

Raza MA, Aziz S, Noreen M, Saeed A, Anjum I, Ahmed M, Raza SM. Artificial Intelligence (AI) in pharmacy: an overview of innovations. INNOVATIONS Pharm 13 (2022).

Zhang X. Investment analysis based on intrinsic value in the Information Technology and Pharmaceutical sectors for advancements in Digital Healthcare. Finance Econ 1 (2023).

Clark M, Clark T, Bhatti A, Aungst T. The rise of digital health and potential implications for pharmacy practice. J Contemp Pharm Pract. 2017;64:32–40.

Article   Google Scholar  

Health C, Pharmacy CVS. USA, 2023.

MyChart. Epic’s MyChart software system, USA, 2023.

Medisafe MD, Companion. USA, 2023.

Moodle. Moodle open source learning management system, USA, 2023.

PLUS SG. SimMan 3G PLUS advanced emergency care patient simulators, USA, 2023.

Association AP. American Pharmacists Association, USA, 2023.

Fittler A, Ambrus T, Serefko A, Smejkalová L, Kijewska A, Szopa A, Káplár M. Attitudes and behaviors regarding online pharmacies in the aftermath of COVID-19 pandemic: at the tipping point towards the new normal. Front Pharmacol. 2022;13:1070473.

Article   PubMed   PubMed Central   Google Scholar  

Hiskey O. The era of telehealth pharmacy practice. J Am Pharmacists Association. 2022;62:10–1.

Plantado ANR, de Guzman HJd, Mariano JEC, Salvan MRAR, Benosa CAC, Robles YR. Development of an online telepharmacy service in the Philippines and analysis of its usage during the COVID-19 pandemic. J Pharm Pract. 2023;36:227–37.

Article   PubMed   Google Scholar  

Zhang PC. The future of pharmacy is intertwined with digital health innovation. Can Pharmacists Journal/Revue Des Pharmaciens Du Can. 2022;155:7–8.

Miller R, Wafula F, Onoka CA, Saligram P, Musiega A, Ogira D, Okpani I, Ejughemre U, Murthy S, Garimella S. When technology precedes regulation: the challenges and opportunities of e-pharmacy in low-income and middle-income countries. BMJ Global Health 6 (2021).

Shawaqfeh MS, Al Bekairy AM, Al-Azayzih A, Alkatheri AA, Qandil AM, Obaidat AA, Harbi SA, Muflih SM. Pharmacy students perceptions of their distance online learning experience during the COVID-19 pandemic: a cross-sectional survey study. J Med Educ Curric Dev. 2020;7:2382120520963039.

Lee CY, Lee SWH. Impact of the educational technology use in undergraduate pharmacy teaching and learning–A systematic review. Pharm Educ. 2021;21:159–68.

Strawbridge J, Hayden JC, Robson T, Flood M, Cullinan S, Lynch M, Morgan AT, O’Brien F, Reynolds R, Kerrigan SW. Educating pharmacy students through a pandemic: reflecting on our COVID-19 experience. Res Social Administrative Pharm. 2022;18:3204–9.

Lin B, Wu S. Digital transformation in personalized medicine with artificial intelligence and the internet of medical things. OMICS. 2022;26:77–81.

Article   CAS   PubMed   Google Scholar  

Company M. Trends disrupting pharmacy value pools and potential implications for the value chain, 2018.

Stoumpos AI, Kitsios F, Talias MA. Digital Transformation in Healthcare: Technology Acceptance and its applications. Int J Environ Res Public Health. 2023;20:3407.

Kraus S, Schiavone F, Pluzhnikova A, Invernizzi AC. Digital transformation in healthcare: analyzing the current state-of-research. J Bus Res. 2021;123:557–67.

Jefferies JG, Bishop S, Hibbert S. Customer boundary work to navigate institutional arrangements around service interactions: exploring the case of telehealth. J Bus Res. 2019;105:420–33.

Patrício L, Teixeira JG, Vink J. A service design approach to healthcare innovation: from decision-making to sense-making and institutional change. AMS Rev. 2019;9:115–20.

Hong KS, Lee D. Impact of operational innovations on customer loyalty in the healthcare sector. Service Bus. 2018;12:575–600.

Laurenza E, Quintano M, Schiavone F, Vrontis D. The effect of digital technologies adoption in healthcare industry: a case based analysis. Bus Process Manage J. 2018;24:1124–44.

Mazor I, Heart T, Even A. Simulating the impact of an online digital dashboard in emergency departments on patients length of stay. J Decis Syst. 2016;25:343–53.

Rubbio I, Bruccoleri M, Pietrosi A, Ragonese B. Digital health technology enhances resilient behaviour: evidence from the ward. Int J Oper Prod Manage. 2020;40:34–67.

Hikmet N, Bhattacherjee A, Menachemi N, Kayhan VO, Brooks RG. The role of organizational factors in the adoption of healthcare information technology in Florida hospitals. Health Care Manag Sci. 2008;11:1–9.

Agarwal R, Gao G, DesRoches C, Jha AK. Research commentary—the digital transformation of healthcare: current status and the road ahead. Inform Syst Res. 2010;21:796–809.

Cucciniello M, Lapsley I, Nasi G. Managing health care in the digital world: a comparative analysis. Health Serv Manage Res. 2016;29:132–42.

Eden R, Burton-Jones A, Casey V, Draheim M. Digital transformation requires workforce transformation. MIS Q Exec. 2019;18:1–17.

Google Scholar  

Huber C, Gärtner C. Digital transformations in healthcare professionals’ work: Dynamics of autonomy, control and accountability. Manage Revue. 2018;29:139–61.

Burtch G, Chan J. Investigating the relationship between medical crowdfunding and personal bankruptcy in the United States: evidence of a digital divide. MIS Quarterly (Forthcoming; 2018.

Seddon JJJM, Currie WL. Healthcare financialisation and the digital divide in the European Union: narrative and numbers. Inf Manag. 2017;54:1084–96.

Marques IC, Ferreira JJ. Digital transformation in the area of health: systematic review of 45 years of evolution. Health Technol. 2020;10:575–86.

Naik N, Hameed B, Sooriyaperakasam N, Vinayahalingam S, Patil V, Smriti K, Saxena J, Shah M, Ibrahim S, Singh A. Transforming healthcare through a digital revolution: a review of digital healthcare technologies and solutions. Front Digit Health. 2022;4:919985.

Canada. Virtual care policy framework, Canada, 2023.

Dhaliwall S. Telepharmacy services in Canada. Canada: Hospital News; 2018.

Telehealth HHSgov. Telehealth services in the United States, USA, 2023.

HRSA. Health Resources & Services Administration, USA, 2023.

UK.digital. health, Digital health and care, UK, 2023.

Australia AT, Services. Australia, 2023.

Imenokhoeva M. Telehealth in the European Union: Improving Access to Healthcare, HIMSS, EU, 2020.

Lucy d’Arville, Boulton A, Kapur V. Asia Pacific, Telehealth Adoption is expected to soar through 2024. BIAN and Company; 2022.

Intan Sabrina M, Defi IR. Telemedicine guidelines in South East Asia—a scoping review. Front Neurol. 2021;11:581649.

Wolf.Theiss. Telemedicine– the future of healthcare in Central and Eastern Europe, 2022.

Al-Samarraie H, Ghazal S, Alzahrani AI, Moody L. Telemedicine in Middle Eastern countries: Progress, barriers, and policy recommendations. Int J Med Informatics. 2020;141:104232.

Mahdi AlBasri H, Elwan P, Georgiev, Ustun A. Growth opportunities for digital health in KSA and UAE. McKinsey: McKinsey; 2022.

Ibrahim OM, Ibrahim RM, Al Meslamani AZ, Al Mazrouei N. Role of telepharmacy in pharmacist counselling to coronavirus disease 2019 patients and medication dispensing errors. J Telemed Telecare. 2023;29:18–27.

Unni EJ, Patel K, Beazer IR. Hung, Telepharmacy during COVID-19: a scoping review. Pharmacy. 2021;9:183.

Leila Shafiee Hanjani JS, Bell, Freeman CR. Undertaking medication review by telehealth. Australian J Gen Pract. 2020;49:826–31.

Bejarano AP, Santos PV, Robustillo-Cortés MdlA, Gómez ES, Rubio MDS. Implementation of a novel home delivery service during pandemic. Eur J Hosp Pharm (2020) ejhpharm–2020.

Elson EC, Oermann C, Duehlmeyer S, Bledsoe S. Use of telemedicine to provide clinical pharmacy services during the SARS-CoV-2 pandemic. Am J Health-System Pharm. 2020;77:1005–6.

Li H, Zheng S, Liu F, Liu W, Zhao R. Fighting against COVID-19: innovative strategies for clinical pharmacists. Res Social Administrative Pharm. 2021;17:1813–8.

Margusino-Framiñán L, Illarro-Uranga A, Lorenzo-Lorenzo K, Monte-Boquet E, Márquez-Saavedra E, Fernández-Bargiela N, Gómez-Gómez D, Lago-Rivero N, Poveda-Andrés JL, Díaz-Acedo R, Hurtado-Bouza JL, Sánchez-Gundín J, Casanova-Martínez C. Morillo-Verdugo, Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy Farmacia Hospitalaria. 2020;44:61–5.

PubMed   Google Scholar  

Hua X, Gu M, Zeng F, Hu H, Zhou T, Zhang Y, Shi C. Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic. J Am Pharmacists Association. 2020;60:431–e4381.

Asseri AA, Manna MM, Yasin IM, Moustafa MM, Roubie FM, El-Anssasy SM, Baqawie SK. Implementation and evaluation of telepharmacy during COVID-19 pandemic in an academic medical city in the Kingdom of Saudi Arabia: paving the way for telepharmacy. World J Adv Res Reviews. 2020;7:218–26.

Segal EM, Alwan L, Pitney C, Taketa C, Indorf A, Held L, Lee KS, Son M, Chi M, Diamantides E, Gosser R. Establishing clinical pharmacist telehealth services during the COVID-19 pandemic. Am J Health-System Pharm. 2020;77:1403–8.

Bukhari N, Rasheed H, Nayyer B, Babar Z-U-D. Pharmacists at the frontline beating the COVID-19 pandemic. J Pharm Policy Pract. 2020;13:8.

Smith RF. The private sector is taking the lead on enabling digital inclusion. Here’s how. in: W.E. Forum, editor, World Economic Forum, 2021.

Dal Mas F, Massaro M, Rippa P, Secundo G. The challenges of digital transformation in healthcare: an interdisciplinary literature review, framework, and future research agenda. Technovation. 2023;123:102716.

Ianculescu M, Alexandru A. Microservices–A Catalyzer for Better Managing Healthcare Data Empowerment. Stud Inf Control. 2020;29:231–42.

López-Martínez F, Núñez-Valdez ER, García-Díaz V, Bursac Z. A case study for a big data and machine learning platform to improve medical decision support in population health management. Algorithms. 2020;13:102.

Ganapathy K, Reddy S. Technology enabled remote healthcare in public private partnership mode: A story from India. Telemedicine, Telehealth and Telepresence: Principles, Strategies, Applications, and New Directions (2021) 197–233.

Gleiss A, Kohlhagen M, Pousttchi K. An apple a day–how the platform economy impacts value creation in the healthcare market. Electron Markets. 2021;31:849–76.

Bonacina S, Koch S, Meneses I, Chronaki C. Can the European EHR exchange format support shared decision making and citizen-driven health science? Public Health and Informatics, IOS; 2021. pp. 1056–60.

Samuel L, TRANSFORMING THE HEALTHCARE SYSTEM: THE PUBLIC-PRIVATE HEALTHCARE DICHOTOMY IN INDIA IN THE ERA OF DIGITAL HEALTH., Proceedings of the International Conference on Public Health, 2020, pp. 18–31.

Antarsih NR, Setyawati SP, Ningsih S, Sulaiman E, Pujiastuti N. Telehealth Business Potential in Indonesia, International Conference on Social, Economics, Business, and Education (ICSEBE 2021), Atlantis Press, 2022, pp. 73–78.

Loccioni LG. Italy, 2023.

Casprini E, Palumbo R. Reaping the benefits of digital transformation through Public-Private Partnership: A service ecosystem view applied to healthcare. Global Public Policy Gov. 2022;2:453–76.

APOTECAchemo. APOTECAchemo Advanced Robotic Chemotherapy Drug Compounding Systems, Italy, 2023.

Velayati F, Ayatollahi H, Hemmat M, Dehghan R. Telehealth business models and their components: systematic review. J Med Internet Res. 2022;24:e33128.

Barker GP, Krupinski EA, McNeely RA, Holcomb MJ, Lopez AM, Weinstein RS. The Arizona telemedicine program business model. J Telemed Telecare. 2005;11:397–402.

Lee Y-L, Chang P. Modeling a mobile health management business model for chronic kidney disease, Nursing Informatics 2016, IOS Press, 2016, pp. 1047–1048.

Dijkstra SJ, Jurriëns JA, van der Mei RD. A business model for telemonitoring services, 14th Annual High Technology Small Firms Conference, HTSF 2006, University of Twente, 2006.

Grustam AS, Vrijhoef HJ, Poulikidis V, Koymans R, Severens JL. Extending the business-to-business (B2B) model towards a business-to-consumer (B2C) model for telemonitoring patients with chronic heart failure. J Bus Models. 2018;6:106–29.

Lin T-C, Chang H-J, Huang C-C. An analysis of telemedicine in Taiwan: a business model perspective. Int J Gerontol. 2011;5:189–92.

Peters C, Blohm I, Leimeister JM. Anatomy of successful business models for complex services: insights from the telemedicine field. J Manage Inform Syst. 2015;32:75–104.

Lin S-H, Liu J-H, Wei J, Yin W-H, Chen H-H, Chiu W-T. A business model analysis of telecardiology service. Telemedicine e-Health. 2010;16:1067–73.

Mun SK, Tohme WG, Platenberg RC, Choi I. Teleradiology and emerging business models. J Telemed Telecare. 2005;11:271.

Kijl B, Nieuwenhuis LJ, Veld RM, Hermens HJ. and M.M. Vollenbroek-Hutten, Deployment of e-health services–a business model engineering strategy. Journal of telemedicine and telecare 16 (2010) 344–353.

Fusco F, Turchetti G, Interactive Business Models for Telerehabilitation after Total Knee Replacement.: Preliminary Results from Tuscany, Bioinformatics and Biomedical Engineering: Third International Conference, IWBBIO 2015, Granada, Spain, April 15–17, 2015. Proceedings, Part II 3, Springer, 2015, pp. 502–511.

Hidefjäll P, Titkova D. Business model design for a wearable biofeedback system, pHealth, 2015, pp. 213–224.

Oderanti FO, Li F. A holistic review and framework for sustainable business models for assisted living technologies and services. Int J Healthc Technol Manage. 2016;15:273–307.

Valbuena VS, Seelye S, Sjoding MW, Valley TS, Dickson RP, Gay SE, Claar D, Prescott HC, Iwashyna TJ. Racial bias and reproducibility in pulse oximetry among medical and surgical inpatients in general care in the Veterans Health Administration 2013-19: multicenter, retrospective cohort study. BMJ 378 (2022).

Bai G, Rajgopal S, Srivastava A, Zhao R. Profitability and risk-return comparison across health care industries, evidence from publicly traded companies 2010–2019. PLoS ONE. 2022;17:e0275245.

Article   CAS   PubMed   PubMed Central   Google Scholar  

McCall CJ, DeCaprio D, Gartner J. The Measurement and Mitigation of Algorithmic Bias and Unfairness in Healthcare AI Models Developed for the CMS AI Health Outcomes Challenge. medRxiv (2022) 2022.09. 29.22280537.

Hsueh P-YS. Ecosystem of patient-centered research and information System Design, Personal Health Informatics: patient participation in Precision Health. Springer; 2022. pp. 329–51.

Martin KI, Glaser DA. Cosmeceuticals: the new medicine of beauty. Mo Med. 2011;108:60.

PubMed   PubMed Central   Google Scholar  

Pandey A, Jatana GK, Sonthalia S, Cosmeceuticals SP. StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC., Treasure Island (FL) ineligible companies. Disclosure: Gurpoonam Jatana declares no relevant financial relationships with ineligible companies. Disclosure: Sidharth Sonthalia declares no relevant financial relationships with ineligible companies., 2023.

Morganti P, Morganti G, Gagliardini A, Lohani A. From cosmetics to innovative cosmeceuticals—Non-woven tissues as New Biodegradable Carriers. Cosmetics. 2021;8:65.

Article   CAS   Google Scholar  

Market C. Fortune Business Insights., Cosmeceuticals Market, 2023.

LLP SMR. Global Cosmeceuticals Market, A $95.75 Billion Industry Opportunity by 2030., 2022.

R.a. Markets, Global Cosmeceuticals Market - Outlook & Forecast 2023–2028, 2023.

Research SM. Industry Report and Statistics (Facts & Figures) - Number of Users, Price, Demand & Sales Analysis by Product & Distribution Channel, 2021.

Company M. Meeting changing consumer needs: The US retail pharmacy of the future, 2023.

Ascenso FNS. L’Oréal Portugal: a digital challenge for the active cosmetics division, 2016.

cosmeticaactiva. L’Oreal E-Learning Platform in Portugal, 2023.

Bach D, Newman AL. Governing lipitor and lipstick: capacity, sequencing, and power in international pharmaceutical and cosmetics regulation. Rev Int Polit Econ. 2010;17:665–95.

Organization WH. Quality assurance of pharmaceuticals. a compendium of guidelines and related materials: Good manufacturing practices and inspection, 2007.

Rai S, Gupta A, Punetha V. Regulations of Cosmetics across the Globe. Applied Clinical Research. Clin Trials Regul Affairs. 2015;2:137–44.

Natural VLAMBERT. & Organic Living; Say ‘No’ To Chemicals For A Healthy Life. in: Raconteur, editor, 2016.

Agency EM. The European regulatory system for medicines, 2023.

FDA, Food and Drug Adimenstration in the United States of America, 2023.

Cosmetics I, Market. Industry, Entrepreneurship and SMEs, EU, European Commission 2023.

EEU EEU. TECHNICAL REGULATION ON THE SAFETY OF COSMETICS AND PERFUMERY, 2015.

Danghyan L. Armenian regulatory framework of the cosmetics and pharmaceutical industries, and its compliance with international regulations. Whether the existing regulatory framework of cosmetics and pharmaceutical industries complies with international best practice and ensures product safety and consumer protection. American University of Armenia; 2020.

TGA. Australian Public Assessment Report for Bimatoprost, 2017.

Kwa M, Welty LJ, Xu S. Adverse events reported to the US Food and Drug Administration for cosmetics and personal care products. JAMA Intern Med. 2017;177:1202–4.

DeKoven JG, Warshaw EM, Belsito DV, Sasseville D, Maibach HI, Taylor JS, Marks JG, Fowler JF, Mathias CT, DeLeo VA. North American contact dermatitis group patch test results 2013–2014. Dermatitis. 2017;28:33–46.

Janetos TM, Kwa M, Xu S. Regulation of cosmetics. JAMA Intern Med. 2018;178:1000–1.

Daum C. Self-Regulation in the Cosmetic Industry: A Necessary Reality or a Cosmetic Illusion? 2006.

Schaffer S, Reading Our Lips.: The History of Lipstick Regulation in Western Seats of Power, 2006.

Lincoln JE. Overview of the us fda gmps: good manufacturing practice (gmp)/quality system (qs) regulation (21 CFR part 820). J Validation Technol. 2012;18:17.

van der Heijden I, Pletneva N, Boyer C. How to protect consumers against the risks posed by the online pharmacy market. Swiss Med Inf 29 (2013).

Agency EM. Buying medicines online, 2015.

Union E. Buying medicine online, 2023.

ISPE. Regulating Online Pharmacies & Medicinal Product E-Commerce, 2019.

Swissmedic. Guideline on medicines and the Internet, 2020.

Kulali H. Online Pharmacy in Switzerland: A Full Guide. 2023, Pharmapidya, 2023.

Swissmedic. Current law, 2019.

El Hajj MS, Mekkawi R, Elkaffash R, Saleh R, Awaisi AE, Wilbur K. Public attitudes towards community pharmacy in Arabic speaking Middle Eastern countries: a systematic review. Res Social Administrative Pharm. 2021;17:1373–95.

DelveInsight. The Regulatory process for drug approval in the MENA region, DelveInsight, 2019.

Sallom H, Abdi A, Halboup AM, Başgut B. Evaluation of pharmaceutical care services in the Middle East Countries: a review of studies of 2013–2020. BMC Public Health. 2023;23:1364.

P.B.o. Australia, Guidelines for Dispensing of Medicines., 2019.

Center KLT. Statutes of the Republic of Korea. Pharmaceutical Affairs Act; 2016.

Goryachev I. Russia Federation: Telemedicine Law in Russia, Mondaq, 2018.

Jing M. China FDA stops online med sales, 2016.

L.a.W. o.J. Ministry of Health, List of Sales Sites for over-the-counter Drugs, 2020.

H.S.A.o, Singapore. Dangers of Buying Health Products Online, 2023.

M.o.H.o. Malaysia, Buying Medicines Online: Beware., 2023.

Ganapathy N. India’s pharmacies do battle with online rivals Straitimes, India, 2017.

LegitScript LS. Industry-Leading Certification, 2023.

NABP. The Verified Internet Pharmacy Practice Sites, 2012.

Boyer C, Baujard V, Geissbuhler A. Evolution of health web certification through the HONcode experience. Stud Health Technol Inf. 2011;169:53–7.

Tagde P, Tagde S, Bhattacharya T, Tagde P, Chopra H, Akter R, Kaushik D, Rahman MH. Blockchain and artificial intelligence technology in e-Health. Environ Sci Pollut Res. 2021;28:52810–31.

Walgreen. Convenient virtual care., 2023.

Group O. Otto Group, 2023.

U.o.C.S, Francisco, New UCSF. Robotic Pharmacy Aims to Improve Patient Safety, 2011.

Narayanaswami C, Nooyi R, Govindaswamy SR, Viswanathan R. Blockchain anchored supply chain automation. IBM J Res Dev. 2019;63:7: 1–7.

Khezr S, Moniruzzaman M, Yassine A, Benlamri R. Blockchain technology in healthcare: a comprehensive review and directions for future research. Appl Sci. 2019;9:1736.

Xia Q, Sifah EB, Asamoah KO, Gao J, Du X, Guizani M. MeDShare: Trust-less medical data sharing among cloud service providers via blockchain. IEEE access 5 (2017) 14757–14767.

Mannaro K, Pinna A, Marchesi M. Crypto-trading: Blockchain-oriented energy market, 2017 AEIT International Annual Conference, IEEE, 2017, pp. 1–5.

Rallapalli S, Minalkar A. Improving Healthcare-Big Data Analytics for. J Adv Inform Technol 7 (2016).

Wang H, Song Y. Secure cloud-based EHR system using attribute-based cryptosystem and blockchain. J Med Syst. 2018;42:152.

Cyran MA. Blockchain as a foundation for sharing healthcare data. Blockchain Healthc Today (2018).

Funk E, Riddell J, Ankel F, Cabrera D. Blockchain technology: a data framework to improve validity, trust, and accountability of information exchange in health professions education. Acad Med. 2018;93:1791–4.

Khan PW, Byun Y. A blockchain-based secure image encryption scheme for the industrial internet of things. Entropy. 2020;22:175.

Gomasta SS, Dhali A, Tahlil T, Anwar MM, Ali ABMS. PharmaChain: Blockchain-based drug supply chain provenance verification system. Heliyon. 2023;9:e17957.

Gamage RG, Bandara NS, Diyamullage DD, Senadeera KU, Abeywardena KY, Amarasena N. PharmaGo-An Online Pharmaceutical Ordering Platform, 2021 3rd International Conference on Advancements in Computing (ICAC), IEEE, 2021, pp. 365–370.

Amalia A, Sipahutar PYC, Elviwani E, Purnamasari F. Chatbot Implementation with Semantic Technology for Drugs Information Searching System. Journal of Physics: Conference Series 1566 (2020) 012077.

Trenfield SJ, Awad A, McCoubrey LE, Elbadawi M, Goyanes A, Gaisford S, Basit AW. Advancing pharmacy and healthcare with virtual digital technologies. Adv Drug Deliv Rev. 2022;182:114098.

Anis MS, Hassali MA. Pharmaceutical marketing of over-the-counter drugs in the current digital era: a review. Pharm Sci Asia 49 (2022).

Khan O, Parvez M, Kumari P, Parvez S, Ahmad S. The future of pharmacy: how AI is revolutionizing the industry. Intell Pharm. 2023;1:32–40.

Moshawih S, Hadikhani P, Fatima A, Goh HP, Kifli N, Kotra V, Goh KW, Ming LC. Comparative analysis of an anthraquinone and chalcone derivatives-based virtual combinatorial library. A cheminformatics proof-of-concept study. J Mol Graph Model. 2022;117:108307.

Moshawih S, Goh HP, Kifli N, Idris AC, Yassin H, Kotra V, Goh KW, Liew KB, Ming LC. Synergy between machine learning and Natural products Cheminformatics: application to the lead Discovery of anthraquinone derivatives. Chemical Biology & Drug Design; 2022.

Wong CH, Siah KW, Lo AW. Estimation of clinical trial success rates and related parameters. Biostatistics. 2019;20:273–86.

Moshawih S, Goh HP, Kifli N, Darwesh MAE, Ardianto C, Goh KW, Ming LC. Identification and optimization of TDP1 inhibitors from anthraquinone and chalcone derivatives: consensus scoring virtual screening and molecular simulations. J Biomol Struct Dynamics (2023) 1–25.

Moore JH, Margreitter C, Janet JP, Engkvist O, de Groot BL, Gapsys V. Automated relative binding free energy calculations from SMILES to ∆∆G. Commun Chem. 2023;6:82.

Moshawih S, Lim AF, Ardianto C, Goh KW, Kifli N, Goh HP, Jarrar Q, Ming LC. Target-based small Molecule Drug Discovery for Colorectal Cancer: a review of Molecular pathways and in Silico studies. Biomolecules. 2022;12:878.

Download references

Acknowledgements

The researcher would like to thank the Deanship of Scientific Research, Qassim University for funding the publication of this project.

Deanship of Scientific Research, Qassim University

Author information

Authors and affiliations.

Department of Pharmacology, College of Medicine, Qassim University, Buraydah, Saudi Arabia

Ahmad Almeman

You can also search for this author in PubMed   Google Scholar

Contributions

Conceived the conceptual framework, Wrote the paper, Designed search strategies, Critically reviewed the manuscript for important intellectual content: A.A.

Corresponding author

Correspondence to Ahmad Almeman .

Ethics declarations

Ethical approval and consent to participate.

Not applicable.

Consent for publication

Competing interests.

The author declares no competing interest.

Additional information

Publisher’s note.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ . The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Cite this article.

Almeman, A. The digital transformation in pharmacy: embracing online platforms and the cosmeceutical paradigm shift. J Health Popul Nutr 43 , 60 (2024). https://doi.org/10.1186/s41043-024-00550-2

Download citation

Received : 14 February 2024

Accepted : 09 April 2024

Published : 08 May 2024

DOI : https://doi.org/10.1186/s41043-024-00550-2

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

• Digital transformation
• Healthcare technology
• Cosmeceuticals
• Global health
• Patient care
• 2019 novel coronavirus
• Drug safety

Journal of Health, Population and Nutrition

ISSN: 2072-1315

• Submission enquiries: [email protected]
• General enquiries: [email protected]